No results were found for the filter!
Prod.Nr. | Description | Sequence; | Price € | |
---|---|---|---|---|
EP14868_5 |
HIV gag p17 28-36 (HLA-A*24)
|
KYKLKHIVW | 57,50 | HLA-A*24 |
EP14866 |
HIV gag p24 128-135 (HLA-B*08:01)
|
VVPCEPPEV | 57,50 | HLA-A*02:01 |
LB02139 |
Aquaporin-4, human Peptide Pool
Pool of 78 peptides derived from a peptide scan (15mers with 11 aa overlap) through Aquaporin-4 protein... |
172,50 | P55087 Homo sapiens (human) T-cell stimulation | |
LB02145 |
XBB.1.5.X Omicron full length SCoV2 (Spike Glycoprotein) Peptide Pool
XBB.1.5.X Omicron peptide pool covers the whole spike glycoprotein with all mutations of the new omicron... |
805,00 | P0DTC2 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB02146 |
Coagulation factor VIII, human Peptide Pool
Pool of 585 peptides (delivered in three sub pools with 195 peptides each) derived from a peptide scan... |
877,50 | P00451 Homo sapiens (human) | |
LB02160 |
Rabies virus (Glycoprotein) Peptide Pool
Pool of 129 peptides derived from a peptide scan (15mers with 11 aa overlap) through Glycoprotein (Uni-Prot... |
207,00 | P19462 Rabies virus (strain HEP-Flury) T-cell immunity | |
LB02149 |
Alpha-crystallin B chain (human) Peptide Pool
Pool of 41 peptides derived from a peptide scan (15mers with 11 aa overlap) through Alpha-crystallin B... |
172,50 | P02511 Homo sapiens (human) | |
LB02154 |
Hepatocyte cell adhesion molecule (human) Peptide Pool
Pool of 102 peptides derived from a peptide scan (15mers with 11 aa overlap) through Hepatocyte cell... |
172,50 | Q14CZ8 Homo sapiens (human) | |
LB02144 |
Thyroid-stimulating hormone receptor, human Peptide Pool
Pool of 189 peptides derived from a peptide scan (15mers with 11 aa overlap) through Thyroid-stimulating... |
276,00 | P16473 Homo sapiens (human) | |
LB02129 |
Insulin, human Peptide Pool
Pool of 25 peptides derived from a peptide scan (15mers with 11 aa overlap) through Insulin (Uni-Prot ID... |
172,50 | P01308 Homo sapiens (human) T-cell stimulation | |
LB02128 |
Glutamate decarboxylase 2 / GAD2 / GAD65 Peptide Pool
Pool of 144 peptides derived from a peptide scan (15mers with 11 aa overlap) through Glutamate... |
218,50 | Q05329 Homo sapiens (human) T-cell stimulation | |
LB02135 |
MBP Isoform 1, human Peptide Pool
Pool of 74 peptides derived from a peptide scan (15mers with 11 aa overlap) through Myelin basic protein... |
172,50 | P02686-1 Homo sapiens (human) T-cell stimulation | |
LB02134 |
PLP1, human Peptide Pool
Pool of 67 peptides derived from a peptide scan (15mers with 11 aa overlap) through Myelin proteolipid... |
172,50 | P60201 Homo sapiens (human) T-cell stimulation | |
LB02138 |
MBP Isoform 5, human Peptide Pool
Pool of 40 peptides derived from a peptide scan (15mers with 11 aa overlap) through Isoform 5 ofMyelin... |
172,50 | P02686-5 Homo sapiens (human) T-cell stimulation | |
LB02133 |
PTP IA-2, human Peptide Pool
Pool of 242 peptides derived from a peptide scan (15mers with 11 aa overlap) through receptor-type... |
218,50 | Q16849 Homo sapiens (human) T-cell stimulation | |
LB01953 |
Eta Variant B.1.525 SCoV2 (Spike Glycoprotein) Peptide Pool
This peptide pool with 31 peptides covers all mutations in the Spike Glycoprotein derived from the eta... |
230,00 | P0DTC2 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01952 |
Zeta Variant P.2 SCoV2 (Spike Glycoprotein) Peptide Pool
This peptide pool with 12 peptides covers all mutations in the Spike Glycoprotein derived from the zeta... |
230,00 | P0DTC2 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01951 |
Epsilon Variant B.1.427/B.1.429 SCoV2 (Spike Glycoprotein) Peptide Pool
This peptide pool with 14 peptides covers all mutations in the Spike Glycoprotein derived from the epsilon... |
230,00 | P0DTC2 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB02118 |
HIV-1 B Gag Peptide Pool
Pool of 123 peptides derived from a peptide scan (15mers with 11 aa overlap) through Gag polyprotein... |
230,00 | P04591 Human immunodeficiency virus type 1 group M subtype B (isolate HXB2) (HIV-1)HIV, AIDS T-cell immunity | |
LB02113 |
M. tuberculosis esxA esaT6 Peptide Pool
Pool of 21 peptides derived from a peptide scan (15mers with 11 aa overlap) through ESAT-6 (Uni-Prot ID:... |
172,50 | P9WNK7 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)Opportunistic infections, Respiratory infection, Tuberculosis T-cell immunity | |
LB02112 |
M. tuberculosis esxB CFP-10 Peptide Pool
Pool of 23 peptides derived from a peptide scan (15mers with 11 aa overlap) through ESAT-6-like protein... |
172,50 | P9WNK5 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)Opportunistic infections, Respiratory infection, Tuberculosis T-cell immunity | |
LB01958 |
HHV5 UL44 Peptide Pool
Pool of 106 peptides derived from a peptide scan (15mers with 11 aa overlap) through DNA polymerase... |
230,00 | P04591 Human cytomegalovirus (strain AD169) (HHV-5) (Human herpesvirus 5) T-cell immunity | |
LB01852 |
MOG (human) Peptide Pool
Pool of 59 peptides derived from a peptide scan (15mers with 11 aa overlap) through Myelin-oligodendrocyte... |
172,50 | Q16653 Homo sapiens (Human) T-cell immunity | |
LB02082 |
RBD B.1.617.2 (Delta) SCoV2 (Spike Glycoprotein) Peptide Pool
Pool of 53 peptides derived from a peptide scan (Peptide scan (15mers with 11 aa overlap)) through Receptor... |
230,00 | P0DTC2 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)Covid-19, Infection, Respiratory infection T-cell immunity | |
LB02088 |
M. tuberculosis Ag85B Peptide Pool
Pool of 79 peptides derived from a peptide scan (15mers with 11 aa overlap) through Diacylglycerol... |
201,25 | P9WQP1 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)Opportunistic infections, Respiratory infection, Tuberculosis T-cell immunity | |
LB02087 |
M. tuberculosis Alpha-crystallin Peptide Pool
Pool of 34 peptides derived from a peptide scan (15mers with 11 aa overlap) through Alpha-crystallin... |
172,50 | P9WMK1 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)Opportunistic infections, Respiratory infection, Tuberculosis T-cell immunity | |
LB02000 |
Omicron full length B.1.1.529 SCoV2 (Spike Glycoprotein) Peptide Pool
This peptide pool covers the whole spike glycoprotein with all mutations of the new omicron variant of... |
805,00 | P0DTC2 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB02055 |
BA.4/BA.5 Omicron full length SCoV2 (Spike Glycoprotein) Peptide Pool
BA.4/BA.5 Omicron peptide pool covers the whole spike glycoprotein with all mutations of the new omicron... |
805,00 | P0DTC2 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB02077 |
M. tuberculosis hspX Peptide Pool
Pool of 34 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Heat shock... |
172,50 | G0TM25 Mycobacterium canettii (strain CIPT 140010059)n/a Cancer biomarker research, T-cell immunity | |
LB01972 |
Zinc transporter 8 human Peptide Pool
Pool of 90 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Zinc... |
172,50 | Q8IWU4 Homo sapiens (Human)n/a n/a | |
LB01971 |
Interleukin-22 human Peptide Pool
Pool of 42 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
172,50 | Q9GZX6 Homo sapiens (Human)n/a n/a | |
LB01966 |
Interleukin-17A human Peptide Pool
Pool of 36 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
172,50 | Q16552 Homo sapiens (Human)n/a n/a | |
LB01937 |
Mannoprotein MP65 Peptide Pool
Pool of 92 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
172,50 | Q9HEP1 Candida albicans (Yeast)n/a n/a | |
LB01936 |
Secreted protein RBT4 Peptide Pool
Pool of 87 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Secreted... |
172,50 | Q5AB48 Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)n/a n/a | |
LB01935 |
Tos1p Peptide Pool
Pool of 114 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Tos1p... |
172,50 | A0A1D8PJA8 Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)n/a n/a | |
LB01933 |
Secreted beta-glucosidase SUN41 Peptide Pool
Pool of 102 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Secreted... |
172,50 | Q59NP5 Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)n/a n/a | |
LB01932 |
Phosphoglycerate kinase Peptide Pool
Pool of 102 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
172,50 | P46273 Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)n/a n/a | |
LB01929 |
Transaldolase Peptide Pool
Pool of 78 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
172,50 | Q5A017 Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)n/a n/a | |
LB01730 |
HBV Protein P Peptide Pool
Pool of 209 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein P... |
230,00 | Q9WRL0 Hepatitis B virus (HBV)n/a n/a | |
LB02078 |
M. tuberculosis esxH (TB10.4) Peptide Pool
Pool of 22 peptides derived from a peptide scan (15mers with 11 aa overlap) through ESAT-6-like protein... |
172,50 | P9WNK3 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)Opportunistic infections, Respiratory infection, Tuberculosis T-cell immunity | |
LB02072 |
HTLV-1 basic zipper factor (HBZ_HTL1A) Peptide Pool
Pool of 50 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Human... |
172,50 | P0C746 Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) (HTLV-1)n/a n/a | |
LB01816 |
HHV1 Envelope Glycoprotein D Peptide Pool
Pool of 96 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Envelope... |
172,50 | P57083 Human herpesvirus 1 (strain Patton) (HHV-1) (Human herpes simplex virus 1)n/a n/a | |
LB01815 |
f22 Peptide Pool
Pool of 107 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Enolase... |
172,50 | Q96X30 Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) (Aspergillus fumigatus) | |
LB01814 |
crf1 Peptide Pool
Pool of 96 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Probable... |
172,50 | Q8J0P4 Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) (Aspergillus fumigatus) | |
LB01461 |
HUMAN ENO1 Peptide Pool
Pool of 106 peptides derived from a peptide scan (15mers with 11 aa overlap) through Enolase 1, (Alpha),... |
172,50 | A0A024R4F1 Homo sapiensn/a n/a | |
LB01980 |
pH-regulated antigen PRA1 Peptide Pool
Pool of 72 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
172,50 | P87020 Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)n/a n/a | |
LB01979 |
Candidapepsin-5 Peptide Pool
Pool of 102 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
172,50 | P43094 Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)n/a n/a | |
LB01934 |
Hyphally regulated cell wall protein 1 Peptide Pool
Pool of 227 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Hyphally... |
172,50 | Q5AL03 Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)n/a n/a | |
LB01931 |
Phosphoglycerate mutase Peptide Pool
Pool of 60 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
172,50 | P82612 Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)n/a n/a | |
LB01930 |
Glyceraldehyde-3-phosphate dehydrogenase Peptide Pool
Pool of 81 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
172,50 | Q5A017 Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast) n/a n/a | |
LB01928 |
Elongation factor 2 Peptide Pool
Pool of 208 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Elongation... |
218,50 | Q5A0M4 Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)n/a n/a | |
LB01956 |
Kappa Variant B.1.617.1 SCoV2 (Spike Glycoprotein) Peptide Pool
This peptide pool with 25 peptides covers all mutations in the Spike Glycoprotein derived from the kappa... |
230,00 | P0DTC2 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01813 |
Candida (MP65) Peptide Pool
Pool of 92 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
172,50 | Q9HEP1 Candida albicans (Yeast)Infection, Opportunistic oral and genital infections, AIDS, Cancer chemotherapy, Transplantation T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01698 |
HHV6 (U90) Peptide Pool
Pool of 267 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein... |
258,75 | Q77PU6 Human herpesvirus 6B (strain Z29) (HHV-6 variant B) (Human B lymphotropic virus)Infection, Exanthem subitum T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01691 |
RSVA Peptide Pool
Pool of 72 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Major... |
172,50 | P03423 Human respiratory syncytial virus A (strain A2)n/a n/a | |
LB02001 |
IFNB1 Peptide Pool
Pool of 44 peptides derived from a peptide scan (15mers with 11 aa overlap) through Human Interferon beta... |
172,50 | P01574 Homo sapiens Antigen specific T-cell stimulation, Immune monitoring, T-cell assays, T-cell expansion | |
LB02063 |
HHV8 K6 Peptide Pool
Pool of 21 peptides derived from a peptide scan (15mers with 11 aa overlap) through Human herpesvirus 8... |
172,50 | Q76RJ0 Homo sapiens Antigen specific T-cell stimulation, Immune monitoring, T-cell assays, T-cell expansion | |
LB02048 |
HPV16 E6 Peptide Pool
Pool of 37 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein E6 (Swiss-Prot... |
172,50 | P03126 Human papillomavirus type 16Cancer, Malignant genital cancers Antigen specific T-cell stimulation, Immune monitoring, T-cell assays, T-cell expansion | |
LB02047 |
HPV16 E7 Peptide Pool
Pool of 22 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein E7 (Swiss-Prot... |
172,50 | P03129 Human papillomavirus type 16Cancer, Malignant genital cancers Antigen specific T-cell stimulation, Immune monitoring, T-cell assays, T-cell expansion | |
LB02041 |
HPV18 (L2) Peptide Pool
Pool of 113 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein L2 (Swiss-Prot... |
291,00 | P06793 Human papillomavirus type 18Cancer, Malignant genital cancers Antigen specific T-cell stimulation, Immune monitoring, T-cell assays, T-cell expansion | |
LB02040 |
HPV16 (L2) Peptide Pool
Pool of 116 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein L2 (Swiss-Prot... |
291,00 | P03107 Human papillomavirus type 16Cancer, Malignant genital cancers Antigen specific T-cell stimulation, Immune monitoring, T-cell assays, T-cell expansion | |
LB02039 |
HPV18 (L1) Peptide Pool
Pool of 140 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein L1 (Swiss-Prot... |
291,00 | P06794 Human papillomavirus type 18Cancer, Malignant genital cancers Antigen specific T-cell stimulation, Immune monitoring, T-cell assays, T-cell expansion | |
LB02038 |
HPV16 (L1) Peptide Pool
Pool of 124 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein L1 (Swiss-Prot... |
291,00 | Q9WLQ6 Human papillomavirus type 16Cancer, Malignant genital cancers Antigen specific T-cell stimulation, Immune monitoring, T-cell assays, T-cell expansion | |
LB02017 |
Glutamic acid decarboxylase / GAD65 Peptide Pool
Pool of 102 peptides derived from a peptide scan (15mers with 11 aa overlap) through Glutamic acid... |
172,50 | Q9UGI5 Homo sapiens | |
LB01982 |
Op4p Peptide Pool
Pool of 99 peptides derived from a peptide scan (15mers with 11 aa overlap) through Op4p (uniprot... |
172,50 | A0A1D8PFJ9 Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast) | |
LB01981 |
pH-responsive protein 1 Peptide Pool
Pool of 135 peptides derived from a peptide scan (15mers with 11 aa overlap) through pH-responsive protein... |
172,50 | P43076 Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast) | |
LB01967 |
BKV VP1 Peptide Pool
Pool of 88 peptides derived from a peptide scan (15mers with 11 aa overlap) through Major capsid protein... |
218,50 | P14996 Homo sapiens Antigen specific T-cell stimulation, Immune monitoring, T-cell assays, T-cell expansion | |
LB01568 |
Mesothelin (290-625) Peptide Pool
Pool of 82 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein Mesothelin... |
172,50 | Q13421 Homo sapiens Antigen specific T-cell stimulation, Immune monitoring, T-cell assays, T-cell expansion | |
LB01854 |
HCMVA (IE1) Peptide Pool
Pool of 120 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through 55 kDa... |
218,50 | P13202 Human cytomegalovirus (HHV-5)Infection, Control, Cancer, TORCH, Infectious mononucleosis, CMV hepatitis, Retinitis, Colitis, Pneumonitis, Esophagitis, AIDS, Cancer chemotherapy, Transplantation T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
EP14526_5 |
p53 (Y220C)
|
VVPCEPPEV | 57,50 | HLA-A*02:01 |
LB02018 |
Delta Variant B.1.617.2 SCoV2 wt (Spike Glycoprotein) Peptide Pool
This pool consists of 27 peptides of the spike protein and represent the wildtype peptides to the mutations... |
230,00 | P0DTC2 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB02004 |
Omicron Variant B.1.1.529 SCoV2 wt (Spike Glycoprotein) Peptide Pool
This pool consists of 82 peptides of the spike protein and represent the wildtype peptides to the mutations... |
230,00 | P0DTC2 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01999 |
Omicron Variant B.1.1.529 SCoV2 (Spike Glycoprotein) Peptide Pool
This peptide pool with 80 peptides covers all mutations in the Spike Glycoprotein derived from the omicron... |
230,00 | P0DTC2 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
EP02373_5 |
Trp2 180-188
This peptide is derived from tyrosinase-related protein 2 (TRP-2) residues 180-188. TRP-2 peptide, also... |
SVYDFFVWL | 57,50 | Cancer Antigen specific T-cell stimulation, T-cell assays, T-cell expansion |
EP10199_5 |
[Phe17] - Apelin
Apelin has been found to be expressed in the spinal cord and the human brain and when performing... |
KFRRQRPRLSHKGPMPF | 115,00 | |
EP14814_5 |
SARS-CoV-2 Surface GP A2 1000-1008 (HLA-A*02:01)
RLQSLQTYV is an antigen-specific SARS-CoV-2 peptide |
RLQSLQTYV | 92,00 | SARS-CoV-2(HLA-A*02:01)Coronavirus(COVID-19) Flow Cytometry |
EP10086_5 |
[beta]-Casomorphin (1-7), bovine
# |
YPFPGPI | 57,50 | |
EP07851_5 |
Influenza A virus HA 306-318 (DRB1*01:01)
Antigen Peptide Influenza PKYVKQNTLKLAT for stimulation of antigen-specific T cells in T cell assays such... |
PKYVKQNTLKLAT | 92,00 | DRB1*01:01Influenza, Respiratory infection Antigen specific T-cell stimulation, T-cell assays, T-cell expansion |
EP14927_5 |
Human PRAME 254-262 (HLA-A24)
# |
PYLGQMINL | 57,50 | |
EP15832_5 |
HEL 11-25
# |
AMKRHGLDNYRGYSL | 115,00 | |
EP14494_5 |
HCV NS5 672-680 (B*07:02)
RPIDDRFGL is a linear peptidic epitope (epitope ID 180343 ) studied as part of Genome polyprotein from... |
RPIDDRFGL | 57,50 | HCVB*07:02 T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP10644_5 |
ACTH (1-39) (human)
ACTH (1-39), human is a synthetic peptide corresponding to the first 39 amino acids of human... |
SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF | 241,50 | HUMAN |
EP10600_5 |
ACTH (18-39) (human)
Adrenocorticotropic hormone (ACTH) (18-39) is a C-terminal peptide fragment of ACTH, a peptide hormone... |
RPVKVYPNGAEDESAEAFPLEF | 172,50 | HUMAN |
LB01957 |
Lambda Variant C.37 SCoV2 (Spike Glycoprotein) Peptide Pool
This peptide pool with 25 peptides covers all mutations in the Spike Glycoprotein derived from the lambda... |
230,00 | P0DTC2 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01955 |
Iota Variant B.1.526 SCoV2 (Spike Glycoprotein) Peptide Pool
This peptide pool with 21 peptides covers all mutations in the Spike Glycoprotein derived from the iota... |
230,00 | P0DTC2 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01947 |
Delta Variant B.1.617.2 SCoV2 (Spike Glycoprotein) Peptide Pool
This peptide pool with 27 peptides covers all mutations in the Spike Glycoprotein derived from the delta... |
230,00 | P0DTC2 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01946 |
Gamma Variant P.1 SCoV2 (Spike Glycoprotein) Peptide Pool
This peptide pool with 36 peptides covers all mutations in the Spike Glycoprotein derived from the gamma... |
230,00 | P0DTC2 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01945 |
Beta Variant B.1.351 SCoV2 (Spike Glycoprotein) Peptide Pool
This peptide pool with 34 peptides covers all mutations in the Spike Glycoprotein derived from the beta... |
230,00 | P0DTC2 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01944 |
Alpha Variant B.1.1.7 SCoV2 (Spike Glycoprotein) Peptide Pool
This peptide pool with 31 peptides covers all mutations in the Spike Glycoprotein derived from the alpha... |
230,00 | P0DTC2 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01720 |
RSV Sub Peptide Pool (>95% HPLC)
This pool consists of 28 peptides, each corresponding to a defined HLA class I-restricted T cell epitope... |
63,25 | n/a Respiratory Syncytial Virusn/an/a n/a | |
LB01713 |
CMV Sub Peptide Pool (>95% HPLC)
This pool consists of 14 peptides, each corresponding to a defined HLA class I-restricted T cell epitope... |
63,25 | n/a Human cytomegalovirusInfection, Control, Cancer, TORCH, Infectious mononucleosis, CMV hepatitis, Retinitis, Colitis, Pneumonitis, Esophagitis, AIDS, Cancer chemotherapy, Transplantation T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
EP14430_5 |
Proinsulin 90-104
This is a Proinsulin-derived peptide of GIVEQCCTSICSLYQ sequence covering 90-104 and DRB1*04:01 molecule. |
GIVEQCCTSICSLYQ | 115,00 | HUMANDRB1*04:01 |
LB01716 |
HBV Sub Peptide Pool (>95% HPLC)
This pool consists of 9 peptides, each corresponding to a defined HLA class I-restricted T cell epitope... |
63,25 | n/a Hepatitis B virusn/an/a n/a | |
EP14582_5 |
EBV LMP-2 340-349 mutant (HLA-A*11:01) 348T
SSCSSCPLTK is a linear mutated peptidic epitope (epitope ID60930) studied as part of Latent membrane... |
SSCSSCPLTK | 57,50 | EBVHLA-A*11:01Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP12225_5 |
RSV Fusion protein 540-548 (HLA-A*02:01)
# |
SLIAVGLLL | 57,50 | Human respiratory syncytial virusHLA-A*02:01 |
EP12117_1 |
HIV Env 586-593 (HLA-B*08:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
YLKDQQLL | 57,50 | HIVHLA-B*08:01AIDS (HIV) Flow Cytometry Immunohistochemistry |
EP11243_1 |
HIV env 816-825 (HLA-A*02:01)
Correlation between HLA class I and spontaneous control of HIV-1 was significant for 7-8 epitopes when 341... |
SLLNATAIAV | 57,50 | HIVHLA-A*02:01AIDS (HIV) Flow Cytometry Immunohistochemistry |
EP11238_1 |
LCMV envelope gp 10-18 (HLA-A*02:01)
ALPHIIDEV is a linear peptidic epitope (epitope ID2814) studied as part of Pre-glycoprotein polyprotein GP... |
ALPHIIDEV | 57,50 | LCMVHLA-A*02:01 Flow Cytometry |
EP11183_1 |
gp100 170-178 (HLA-A*24:02)
# |
VYFFLPDHL | 57,50 | HumanHLA-A*24:02Cancer Flow Cytometry |
EP11146_1 |
EBV EBNA-1 407-417 mutant (HLA-B*35:08) 411D
EBV EBNA1-derived peptide of HPVGDADYFEY covering 407-417 and B*35:08 molecule. HPVGDADYFEY is a linear... |
HPVGDADYFEY | 92,00 | EBVHLA-B*35:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11145_1 |
EBV EBNA-1 407-417 mutant (HLA-B*35:01) 410A
EBNA1-derived peptide of HPVAEADYFEY covering 407-417 and B*35:08 molecule. HPVAEADYFEY is a linear... |
HPVAEADYFEY | 92,00 | EBVHLA-B*35:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP09893_1 |
MBP (63–81)
# |
ARTTHYGSLPQKSQRSQ | 149,50 | Multiple Sclerosis |
EP09881_1 |
MOG 94 - 110, human
Myelin oligodendrocyte glycoprotein (MOG)94 - 110, a minor component of CNS myelin, is expressed in central... |
GFTCFFRDHSYQEEAAM | 195,50 | Human Multiple Sclerosis |
EP09869_1 |
MOG 40-55
Myelin oligodendrocyte glycoprotein (MOG) 40-55, a minor component of CNS myelin, is expressed in central... |
YRSPFSRVVHLYRNGK | 115,00 | Mouse, Rat Multiple Sclerosis |
EP09868_1 |
MOG 40-54
Myelin oligodendrocyte glycoprotein (MOG) 40-54, a minor component of CNS myelin, is expressed in central... |
YRSPFSRVVHLYRNG | 115,00 | Mouse, Rat Multiple Sclerosis |
EP09839_1 |
MBP (54-72) human
MBP (54-72) human - SHHAARTTHYGSLPQKSQR represents a short peptide sequence of the protein lipid part of... |
SHHAARTTHYGSLPQKSQR | 195,50 | HumanMultiple Sclerosis |
EP09835_1 |
MOG 97-108
Myelin oligodendrocyte glycoprotein (MOG)97 - 108, a minor component of CNS myelin, is expressed in central... |
TCFFRDHSYQEE | 115,00 | Mouse, Rat Multiple Sclerosis |
EP01741_1 |
FLAG
This epitope tag is a short hydrophilic, highly charged peptide. It is the most widely used epitope tag... |
DYKDDDDK | 92,00 | Western blotting, Immunofluorescent staining,Protein purification and immunoprecipitation with beads |
EP12210_1 |
RSV MP 229-237 (HLA-A*01:01)
# |
YLEKESIYY | 57,50 | Human immunodeficiency virus |
EP11182_1 |
gp100 17-25 (HLA-A*03:01)
# |
ALLAVGATK | 57,50 | HumanHLA-A*03:01 Flow Cytometry Immunohistochemistry |
LB01954 |
Theta Variant P.3 SCoV2 (Spike Glycoprotein) Peptide Pool
This peptide pool with 30 peptides covers all mutations in the Spike Glycoprotein derived from the theta... |
230,00 | P0DTC2 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01358 |
CEF (classic) Peptide Pool (>95% HPLC)
The CEF peptide pool is a lyophilized mixture of 23 peptides from cytomegalovirus (CMV), Epstein-Barr virus... |
74,75 | n/a Cytomegalovirus, Epstein- Barr virus and Influenza virusControl T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01359 |
CEF (advanced) Peptide Pool (>95% HPLC)
The CEF peptide pool is a lyophilized mixture of 32 peptides from cytomegalovirus (CMV), Epstein-Barr virus... |
92,00 | n/a Cytomegalovirus, Epstein- Barr virus and Influenza virusControl T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
EP11309_1 |
IGRP 228–236 (HLA-A*02:01)
LNIDLLWSV is a linear peptidic epitope (epitope ID103368) studied as part of Glucose-6-phosphatase 2 from... |
LNIDLLWSV | 57,50 | HumanHLA-A*02:01 MHC Multimer |
EP11342_1 |
MAGE-A3 168-176 (HLA-A*01:01)
EVDPIGHLY is a linear peptidic epitope (epitope ID14672) studied as part of Melanoma-associated antigen 3... |
EVDPIGHLY | 57,50 | Human HLA-A*01:01Cancer;Melanoma Flow Cytometry |
EP14042_1 |
LCMV NP 309-328
SGEGWPYIACRTSIVGRAWE is a linear peptidic epitope studied as part of Nucleoprotein from Lymphocytic... |
SGEGWPYIACRTSIVGRAWE | 195,50 | LCMVmeningitis, encephalitis ,meningoencephalitis Flow Cytometry |
EP14617_1 |
SARS-CoV-2 Surface GP_1 B7 (HLA-B*07:02)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
SPRRARSVA | 92,00 | SARS-CoV-2HLA-B*07:02Coronavirus(COVID-19) Flow Cytometry |
LB01856 |
HUMAN (Actin) Peptide Pool
Pool of 92 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Actin,... |
172,50 | P68133 Homo sapiens (Human)Control T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01855 |
EBV (GP350/GP340) Peptide Pool
Pool of 224 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Envelope... |
218,50 | P03200 Epstein-Barr virus (strain B95-8) (HHV-4) (Human herpesvirus 4)Infection, Cancer, Hodgkin's lymphoma, Burkitt's lymphoma, Nasopharyngeal carcinoma, Dermatomyositis, Systemic lupus erythematosus, Rheumatoid arthritis, Sjgren's syndrome, Multiple sclerosis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01853 |
HCMVA (IE2) Peptide Pool
Pool of 143 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through 45 kDa... |
218,50 | P19893 Human cytomegalovirus (HHV-5)Infection, Control, Cancer, TORCH, Infectious mononucleosis, CMV hepatitis, Retinitis, Colitis, Pneumonitis, Esophagitis, AIDS, Cancer chemotherapy, Transplantation T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01848 |
HCoV-OC43 Membrane protein M Peptide Pool
Pool of 55 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Membrane... |
230,00 | Q01455 Human coronavirus OC43 (HCoV-OC43)n/a n/a | |
LB01847 |
HCoV-OC43 Nucleoprotein N Peptide Pool
Pool of 110 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
230,00 | P33469 Human coronavirus OC43 (HCoV-OC43)n/a n/a | |
LB01846 |
HCoV-NL63 Membrane protein M Peptide Pool
Pool of 54 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Membrane... |
230,00 | Q6Q1R9 Human coronavirus NL63 (HCoV-NL63)n/a n/a | |
LB01845 |
HCoV-NL63 Nucleoprotein N Peptide Pool
Pool of 92 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
230,00 | Q6Q1R8 Human coronavirus NL63 (HCoV-NL63)n/a n/a | |
LB01844 |
HCoV-HKU1 (isolate N5) Membrane protein M Peptide Pool
Pool of 53 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Membrane... |
230,00 | Q0ZME4 Human coronavirus HKU1 (isolate N5) (HCoV-HKU1)n/a n/a | |
LB01843 |
HCoV-HKU1 (isolate N5) Nucleoprotein N Peptide Pool
Pool of 108 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
230,00 | Q0ZME3 Human coronavirus HKU1 (isolate N5) (HCoV-HKU1)n/a n/a | |
LB01842 |
HCoV-229E Membrane protein M Peptide Pool
Pool of 54 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Membrane... |
230,00 | P15422 Human coronavirus 229E (HCoV-229E)n/a n/a | |
LB01841 |
HCoV-229E Nucleoprotein N Peptide Pool
Pool of 95 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
230,00 | P15130 Human coronavirus 229E (HCoV-229E)n/a n/a | |
LB01819 |
VZV (IE63) Peptide Pool
Pool of 67 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
172,50 | Q77NN7 Varicella-zoster virus (strain Oka vaccine) (HHV-3) (Human herpesvirus 3)Infection, Transplantation, Chicken Pox, Herpes Zoster, Shingles, Vaccination T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01818 |
VZV (gE) Peptide Pool
Pool of 153 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Envelope... |
195,50 | P09259 Varicella-zoster virus (strain Dumas) (HHV-3) (Human herpesvirus 3)Infection, Transplantation, Chicken Pox, Herpes Zoster, Shingles, Vaccination T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response, ELISPOT, ICS, Immune monitoring, Proliferation assay, T-cell expansion | |
LB01817 |
Influenza A (H1N1) HA Peptide Pool
Pool of 139 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
230,00 | C3W5S1 Influenza A virus (strain swl A/California/04/2009 H1N1)n/a n/a | |
LB01797 |
SARS-CoV-2 (NS7a) Peptide Pool
Pool of 28 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire... |
172,50 | P0DTC7 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01795 |
SARS-CoV-2 (ORF9c) Peptide Pool
Pool of 16 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
172,50 | P0DTD3 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)COVID-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01794 |
SARS-CoV-2 (M-Protein) Peptide Pool
Pool of 53 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Membrane... |
201,25 | P0DTC5 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)COVID-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01793 |
SARS-CoV-2 (VEMP) Peptide Pool
Pool of 16 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Envelope... |
172,50 | P0DTC4 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01792 |
SARS-CoV-2 (Spike Glycoprotein) Peptide Pool
Pool of 316 overlapping peptides (delivered in two subpools of 158 & 158 peptides) derived from a peptide... |
575,00 | P0DTC2 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01791 |
SARS-CoV-2 (ORF9b) Peptide Pool
Pool of 22 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire... |
172,50 | P0DTD2 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)COVID-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01790 |
SARS-CoV-2 (ORF10) Peptide Pool
Pool of 7 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire... |
172,50 | A0A663DJA2 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01789 |
SARS-CoV-2 (NS8) Peptide Pool
Pool of 28 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire... |
172,50 | P0DTC8 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01788 |
SARS-CoV-2 (NS7b) Peptide Pool
Pool of 8 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire... |
172,50 | P0DTD8 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)COVID-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01787 |
SARS-CoV-2 (NS6) Peptide Pool
Pool of 13 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire... |
172,50 | P0DTC6 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01786 |
SARS-CoV-2 (N-Protein) Peptide Pool
Pool of 102 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
230,00 | P0DTC9 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)COVID-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune respons | |
LB01785 |
SARS-CoV-2 (ORF3a) Peptide Pool
Pool of 66 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein... |
230,00 | P0DTC3 Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)COVID-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01783 |
HCoV-229E (Spike Glycoprotein) Peptide Pool
Pool of 291 overlapping peptides (delivered in two subpools of 146 & 145 peptides) derived from a peptide... |
517,50 | P15423 Human coronavirus 229E (HCoV-229E)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01784 |
HCoV-OC43 (Spike Glycoprotein) Peptide Pool
Pool of 336 overlapping peptides (delivered in two subpools of 168 & 168 peptides) derived from a peptide... |
517,50 | P36334 Human coronavirus OC43 (HCoV-OC43)Covid-19, Infection, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01774 |
Influenza A (M1) Peptide Pool
Pool of 61 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Matrix... |
201,25 | B4UPA8 Influenza A virus (strain A/Puerto Rico/8/1934 H1N1)Influenza; Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01757 |
HUMAN IGF2BP3 Peptide Pool
Pool of 142 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through IGF2... |
276,00 | O00425 Homo sapiensDiabetes T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01756 |
HUMAN TTK Peptide Pool
Pool of 212 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Dual... |
287,50 | P33981 Homo sapiensn/a n/a | |
LB01751 |
HUMAN CEP55 Peptide Pool
Pool of 114 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
230,00 | Q53EZ4 Homo sapiensn/a n/a | |
LB01750 |
HUMAN PBK Peptide Pool
Pool of 78 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
230,00 | Q96KB5 Homo sapiensn/a n/a | |
LB01749 |
HUMAN MAGEA6 Peptide Pool
Pool of 76 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
230,00 | P43360 Homo sapiensCancer, Melanoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01731 |
MOUSE Survivin Peptide Pool
Pool of 33 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Baculoviral... |
172,50 | O70201 Mus musculus (Mouse)Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01718 |
HIV SUB Peptide Pool (95% HPLC)
The peptides of this product are supplied as trifluoracetate salts. This pool consists of 22 peptides, each... |
172,50 | n/a human | |
LB01715 |
Influenza SUB Peptide Pool (>95% HPLC)
This pool consists of 17 peptides, each corresponding to a defined HLA class I-restricted T cell epitope... |
63,25 | n/a Influenza A virusn/a n/a | |
LB01714 |
EBV SUB Peptide Pool (>95% HPLC)
This pool consists of 26 peptides, each corresponding to a defined HLA class I-restricted T cell epitope... |
172,50 | n/a humann/a n/a | |
LB01701 |
HTLV-1 (TAX) Peptide Pool
Pool of 86 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein... |
201,25 | P03409 Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) (HTLV-1)n/a n/a | |
LB01700 |
HHV8 (K8.1) Peptide Pool
Pool of 55 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
201,25 | O36551 Human herpesvirus 8 (HHV-8) (Kaposi's sarcoma-associated herpesvirus)Infection, Exanthem subitum T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01699 |
HHV8 (K8) Peptide Pool
Pool of 57 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through K8 alpha... |
201,25 | O92597 Human herpesvirus 8 (HHV-8) (Kaposi's sarcoma-associated herpesvirus)Infection, Exanthem subitum T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01697 |
HHV6 (U54) Peptide Pool
Pool of 112 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through U54... |
201,25 | Q9QJ29 Human herpesvirus 6B (strain Z29) (HHV-6 variant B) (Human B lymphotropic virusInfection, Exanthem subitum T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01696 |
EBV (LMP2A) Peptide Pool
Pool of 27 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Latent... |
172,50 | A8CDV5 Epstein-Barr virus (strain GD1) (HHV-4) (Human herpesvirus 4)Infection, Cancer, Hodgkin's lymphoma, Burkitt's lymphoma, Nasopharyngeal carcinoma, Dermatomyositis, Systemic lupus erythematosus, Rheumatoid arthritis, Sjgren's syndrome, Multiple sclerosis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01693 |
HUMAN MAGEC1 Peptide Pool
Pool of 283 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
230,00 | O60732 Homo sapiensCancer, Melanoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01692 |
HUMAN MAGEA4 Peptide Pool
Pool of 77 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
201,25 | P43358 Homo sapiensCancer, Melanoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01690 |
EBV (LMP2) Peptide Pool
Pool of 122 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Latent... |
247,25 | P13285 Epstein-Barr virus (strain B95-8) (HHV-4) (Human herpesvirus 4)Infection, Cancer, Hodgkin's lymphoma, Burkitt's lymphoma, Nasopharyngeal carcinoma, Dermatomyositis, Systemic lupus erythematosus, Rheumatoid arthritis, Sjgren's syndrome, Multiple sclerosis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01689 |
EBV (LMP1) Peptide Pool
Pool of 94 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Latent... |
241,50 | P03230 Epstein-Barr virus (strain B95-8) (HHV-4) (Human herpesvirus 4)Infection, Cancer, Hodgkin's lymphoma, Burkitt's lymphoma, Nasopharyngeal carcinoma, Dermatomyositis, Systemic lupus erythematosus, Rheumatoid arthritis, Sjgren's syndrome, Multiple sclerosis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01688 |
EBV (EBNA-3b) Peptide Pool
Pool of 234 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
218,50 | Q1HVG4 Epstein-Barr virus (strain AG876) (HHV-4) (Human herpesvirus 4)Infection, Cancer, Hodgkin's lymphoma, Burkitt's lymphoma, Nasopharyngeal carcinoma, Dermatomyositis, Systemic lupus erythematosus, Rheumatoid arthritis, Sjgren's syndrome, Multiple sclerosis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01687 |
HPV (BK-Virus LT) Peptide Pool
Pool of 171 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Large T... |
276,00 | P03071 BK polyomavirus (BKPyV) (Human polyomavirus 1)Infection, AIDS, Cancer chemotherapy, Transplantation, Merkel cell carcinoma, PML and BK nephropathy T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01686 |
HUMAN PRAME/OIP4 Peptide Pool
Pool of 125 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Melanoma... |
207,00 | P78395 Homo sapiensCancer, Melanoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01676 |
HUMAN TSGA10 Peptide Pool
Control Pool of 172 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
276,00 | Q9BZW7 Homo sapiensn/a n/a | |
LB01675 |
HUMAN GKAP1 Peptide Pool
Pool of 89 peptides derived from a peptide scan (15mers with 11 aa overlap) through G kinase-anchoring... |
172,50 | Q5VSY0 Homo sapiensn/a n/a | |
LB01674 |
EBV EBNA-1 Peptide Pool
Pool of 158 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
218,50 | P03211 Epstein-Barr virus (strain B95-8) (HHV-4) (Human herpesvirus 4)Infection, Cancer, Hodgkin's lymphoma, Burkitt's lymphoma, Nasopharyngeal carcinoma, Dermatomyositis, Systemic lupus erythematosus, Rheumatoid arthritis, Sjgren's syndrome, Multiple sclerosis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01673 |
HUMAN CT83 Peptide Pool (KKLC1)
Pool of 26 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Kita-kyushu... |
172,50 | Q5H943 Homo sapiensCancer, Malignant genital cancers T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01672 |
HUMAN CT45A1 Peptide Pool
Pool of 45 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
149,50 | Q5HYN5 Homo sapiensInfection, Control, Cancer, TORCH, Infectious mononucleosis, CMV hepatitis, Retinitis, Colitis, Pneumonitis, Esophagitis, AIDS, Cancer chemotherapy, Transplantation T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01670 |
HUMAN LAGE1 (CTAG2) Peptide Pool
Pool of 50 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
172,50 | O75638 Homo sapiensn/a n/a | |
LB01669 |
HUMAN XAGE-1 Peptide Pool
Pool of 18 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through X antigen... |
115,00 | Q9HD64 Homo sapiensn/a n/a | |
LB01668 |
HUMAN MAGED1 Peptide Pool
Pool of 192 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
230,00 | Q9Y5V3 Homo sapiensCancer, Melanoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01667 |
EBV (BZLF1) Peptide Pool
Pool of 59 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
201,25 | P03206 Epstein-Barr virus (strain B95-8) (HHV-4) (Human herpesvirus 4)Infection, Cancer, Hodgkin's lymphoma, Burkitt's lymphoma, Nasopharyngeal carcinoma, Dermatomyositis, Systemic lupus erythematosus, Rheumatoid arthritis, Sjgren's syndrome, Multiple sclerosis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01666 |
JC polyomavirus (Large T antigen) Peptide Pool
Pool of 170 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Large T... |
253,00 | P03072 JC polyomavirus (JCPyV) (JCV)n/a n/a | |
LB01654 |
HUMAN AFP Peptide Pool
Pool of 150 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
276,00 | P02771 Homo sapiensCancer, Liver T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01561 |
JC polyomavirus (VP1) Peptide Pool
Pool of 86 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Major... |
201,25 | P03089 JC polyomavirus (JCPyV) (JCV)n/a n/a | |
LB01471 |
HUMAN WT1 Peptide Pool
Pool of 110 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Wilms... |
207,00 | P19544 Homo sapiensCancer, Wilms tumor 1 T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01445 |
Meso GPI (271-630) Sub Peptide Pool
Pool of 88 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Mesothelin... |
172,50 | n/a Homo sapiens | |
LB01404 |
HUMAN Melan-A/MART-1 Peptide Pool
Pool of 27 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Melanoma... |
172,50 | Q16655 Homo sapiensCancer, Melanoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01403 |
HUMAN MAGEA3 Peptide Pool
Pool of 76 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
201,25 | P43357 Homo sapiensCancer, Melanoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01402 |
HUMAN MAGEA1 Peptide Pool
Pool of 75 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
201,25 | P43355 Homo sapiensCancer, Melanoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01362 |
HUMAN NY-ESO-1 Peptide Pool
Pool of 43 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
172,50 | P78358 Homo sapiensCancer, Testis/ovary cance T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01361 |
EBV (EBNA-3a) Peptide Pool
Pool of 234 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
218,50 | P12977 Epstein-Barr virus (strain B95-8) (HHV-4) (Human herpesvirus 4)Infection, Cancer, Hodgkin's lymphoma, Burkitt's lymphoma, Nasopharyngeal carcinoma, Dermatomyositis, Systemic lupus erythematosus, Rheumatoid arthritis, Sjgren's syndrome, Multiple sclerosis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01352 |
HUMAN Tyrosinase-related protein2 Peptide Pool
Pool of 127 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
207,00 | P40126 Homo sapiensCancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01351 |
HUMAN Tyrosinase Peptide Pool
Pool of 130 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Tyrosinase... |
207,00 | P14679 Homo sapiensn/a n/a | |
LB01350 |
HUMAN gp100 Peptide Pool
Pool of 163 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Melanocyte... |
218,50 | P40967 Homo sapiensCancer, Epithelium T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01349 |
HUMAN Survivin Peptide Pool
Pool of 33 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Baculoviral... |
172,50 | O15392 Homo sapiensCancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01348 |
HUMAN (SOX2) Peptide Pool
Pool of 77 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through... |
201,25 | P48431 Homo sapiensCancer, Microphthalmia syndromic type 3 T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
LB01232 |
HCMVA (pp65) Peptide Pool
Control Pool of 138 peptides derived from a peptide scan (15mers with 11 aa overlap) through 65 kDa... |
178,25 | P06725 Human cytomegalovirus (strain AD169) (HHV-5) (Human herpesvirus 5Infection, Control, Cancer, TORCH, Infectious mononucleosis, CMV hepatitis, Retinitis, Colitis, Pneumonitis, Esophagitis, AIDS, Cancer chemotherapy, Transplantation T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
EP12190_1 |
BCR-ABL 926-934 (HLA-A*02:01)
# |
SSKALQRPV | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry |
EP11430_1 |
hTRT 615-624 (HLA-A*02:01)
# |
ALLTSRLRFI | 57,50 | HumanHLA-A*02:01Cancerother name: Telomerase reverse transcriptase (hTRT) 461-469 Flow Cytometry |
EP11407_1 |
PSMA/PSM-P1 4-12 (HLA-A*02:01)
# |
LLHETDSAV | 57,50 | HumanHLA-A*02:01 Flow Cytometry |
EP11405_1 |
PSMA 85-93 (HLA-A*02:01)
# |
SLFEPPPPG | 57,50 | HumanHLA-A*02:01 Flow Cytometry |
EP11404_1 |
PSMA 663-671 (HLA-A*02:01)
# |
MMNDQLMFL | 57,50 | HumanHLA-A*02:01 Flow Cytometry |
EP11388_1 |
PAP-3 135-143 (HLA-A*02:01)
# |
ILLWQPIPV | 57,50 | HumanHLA-A*02:01Humane Papillomviren (HPV) Flow Cytometry |
EP11361_1 |
mTERT 572-580 (HLA-A*02:01)
# |
YLFFYRKSV | 57,50 | mouseHLA-A*02:01Cancerother name: Tumor Mucin Antigen 13-21 Flow Cytometry |
EP11359_1 |
Mesothelin 20-28 (HLA-A*02:01)
# |
SLLFLLFSL | 57,50 | HumanHLA-A*02:01 Flow Cytometry Immunohistochemistry |
EP11112_1 |
CEA 605-613 mutant (HLA-A*02:01) 610D
# |
YLSGADLNL | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry |
EP11087_1 |
BCR-ABL (HLA-A*02:01)
# |
GVRGRVEEI | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry |
EP07917_1 |
LCMV gp 276-286 (H-2 Db)
LCMV gp(276-286) peptide SGVENPGGYCL (H-2 Db) is a single peptide for stimulation of T cells. The peptide... |
SGVENPGGYCL | 57,50 | LCMVH-2 Dbmeningitis, encephalitis ,meningoencephalitis Flow Cytometry |
EP07895_1 |
HIV p24-Gag 30-40 (HLA-B*57:01)
HIV p24-Gag peptide KAFSPEVIPMF (HLA-B*5701) is a single peptide for stimulation of T cells. The peptide... |
KAFSPEVIPMF | 57,50 | HIVHLA-B*57:01AIDS (HIV) Flow Cytometry |
EP07878_1 |
CEA 605-613 (HLA-A*02:01)
CAP1 peptide YLSGANLNL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from... |
YLSGANLNL | 57,50 | HumanHLA-A*02:01Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07874_1 |
HIV gag 197-205 (H-2 Kd)
Antigen Peptide Gag Pol polyprotein H-2 Kd (AMQMLKETI) for stimulation of antigen-specific T cells in T... |
AMQMLKETI | 57,50 | HIVH-2 KdAIDS (HIV) Flow Cytometry |
EP07864_1 |
LCMV GP 33-41 (H-2 Db)
LCMV gp33 peptide KAVYNFATM (H-2 Db) is a single peptide for stimulation of T cells. The peptide from... |
KAVYNFATM | 57,50 | LCMVH-2 Dbmeningitis, encephalitis ,meningoencephalitis Flow Cytometry |
EP07863_1 |
LLO 91-99 (H-2 Kd)
Antigen Peptide Listeriolysin O H-2 Kd (GYKDGNEYI) for stimulation of antigen-specific T cells in T cell... |
GYKDGNEYI | 57,50 | Listeria monocytogenesH-2 KdListeriosis Flow Cytometry |
EP07742_1 |
Influenza A NP 366-374 (H-2 Db)
Influenza peptide ASNENMETM (H-2 Db) is a single peptide for stimulation of T cells. The peptide from... |
ASNENMETM | 57,50 | Influenza VirusH-2 DbInfection, Influenza, Swine Flu, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07865_1 |
HA-1 137-145 His139 (HLA-A*02:01)
Antigen Peptide HA-1 137-145 His139 (HLA-A*02:01) VLHDDLLEA for stimulation of antigen-specific T cells in... |
VLHDDLLEA | 57,50 | HumanHLA-A*02:01GAD2; glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa); GAD65; glutamate decarboxylase 2; GAD-65; 65 kDa glutamic acid decarboxylase; Glutamate decarboxylase-2 (pancreas); glutamate decarboxylase 65 kDa isoform Flow Cytometry |
EP07913_1 |
Survivin 5-14 (HLA-A*02:01)
Single peptide (TLPPAWQPFL) for stimulation of human Survivin (5-14)-specific CD8+ T-cells. The peptide is... |
TLPPAWQPFL | 57,50 | HumanHLA-A*02:01Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07894_1 |
HIV p24-Gag 263-272 (HLA-B*27:05)
KRWIILGLNK is a linear peptidic epitope (epitope ID33250) studied as part of Gag-Pol polyprotein from Human... |
KRWIILGLNK | 57,50 | HIVHLA-B*27:05AIDS (HIV) Flow Cytometry |
EP07866_1 |
WT1 126-134 (HLA-A*02:01)
RMFPNAPYL is a linear peptidic epitope (epitope ID54882) studied as part of Wilms tumor protein from Homo... |
RMFPNAPYL | 57,50 | HumanHLA-A*02:01Cancer;Wilms tumor 1 T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07888_1 |
CD20 188-196 (HLA-A*02:01)
SLFLGILSV is a linear peptidic epitope (epitope ID140742) studied as part of B-lymphocyte antigen CD20 from... |
SLFLGILSV | 57,50 | HumanHLA-A*02:01Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP06994_1 |
Pr1 169-177 (HLA-A*02:01)
Antigen Peptide Myeloblastin precursor HLA-A*0201 (VLQELNVTV) for stimulation of human Proteinase... |
VLQELNVTV | 57,50 | HLA-A*02:01 |
EP07862_5 |
NY-ESO-1 157-165 (HLA-A*02:01)
NY-ESO-1 157-165 (HLA-A*02:01) peptide SLLMWITQV for stimulation of T-cells. Single peptide SLLMWITQV for... |
SLLMWITQV | 57,50 | HumamHLA-A*02:01 Flow Cytometry |
EP11470_1 |
WT1 235–243 mutant (HLA-A*24:02) 236Y
Wilms tumor protein is a protein that is encoded by the WT1 gene on chromosome 11p in humans. WT1 is a... |
CYTWNQMNL | 57,50 | HumanHLA-A*24:02 |
EP11465_1 |
WT1 317–327 (HLA-A*01:01)
Wilms tumor protein is a protein that is encoded by the WT1 gene on chromosome 11p in humans. WT1 is a... |
TSEKRPFMCAY | 57,50 | HumanHLA-A*01:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1Delivery Time: 10-12 daysAIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1Delivery Time: 10-12 daysAIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1Delivery Time: 10-12 daysAIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1Delivery Time: 10-12 daysAIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1Delivery Time: 10-12 days Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11325_1 |
Insulin B 10-18 (HLA-A*02:01)
HLVEALYLV is a linear peptidic epitope (epitope ID100920) studied as part of Insulin (UniProt:P01308) from... |
HLVEALYLV | 57,50 | HumanHLA-A*02:01Diabetes Flow Cytometry |
EP04609_1 |
OVA-Peptid (323-339) (H-2Kb)
This is a class I (Kb)-restricted peptide epitope of OVA, an octameric peptide from ovalbumin presented by... |
ISQAVHAAHAEINEAGR | 92,00 | H-2 Kb Flow Cytometry |
EP04509_1 |
HCMV pp65 495-503 (HLA-A*02:01)
NLVPMVATV is a linear peptidic epitope (epitope ID44920) studied as part of 65 kDa phosphoprotein from... |
NLVPMVATV | 57,50 | HCMVHLA-A*02:01Infection, Control, Cancer, TORCH, Infectious mononucleosis, CMV hepatitis, Retinitis, Colitis, Pneumonitis, Esophagitis, AIDS, Cancer chemotherapy, Transplantation T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP02030_5 |
MOG 35-55
Myelin oligodendrocyte glycoprotein (MOG) 35-55, a minor component of CNS myelin, is expressed in central... |
MEVGWYRSPFSRVVHLYRNGK | 115,00 | Mouse, Rat Multiple Sclerosis |
EP11150_1 |
EBV EBNA 3B 399-408 (HLA-A*11:01)
Antigen Peptide EBV EBNA3B 399-408 (HLA-A*11:01) AVFDRKSDAK for stimulation of antigen-specific T cells in... |
AVFDRKSDAK | 57,50 | EBVHLA-A*11:01 Flow Cytometry Immunohistochemistry |
EP09838_1 |
MBP (1-11) human
MBP (1-11) human - ASQKRPSQRHG represents a short peptide sequence of the protein lipid part of the myelin... |
ASQKRPSQRHG | 57,50 | HumanMultiple Sclerosis |
EP14997_5 |
LLO 216–227 (H2-Kd)
# |
QLIAKFGTAFKA | 92,00 | Listeria monocytogenesH-2 Kdcancer T-cell assays |
EP14996_1 |
LLO 189-200 (H2-Kd )
# |
WNEKYAQAYPNV | 92,00 | Listeria monocytogenesH-2 Kdcancer T-cell assays |
EP14995_1 |
p60 449–457 (H-2Kd)
# |
IYVGNGQMI | 57,50 | mouseH-2 Kdcancer T cell assays, MHC ligand assays |
EP14994_1 |
p60 476 - 484 (H-2Kd)
# |
KYLVGFGRV | 57,50 | mouseH-2 Kdcancer T cell assays, MHC ligand assays |
EP14993_1 |
P60 217-225 (H-2Kd)
# |
KYGVSVQDI | 57,50 | mouseH-2 Kdcancerother name: Prostatic Acid Phosphatase-3 135-143 T cell assays, MHC ligand assays |
EP14932_1 |
PRAME 242-251 (HLA-A*3)
# |
CTWKLPTLAK | 57,50 | HumanHLA-A*3 |
EP14921_1 |
EBV LMP-2 340-349 mutant (HLA-A*11:01) 348T
# |
SSCSSCPLTK | 57,50 | EBVHLA-A*11:01Epsteinï¾–Barr virus (EBV) |
EP14865_1 |
HIV p24 gag 176-184 mutant (HLA-B*53:01) 183G
# |
QATQEVKGW | 57,50 | AIDS (HIV)HLA-B*53:01AIDS (HIV) |
EP14616_1 |
SARS-CoV-2 Nucleocapsid_3 B7 (HLA-B*07:02)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
KPRQKRTAT | 92,00 | SARS-CoV-2HLA-B*07:02Coronavirus(COVID-19) Flow Cytometry |
EP14615_1 |
SARS-CoV-2 Nucleocapsid_2 B7 (HLA-B*07:02)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
SPRWYFYYL | 92,00 | SARS-CoV-2HLA-B*07:02Coronavirus(COVID-19) Flow Cytometry |
EP14614_1 |
SARS-CoV-2 Nucleocapsid_1 B7 (HLA-B*07:02)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
FPRGQGVPI | 92,00 | SARS-CoV-2HLA-B*07:02Coronavirus(COVID-19) Flow Cytometry |
EP14613_1 |
SARS-CoV-2 Surface GP_3 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
TLDSKTQSL | 92,00 | SARS-CoV-2HLA-A*02:01Coronavirus(COVID-19) Flow Cytometry |
EP14612_1 |
SARS-CoV-2 ORF6 prot_1 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
HLVDFQVTI | 92,00 | SARS-CoV-2HLA-A*02:01Coronavirus(COVID-19) Flow Cytometry |
EP14611_1 |
SARS-CoV-2 ORF3a prot_2 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
ALSKGVHFV | 92,00 | SARS-CoV-2HLA-A*02:01Coronavirus(COVID-19) Flow Cytometry |
EP14610_1 |
SARS-CoV-2 ORF3a prot_1 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
LLYDANYFL | 92,00 | SARS-CoV-2HLA-A*02:01Coronavirus(COVID-19) Flow Cytometry |
EP14609_1 |
SARS-CoV-2 Membrane GP_2 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
SLVKPSFYV | 92,00 | SARS-CoV-2HLA-A*02:01Coronavirus(COVID-19) Flow Cytometry |
EP14608_1 |
SARS-CoV-2 Membrane GP_1 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
KLLEQWNLV | 92,00 | SARS-CoV-2HLA-A*02:01Coronavirus(COVID-19) Flow Cytometry |
EP14605_1 |
SARS-CoV-2 Surface GP_1 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
YLQPRTFLL | 92,00 | SARS-CoV-2HLA-A*02:01Coronavirus(COVID-19) Flow Cytometry |
EP14604_1 |
SARS-CoV Nucleocapsid A2 316-324 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
GMSRIGMEV | 92,00 | SARS-CoV-2HLA-A*02:01Coronavirus(COVID-19) Flow Cytometry |
EP14603_1 |
SARS-CoV Nucleocapsid A2 316-324 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
RLNQLESKM | 92,00 | SARS-CoV-2HLA-A*02:01Coronavirus(COVID-19) Flow Cytometry |
EP14602_1 |
SARS-CoV-2 Nucleocapsid A2 N223-231 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
LLLDRLNQL | 92,00 | SARS-CoV-2HLA-A*02:01Coronavirus(COVID-19) Flow Cytometry |
EP14601_1 |
SARS-CoV Nucleocapsid A2 226-234 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
LALLLLDRL | 92,00 | SARS-CoV-2HLA-A*02:01Coronavirus(COVID-19) Flow Cytometry |
EP14600_1 |
SARS-CoV Nucleocapsid A2 219-227 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
LQLPQGTTL | 92,00 | SARS-CoV-2HLA-A*02:01Coronavirus(COVID-19) Flow Cytometry |
EP14599_1 |
SARS-CoV Nucleocapsid A2 138-146 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
ALNTPKDHI | 92,00 | SARS-CoV-2HLA-A*02:01Coronavirus(COVID-19) Flow Cytometry |
EP14598_1 |
SARS-CoV-2 Membrane GP A2 89-97 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
GLMWLSYFI | 92,00 | SARS-CoV-2HLA-A*02:01Coronavirus(COVID-19) Flow Cytometry |
EP14597_5 |
SARS-CoV-2 Membrane GP A2 61-70 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
TLACFVLAAV | 92,00 | SARS-CoV-2HLA-A*02:01Coronavirus(COVID-19) Flow Cytometry |
EP14596_1 |
SARS-CoV-2 Surface GP A2 1220–1228 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
FIAGLIAIV | 92,00 | SARS-CoV-2HLA-A*02:01Coronavirus(COVID-19) Flow Cytometry |
EP14595_1 |
SARS-CoV-2 Surface GP A2 1192–1200 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
NLNESLIDL | 92,00 | SARS-CoV-2HLA-A*02:01Coronavirus(COVID-19) Flow Cytometry |
EP14594_1 |
SARS-CoV-2 Surface GP A2 978–986 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
LITGRLQSL | 92,00 | SARS-CoV-2HLA-A*02:01Coronavirus(COVID-19) Flow Cytometry |
EP14593_1 |
SARS-CoV-2 Surface GP_2 A2 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
VLNDILSRL | 92,00 | SARS-CoV-2HLA-A*02:01Coronavirus(COVID-19) Flow Cytometry |
EP14592_1 |
SARS-CoV-2 Surface GP A2 958–966 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
ALNTLVKQL | 92,00 | SARS-CoV-2HLA-A*02:01Coronavirus(COVID-19) Flow Cytometry |
EP14591_1 |
SARS-CoV-2 Surface GP A2 691–699 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
SIIAYTMSL | 92,00 | SARS-CoV-2HLA-A*02:01Coronavirus(COVID-19) Flow Cytometry |
EP14590_1 |
SARS-CoV-2 Surface GP A2 424–433 (HLA-A*02:01)
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory... |
KLPDDFTGCV | 92,00 | SARS-CoV-2HLA-A*02:01Coronavirus(COVID-19) Flow Cytometry |
EP14587_1 |
SARS-CoV SSp-1 A2 (HLA-A*02:01)
The sequence is related to the HLA-A*0201-restricted coronavirus SARS-CoV spike protein peptide SSp-1. It... |
RLNEVAKNL | 92,00 | SARS-CoV-2HLA-A*02:01Coronavirus(COVID-19) Flow Cytometry |
EP14505_1 |
DEAD box RNA helicase 355–363 (HLA-C*05:01)
# |
ITASRFKEL | 57,50 | HLA-Cw*05:01 |
EP14504_1 |
Rev 67-75 mutant (HLA-C*05:01) 75L
# |
SAEPVPLQL | 57,50 | HLA-C*05:01 |
EP14433_1 |
GAD65 113-132 (DRB1*04:01)
# |
DVMNILLQYVVKSFDRSTKV | 195,50 | HumanDRB1*04:01 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP14432_1 |
GAD65 274-286 (DRB1*04:01)
# |
IAFTSEHSHFSLK | 149,50 | HumanDRB1*04:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP14431_1 |
GAD65 555-567 (DRB1*04:01)
# |
NFIRMVISNPAAT | 149,50 | HumanDRB1*04:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 2 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP14428_1 |
fn20 env 122-141
# |
DEPLTSLTPRCNTAWNRLKL | 195,50 | Mouse |
EP14368_1 |
SNTB2 351-360
VTEKDLLLY is a linear peptidic epitope studied as part of Beta-2-syntrophin from Homo sapiens (human). This... |
VTEKDLLLY | 57,50 | Human |
EP14315_1 |
HPV E6 31-38
HDIILECV is a linear peptidic epitope studied as part of Protein E6 from Alphapapillomavirus 9, tested in T... |
HDIILECV | 57,50 | HPV Flow Cytometry |
EP14314_1 |
HPV E7 88-97 (HLA-A*11)
GIVCPICSQK is a linear peptidic epitope studied as part of Protein E7 from Alphapapillomavirus 9. This... |
GIVCPICSQK | 57,50 | HPVHLA-A*11 |
EP14313_5 |
HPV E6 133–142
HNIRGRWTGR is a linear peptidic epitope studied as part of Protein E6 from Alphapapillomavirus 9, tested in... |
HNIRGRWTGR | 57,50 | HPV Flow Cytometry |
EP14274_1 |
IE62 593-601 (HLA-A*02:01)
ALWALPHAA is a linear peptidic epitope studied as part of Major viral transcription factor ICP4 homolog... |
ALWALPHAA | 57,50 | VZVHLA-A*02:01 Flow Cytometry |
EP14045_1 |
LCMV GP 118-125
ISHNFCNL is a linear peptidic epitope studied as part of Pre-glycoprotein polyprotein GP complex from... |
ISHNFCNL | 57,50 | LCMVmeningitis, encephalitis ,meningoencephalitis Flow Cytometry |
EP14044_1 |
LCMV NP 205-212
YTVKYPNL is a linear peptidic epitope studied as part of Nucleoprotein from Lymphocytic choriomeningitis... |
YTVKYPNL | 57,50 | LCMVmeningitis, encephalitis ,meningoencephalitis Flow Cytometry |
EP14043_1 |
LCMV NP 201-215
LGLLYTVKYPNLNDL is a linear peptidic epitope studied as part of Nucleoprotein from Lymphocytic... |
LGLLYTVKYPNLNDL | 115,00 | LCMVmeningitis, encephalitis ,meningoencephalitis Flow Cytometry |
EP14041_1 |
TRP1 113-126 Mouse Tyrp2/gp75
CRPGWRGAACNQKI is a linear peptide tested in T cell assays and MHC ligand assay. |
CRPGWRGAACNQKI | 115,00 | mouse |
EP14015_1 |
EBV EBNA-1 72-80 (HLA-B*35:01)
RPQKRPSCI is a linear peptidic epitope studied as part of Epstein-Barr nuclear antigen 1 from Human... |
RPQKRPSCI | 57,50 | HLA-B*35:01 |
EP14013_1 |
HCV NS3 1267-1275
LGFGAYMSK is a linear peptidic epitope studied as part of Genome polyprotein from Hepatitis C virus. This... |
LGFGAYMSK | 57,50 | HCVHepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP14012_1 |
HDV 46-54
DENPWLGNI is a linear peptidic epitope studied as part of Large delta antigen from Hepatitis delta virus,... |
DENPWLGNI | 57,50 | |
EP13089_1 |
CPIM 399–406 (H-2 Kb)
# |
HILIYSDV | 57,50 | HumanH-2 KbAIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP13052_1 |
SUMO2 57-66
# |
IRFRFDGQPI | 57,50 | |
EP13051_1 |
SUMO1 57-67
# |
VPMNSLRFLFE | 57,50 | |
EP13050_1 |
HNRNPA1 339-348 (HLA C*07:02)
GPYGGGGQYF is a linear peptidic epitope studied as part of Heterogeneous nuclear ribonucleoprotein A1-like... |
GPYGGGGQYF | 57,50 | HumanHLA-C*07:02Cancer |
EP13049_1 |
CKS2 11-19 (HLA-C0702)
KYFDEHYEY is a linear peptidic epitope studied as part of Cyclin-dependent kinases regulatory subunit 2... |
KYFDEHYEY | 57,50 | HumanHLA-C*07:02 |
EP12951_1 |
STREP-tag II
NWSHPQFEK is a selected nine-amino acid peptide that displays intrinsic binding affinity towards... |
NWSHPQFEK | 57,50 | Survivin; baculoviral inhibitor of apoptosis repeat-containing 5; BIRC5 |
EP12950_1 |
STREP-tag I
AWRHPQFGG is a selected nine-amino acid peptide that displays intrinsic binding affinity towards... |
AWRHPQFGG | 57,50 | |
EP12930_1 |
NRP-A7 (H-2Kd)
KYNKANAFL is a linear peptidic epitope. This epitope has been studied for immune reactivity in, tested in T... |
KYNKANAFL | 57,50 | H-2 Kd |
EP12929_1 |
NRP-V7 (H-2Kd)
NRP-V7 is a H-2Kd-restricted epitope that is recognized by T-cell receptors expressed by CD8 cells. |
KYNKANVFL | 57,50 | H-2 Kd Flow Cytometry |
EP12631_1 |
WT1 126-134 mutant (HLA-A*02:01) 126Y
Wilms tumor protein is a protein that is encoded by the WT1 gene on chromosome 11p in humans. WT1 is a... |
YMFPNAPYL | 57,50 | HumanHLA-A*02:01 |
EP12479_1 |
Human adenovirus 5 542-550 (HLA-A*02:02)
# |
GLRYRSMLL | 57,50 | HLA-A*02:02other name: Telomerase Reverse Transcriptase (hTRT) 865-873 |
EP12465_1 |
HDV 194-202
FPWDILFPA is a linear peptidic epitope studied as part of Large delta antigen from Hepatitis delta virus,... |
FPWDILFPA | 57,50 | |
EP12464_1 |
HDV 192-200
QGFPWDILF is a linear peptidic epitope studied as part of Large delta antigen from Hepatitis delta virus,... |
QGFPWDILF | 57,50 | |
EP12429_1 |
NS3 73-81 (HLA-B*15:01)
# |
SVKEDLVAY | 57,50 | HLA-B*15:01Hepatitis-C-Virusother name: West Nile virus NY-99 polyprotein precursor |
EP12428_1 |
NS5 465-479
# |
EFGKAKGSRAIWYMW | 115,00 | Hepatitis-C-Virus |
EP12427_1 |
NS4b 77-91
# |
LWNGPMAVSMTGVMR | 115,00 | Hepatitis-C-Virus |
EP12426_1 |
Env 345-359
# |
NKGILVTVNPIASTN | 149,50 | Human immunodeficiency virus 1 |
EP12425_1 |
Env 57-71
# |
RKVCYNAVLTHVKIN | 149,50 | Human immunodeficiency virus 1 |
EP12235_1 |
RSV Fusion glycoprotein F0 precursor 542-550 (HLA-Cw12)
# |
IAVGLLLYC | 57,50 | Human respiratory syncytial virusHLA-Cw*12 |
EP12234_5 |
RSV MP2 64-72 (HLA-B44)
# |
AELDRTEEY | 57,50 | Human immunodeficiency virus |
EP12233_5 |
RSV Fusion glycoprotein F0 precursor 106-114 (HLA-B57)
# |
RARRELPRF | 57,50 | Human respiratory syncytial virusHLA-B*57 |
EP12232_5 |
RSV NP 255-263 (HLA-B*08:01)
# |
QVMLRWGVL | 57,50 | Human immunodeficiency virus Flow Cytometry |
EP12231_1 |
RSV NP 306-314 (HLA-B*07:02)
# |
NPKASLLSL | 57,50 | Human immunodeficiency virus Flow Cytometry |
EP12230_5 |
RSV MP2 151-159 (HLA-A*03:01)
# |
RLPADVLKK | 57,50 | Human immunodeficiency virus |
EP12229_5 |
RSV Fusion protein 250-258 (HLA-A*02:01)
# |
YMLTNSELL | 57,50 | Human respiratory syncytial virusHLA-A*02:01 |
EP12228_5 |
RSV Fusion protein 451-459 (HLA-A*02:01)
# |
SVGNTLYYV | 57,50 | Human respiratory syncytial virusHLA-A*02:01 |
EP12227_5 |
RSV Fusion protein 173-181 (HLA-A*02:01)
# |
STNKAVVSL | 57,50 | Human respiratory syncytial virusHLA-A*02:01 |
EP12226_5 |
RSV Fusion protein 180-188 (HLA-A*02:01)
# |
SLSNGVSVL | 57,50 | Human respiratory syncytial virusHLA-A*02:01 |
EP12224_5 |
RSV NP 16-24 (HLA-A*02:01)
# |
QLLSSSKYT | 57,50 | Human immunodeficiency virus HLA-A*02:01 Flow Cytometry |
EP12223_5 |
RSV Fusion protein 273-281 (HLA-A*02:01)
# |
LMSNNVQIV | 57,50 | Human respiratory syncytial virusHLA-A*02:01 |
EP12222_5 |
RSV Fusion protein 171-179 (HLA-A*02:01)
# |
LLSTNKAVV | 57,50 | Human respiratory syncytial virusHLA-A*02:01 |
EP12221_1 |
RSV Fusion protein 538-546 (HLA-A*02:01)
# |
LLSLIAVGL | 57,50 | Human respiratory syncytial virusHLA-A*02:01 |
EP12220_1 |
RSV Fusion protein 191-199 (HLA-A*02:01)
# |
KVLDLKNYI | 57,50 | Human respiratory syncytial virusHLA-A*02:01 |
EP12219_1 |
RSV Fusion protein 272-280 (HLA-A*02:01)
# |
KLMSNNVQI | 57,50 | Human respiratory syncytial virusHLA-A*02:01 |
EP12218_1 |
RSV Fusion protein 498-506 (HLA-A*02:01)
# |
KINQSLAFI | 57,50 | Human respiratory syncytial virusHLA-A*02:01 |
EP12217_1 |
RSV Fusion protein 394-402 (HLA-A*02:01)
# |
KIMTSKTDV | 57,50 | Human respiratory syncytial virusHLA-A*02:01 |
EP12216_1 |
RSV Fusion protein 159-167 (HLA-A*02:01)
# |
HLEGEVNKI | 57,50 | Human respiratory syncytial virusHLA-A*02:01 |
EP12215_1 |
RSV Fusion protein 114-122 (HLA-A*02:01)
# |
FMNYTLNNT | 57,50 | Human respiratory syncytial virusHLA-A*02:01 |
EP12214_1 |
RSV Fusion protein 140-148 (HLA-A*02:01)
# |
FLLGVGSAI | 57,50 | Human respiratory syncytial virusHLA-A*02:01 |
EP12213_1 |
RSV Fusion protein 82-90 (HLA-A*02:01)
# |
ELDKYKNAV | 57,50 | Human respiratory syncytial virusHLA-A*02:01 |
EP12212_1 |
RSV Fusion protein 170-178 (HLA-A*02:01)
# |
ALLSTNKAV | 57,50 | Human respiratory syncytial virusHLA-A*02:01 |
EP12211_1 |
RSV Fusion protein 10-18 (HLA-A*02:01)
# |
AITTILAAV | 57,50 | Human respiratory syncytial virusHLA-A*02:01 |
EP12208_1 |
HPV E6 52-61 (HLA-B*35:01)
FAFRDLCIVY is a linear peptidic epitope studied as part of Protein E6 from Alphapapillomavirus 9. This... |
FAFRDLCIVY | 57,50 | HPVHLA-B*35:01 Flow Cytometry Immunohistochemistry |
EP12207_1 |
HPV L1 296-304 (HLA-A*11)
AVPDDLYIK is a linear peptidic epitope studied as part of Major capsid protein L1 from Alphapapillomavirus... |
AVPDDLYIK | 57,50 | HPV 16 HLA-A*11 |
EP12206_1 |
HPV E6 75-83 (HLA-A*24:02)
EYRHYCYSL is a linear peptidic epitope studied as part of Protein E6 from Alphapapillomavirus 9. This... |
EYRHYCYSL | 57,50 | HPVHLA-A*24:02 |
EP12205_1 |
HPV E6 87-95 (HLA-A*24:01)
CYSLYGTTL is a linear peptidic epitope studied as part of Protein E6 from Alphapapillomavirus 9. This... |
CYSLYGTTL | 57,50 | HPVHLA-A*24:01 |
EP12204_1 |
HPV16 L1 349-357 (HLA-A*02:01)
ICWGNQLFV is a linear peptidic epitope studied as part of Major capsid protein L1 from Alphapapillomavirus... |
ICWGNQLFV | 57,50 | HPV 16 HLA-A*02:01 |
EP12203_1 |
HPV 16 E2 69–77 (HLA-A*02:01)
ALQAIELQL is a linear peptidic epitope studied as part of Regulatory protein E2 from Alphapapillomavirus 9.... |
ALQAIELQL | 57,50 | HPV 16HLA-A*02:01other name: Heme oxygenase-1 212-220 (HLA-A*02:01) Flow Cytometry |
EP12202_1 |
HPV E7 81-89 (HLA-A*02:01)
DLLLGTLNI is a linear peptidic epitope studied as part of Protein E7 from Alphapapillomavirus 10. This... |
DLLLGTLNI | 57,50 | HPV 16 HLA-A*02:01 Flow Cytometry |
EP12200_1 |
PSMA 624-632 (HLA-A*24:02)
# |
TSYVSFDSL | 57,50 | |
EP12199_1 |
PSMA 178-186 (HLA-A*24:02)
# |
NYARTEDFF | 57,50 | |
EP12198_1 |
PSMA 227-235 (HLA-A*24:02)
# |
LYSDPADYF | 57,50 | |
EP12197_1 |
PSMA 441-450 (HLA-A*02:01)
# |
LLQERGVAYI | 57,50 | HLA-A*02:01 |
EP12188_1 |
Survivin 53-62 (HLA-A*11:01)
# |
DLAQCFFCFK | 57,50 | HumanHLA-A*11:01Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP12187_1 |
Survivin 47-56 (Y10) (HLA-A*01:01)
# |
PTENEPDLAY | 57,50 | Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP12184_1 |
PSA 248-257 (HLA-A*24:02)
# |
HYRKWIKDTI | 57,50 | |
EP12181_1 |
PSA 68-77b (HLA-A*01:01)
# |
VSHSFPHPLY | 57,50 | |
EP12156_1 |
TRP2 181-190 (HLA-A*01:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
VYDFFVWLHY | 57,50 | HumanHLA-A*01:01 DRRFY (1521-1529) Flow Cytometry |
EP12155_1 |
MAGE-C2 191-200 (HLA-A*2)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
LLFGLALIEV | 57,50 | HumanHLA-A*2Cancer;Melanoma Flow Cytometry |
EP12154_1 |
MG50 210-218 (HLA-A*02:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
TLHCDCEIL | 57,50 | HumanHLA-A*02:01 Flow Cytometry |
EP12109_1 |
MOG 37-50
Myelin oligodendrocyte glycoprotein (MOG)37-50, a minor component of CNS myelin, is expressed in central... |
VGWYRSPFSRVVHL | 115,00 | Mouse, Rat Multiple Sclerosis |
EP12108_1 |
Influenza NP 147-155 (H-2Kd)
TYQRTRALV is a linear peptidic epitope studied as part of Nucleoprotein from Influenza A virus. This... |
TYQRTRALV | 57,50 | Influenza VirusH-2 KdInfection, Influenza, Swine Flu, Respiratory infectionother name: Flu BNP 85-94 (Influenza B) T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP12107_1 |
Influenza NP 55-63 (HLA-A*02:01)
# |
RLIQNSLTI | 57,50 | Influenza VirusHLA-A*02:01Infection, Influenza, Swine Flu, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP12106_1 |
Influenza NP 218-226 (HLA-A*02:01)
# |
AYERMCNIL | 57,50 | Influenza VirusHLA-A*02:01Infection, Influenza, Swine Flu, Respiratory infectionother name: Flu MP 58, Influenza Matrix Peptide, Influenza Virus Matrix Protein (58-66), NH2-GILGFVFTL-OH. T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP12105_1 |
Influenza A virus (A/Puerto Rico/8/1934 (H1N1)) 36-43 (H-2-Kd)
IGRFYIQM is a linear peptidic epitope studied as part of Nucleoprotein from Influenza A virus. This epitope... |
IGRFYIQM | 57,50 | Influenza VirusH-2 Kd |
EP12104_1 |
Influenza A virus 533-541 (H-2-Kd)
IYSTVASSL is a linear peptidic epitope studied as part of Hemagglutinin from Influenza A virus. This... |
IYSTVASSL | 57,50 | Influenza VirusH-2 Kd |
EP12103_1 |
Influenza A virus (A/Puerto Rico/8/1934(H1N1)) 462-470 (H-2-Kd)
LYEKVKSQL is a linear peptidic epitope (epitope ID40746) studied as part of Hemagglutinin from Influenza A... |
LYEKVKSQL | 57,50 | Influenza VirusH-2 Kd |
EP12102_1 |
Influenza A virus 332-340 (H-2-Db)
# |
TGLRNTPSI | 57,50 | Influenza VirusH-2 Dbother name: CEF24, Influenza Virus PB1 Peptide (591 - 599) |
EP11907_1 |
HCV 2416-2424 (HLA-A26)
# |
DVVCCSMSY | 57,50 | HCVHLA-A*26Hepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11906_1 |
NS3 1581-1589 (HLA A*02:01)
# |
ENLPYLVAY | 57,50 | HLA-A*02:01Hepatitis-C-Virus |
EP11850_1 |
Adpgk Neoepitope (H-2D(b))
# |
ASMTNMELM | 57,50 | H-2 Db |
EP11849_1 |
MuLV p15E (H-2Kb )
KSPWFTTL is a linear peptidic epitope (epitope ID33474) studied as part of Envelope glycoprotein from... |
KSPWFTTL | 57,50 | murine leukemia virus (FrMLV)H-2 Kbother names: Myelin Oligodendrocyte Basic Protein (16 - 37) T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11848_1 |
MCMV m142 24-38 (H1-A(b))
RSRYLTAAAVTAVLQ is a linear peptidic epitope (epitope ID55953) studied as part of Other Murid herpesvirus 1... |
RSRYLTAAAVTAVLQ | 115,00 | MCMVH-1 Db |
EP11847_1 |
LCMV GP33 33-41 (H2-D(b))
KAVYNFATC is a linear peptidic epitope (epitope ID30001) studied as part of Pre-glycoprotein polyprotein GP... |
KAVYNFATC | 57,50 | LCMVH-2 Dbmeningitis, encephalitis ,meningoencephalitis Flow Cytometry |
EP11846_1 |
MCMV m139 419-426 (H2-K(b))
TVYGFCLL is a linear peptidic epitope (epitope ID67227) studied as part of Other Murid herpesvirus 1... |
TVYGFCLL | 57,50 | MCMVH-2 Kb Flow Cytometry Immunohistochemistry |
EP11845_1 |
MCMV m38 316-323 (H2-K(b))
SSPPMFRV is a linear peptidic epitope (epitope ID61280) studied as part of Other Murid herpesvirus 1... |
SSPPMFRV | 57,50 | MCMVH-2 Kb |
EP11844_1 |
MCMV M45 985-993 (H-2Db)
MCMV-derived peptide of HGIRNASFI sequence covering 985-993 and H-2Db molecule. It recognizes mouse CD8 T... |
HGIRNASFI | 57,50 | MCMVH-2 Db Flow Cytometry |
EP11839_1 |
NY-ESO-1 153-170 (HLA-B*15:17)
# |
ITQCFLPVF | 57,50 | HumanHLA-B*15:17 |
EP11838_1 |
NY-ESO-1 158-166 (HLA-A*24:02)
NY-ESO-1 158-166 (HLA-A*24:02) peptide LLMWITQCF for stimulation of T-cells. Single peptide SLLMWITQV for... |
LLMWITQCF | 57,50 | HumanHLA-A*24:02 Flow Cytometry |
EP11837_1 |
NY-ESO-1_LAGE-2 91-101 (HLA-A*24:02)
# |
YLAMPFATPME | 92,00 | HumanHLA-A*24:02 |
EP11836_1 |
PRAME 301-309 (HLA-A*24)
# |
LYVDSLFFL | 57,50 | HumanHLA-A*24Cancer Flow Cytometry |
EP11831_1 |
SLC45A2 (HLA-A*02:01)
# |
SLYSYFQKV | 57,50 | HumanHLA-A*02:01 |
EP11702_1 |
MCMV IE1
The nonamer YPHFMPTNL is an immunodominant T-cell epitope for presentation on H-2Ld MHC class I molecules.... |
YPHFMPTNL | 57,50 | MCMV Flow Cytometry |
EP11701_1 |
Influenza NP 50-57
SDYEGRLI is a linear peptidic epitope (epitope ID57322) studied as part of Nucleoprotein from Influenza A... |
SDYEGRLI | 57,50 | Influenza VirusInfection, Influenza, Swine Flu, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11652_1 |
LL - 37, scrambled
Anti-microbial Peptide Human Host Defense Peptide |
GLKLRFEFSKIKGEFLKTPEVRFRDIKLKDNRISVQR | 201,25 | |
EP11651_1 |
LL - 37
The cathelicidin anti-microbial peptide LL-37 corresponds to aa 134-170 of the human cationic antimicrobial... |
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | 201,25 | other name: Baculoviral IAP repeat-containing protein 7 (280-289); ML-IAP 280-289 |
EP11165_1 |
ESAT6 50-58 (HLA-A*24:02)
# |
AYQGVQQKV | 57,50 | M. tuberculosisHLA-A*24:02 Flow Cytometry Immunohistochemistry |
EP11648_1 |
Anti-H60a 39-46 (H-2Kb)
The vector of anti-H60 peptide T cell receptor (TCR) is constructed for the engineering of T cell to target... |
LTFNYRNL | 57,50 | Zaire ebolavirusH-2 Kb Flow Cytometry |
EP11647_1 |
Derp1 117–127
CQIYPPNVNKI is a linear peptidic epitope (epitope ID242387) studied as part of Der p 1 from... |
CQIYPPNVNKI | 92,00 | |
EP11498_1 |
NY-ESO-1 86-94 (HLA-A*02:01)
# |
RLLEFYLAM | 57,50 | HumanHLA-A*02:01 Flow Cytometry |
EP11497_1 |
NY-ESO-1 93-101 (HLA-B*07:02)
# |
AMPFATPME | 57,50 | HumanHLA-B*07:02 Flow Cytometry |
EP11496_1 |
NY-ESO-1 108–116 (HLA-A*02:01)
# |
SLAQDAPPL | 57,50 | HumanHLA-A*02:01 |
EP11495_1 |
SLC45A3 255-263 (HLA-A*02:01)
# |
ALLPRLHQL | 57,50 | HumanHLA-A*02:01 |
EP11493_1 |
Serine protease hepsin (191-199)
# |
SLLSGDWVL | 57,50 | Human |
EP11492_1 |
Serine protease hepsin (229-237)
# |
GLQLGVQAV | 57,50 | Human |
EP11486_1 |
HBV HBsAg 371-378 (H2-Kb)
IVSPFIPL is a linear peptidic epitope (epitope ID29454) studied as part of Large envelope protein from... |
IVSPFIPL | 57,50 | HBVH-2 Kb |
EP11485_1 |
HBV HBsAg 190-197 (H-2 Kb)
VWLSVIWM is a linear peptidic epitope (epitope ID71948) studied as part of Large envelope protein from... |
VWLSVIWM | 57,50 | HBVH-2 KbAIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Flow Cytometry |
EP11484_1 |
HCMV pp65 512-521 (HLA-B*44:02)
EFFWDANDIY is a linear peptidic epitope (epitope ID11995) studied as part of 65 kDa phosphoprotein from... |
EFFWDANDIY | 57,50 | HCMVHLA-B*44:02Infection, Control, Cancer, TORCH, Infectious mononucleosis, CMV hepatitis, Retinitis, Colitis, Pneumonitis, Esophagitis, AIDS, Cancer chemotherapy, Transplantation T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11483_1 |
EBV EBNA3C 281-290 (HLA-B*44:05)
EBNA3C-derived peptide of EENLLDFVRF covering 281-290 and B*44:05 molecule. The EBV EBNA3C 281-290... |
EENLLDFVRF | 57,50 | EBVHLA-B*44:05 |
EP11482_1 |
EBV BRLF-1 148-156 (HLA-A*03:01)
HLA-A*03:01-restricted epitope from Epstein-Barr Virus , EBV BRLF-1 (148-156). RVRAYTYSK is a linear... |
RVRAYTYSK | 57,50 | HumanHLA-A*03:01EBV Flow Cytometry |
EP11481_1 |
EBV EBNA 3C 258-266 (HLA-B*27:02)(HLA-B*27:05)(HLA-B*27:04)
RRIYDLIEL is a linear peptidic epitope (epitope ID55620) studied as part of Epstein-Barr nuclear antigen 6... |
RRIYDLIEL | 57,50 | EBVHLA-B*27:02 HLA-B*27:05 HLA-B*27:04 |
EP11480_1 |
Influenza Virus M1 128– 135 (HLA-B27) (HLA-B35)
# |
ASCMGLIY | 57,50 | Influenza VirusHLA-B*27 HLA?B*35Infection, Influenza, Swine Flu, Respiratory infectionother name: CEF6, Influenza Virus NP T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11479_1 |
Influenza Virus NP 380-388 (HLA-B*8)
ELRSRYWAI is a linear peptidic epitope (epitope ID13263) studied as part of Nucleoprotein from Influenza A... |
ELRSRYWAI | 57,50 | Influenza VirusHLA-B*8Infection, Influenza, Swine Flu, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11478_1 |
Influenza NP 418-426 (HLA-B*07:02)
LPFDKTTVM is a linear peptidic epitope (epitope ID116124), tested in MHC ligand assay |
LPFDKTTVM | 57,50 | Influenza VirusHLA-B*07:02Infection, Influenza, Swine Flu, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11477_1 |
Influenza Virus NP 91–99 (HLA-A*68:01)
KTGGPIYKR is a linear peptidic epitope (epitope ID33682) studied as part of Nucleoprotein from Influenza A... |
KTGGPIYKR | 57,50 | Influenza VirusHLA-A*68:01Infection, Influenza, Swine Flu, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11476_1 |
Influenza Virus NP 342–351 (HLA-A*03:01)( HLA-A*31:01)( HLA-A*33:01)
RVLSFIKGTK is a linear peptidic epitope (epitope ID56355) studied as part of Nucleoprotein from Influenza A... |
RVLSFIKGTK | 57,50 | Influenza VirusHLA-A*03:01 HLA-A*31:01 HLA-A*33:01Infection, Influenza, Swine Flu, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11475_1 |
Influenza Virus PA 46–54 (HLA-A*02:01)
FMYSDFHFI is a linear peptidic epitope (epitope ID17119) studied as part of Polymerase acidic protein from... |
FMYSDFHFI | 57,50 | Influenza VirusHLA-A*02:01Infection, Influenza, Swine Flu, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11474_1 |
ZnT-8 153-161 (HLA-A*02:01)
VVTGVLVYL is a linear peptidic epitope (epitope ID170038) studied as part of Zinc transporter 8 from Homo... |
VVTGVLVYL | 57,50 | HumanHLA-A*02:01Diabetes Immune monitoring, Immunohistochemistry, T-cell assays |
EP11473_1 |
ZnT-8 266-274 (HLA-A*02:01)
ILKDFSILL is a linear peptidic epitope (epitope ID168874) studied as part of Zinc transporter 8 from Homo... |
ILKDFSILL | 57,50 | HumanHLA-A*02:01Diabetes Immune monitoring, Immunohistochemistry, T-cell assays |
EP11472_1 |
ZnT-8 93-101 (HLA-A*02:01)
HIAGSLAVV is a linear peptidic epitope (epitope ID168764) studied as part of Zinc transporter 8 from Homo... |
HIAGSLAVV | 57,50 | HumanHLA-A*02:01Diabetes Immune monitoring, Immunohistochemistry, T-cell assays |
EP11471_1 |
ZnT-8 114-123 (HLA-A*02:01)
FLLSLFSLWL is a linear peptidic epitope (epitope ID168578) studied as part of Zinc transporter 8 from Homo... |
FLLSLFSLWL | 57,50 | HumanHLA-A*02:01Diabetes T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11469_1 |
WT1 37-45 (HLA-A*02:01)
Wilms tumor protein is a protein that is encoded by the WT1 gene on chromosome 11p in humans. WT1 is a... |
VLDFAPPGA | 57,50 | HumanHLA-A*02:01Cancer |
EP11468_1 |
WT1 187-195 (HLA-A*02:01)
SLGEQQYSV is a linear peptidic epitope (epitope ID59130) studied as part of Wilms tumor protein from Homo... |
SLGEQQYSV | 57,50 | HumanHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11467_1 |
NS3 518–526 (HLA-A*02:01)
YTMDGEYRL is a linear peptidic epitope (epitope ID76121) studied as part of Genome polyprotein from West... |
YTMDGEYRL | 57,50 | HLA-A*02:01Hepatitis-C-Virus |
EP11466_1 |
NS2b 78-87 (HLA-A*02:01)
RLDDDGNFQL is a linear peptidic epitope (epitope ID54501) studied as part of Genome polyprotein from West... |
RLDDDGNFQL | 57,50 | HLA-A*02:01 |
EP11464_1 |
NS5 862–870 (HLA-A*02:01)
ATWAENIQV is a linear peptidic epitope (epitope ID5213) studied as part of Genome polyprotein from West... |
ATWAENIQV | 57,50 | HLA-A*02:01Hepatitis-C-Virus |
EP11463_1 |
VP1 372-380 (HLA-B*07:02)
This peptide is the capsid derived immunodominant adeno-associated virus 2 (AAV2), CD8 T cell epitope.... |
VPQYGYLTL | 57,50 | (HBoV1) (Human bocavirus type 1)HLA-B*07:02Cancer;Gene therapy T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11462_1 |
VP1 80-88 (HLA-B*07:02)
# |
SPERKMLPC | 57,50 | (HBoV1) (Human bocavirus type 1)HLA-B*07:02AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11461_1 |
VP1 182-190 (HLA-B*07:02)
# |
NPTAQSQVM | 57,50 | (HBoV1) (Human bocavirus type 1)HLA-B*07:02AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11459_1 |
VP1 2-10 (HLA-B*07:02)
# |
APTKRKGEC | 57,50 | (HBoV1) (Human bocavirus type 1)HLA-B*07:02AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11458_1 |
VP1 14-22 (HLA-B*07:02)
# |
APKKPKEPV | 57,50 | (HBoV1) (Human bocavirus type 1)HLA-B*07:02AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11457_1 |
VP1 36-44 (HLA-A*02:01)
SITEVECFL is a linear peptidic epitope (epitope ID58721) studied as part of Human polyomavirus 2 protein... |
SITEVECFL | 57,50 | (HBoV1) (Human bocavirus type 1)HLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11456_1 |
BKV VP1 108-116 (HLA-A*02:01)
LLMWEAVTV is a linear peptidic epitope (epitope ID37590) studied as part of Human polyomavirus 1 protein... |
LLMWEAVTV | 57,50 | BK polyomavirus (BKPyV) (Human polyomavirus 1)HLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11455_1 |
VP1 437-445 (HLA-A*02:01)
LIDQYLYYL is a linear peptidic epitope (epitope ID456150) studied as part of Capsid protein VP1 from... |
LIDQYLYYL | 57,50 | (HBoV1) (Human bocavirus type 1)HLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11454_1 |
JCV-VP1 100-108 (HLA-A*02:01)
ILMWEAVTL is a linear peptidic epitope (epitope ID27217) studied as part of Human polyomavirus 2 protein... |
ILMWEAVTL | 57,50 | VirusHLA-A*02:01 Flow Cytometry Immunohistochemistry |
EP11453_1 |
VP1 44-52 (HLA-A*02:01)
AITEVECFL is a linear peptidic epitope (epitope ID2102) studied as part of Human polyomavirus 1 protein... |
AITEVECFL | 57,50 | (HBoV1) (Human bocavirus type 1)HLA-A*02:01Merkel cell carcinoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11452_1 |
AAV VP1 492-500 (HLA-A*01:01)
# |
SADNNNSEY | 57,50 | Adeno-associated virus - 6HLA-A*01:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11451_1 |
Vaccinia virus Host range protein 2 74-82 (HLA-A*02:01)
KVDDTFYYV is a linear peptidic epitope (epitope ID 33967) studied as part of Interferon antagonist C7 from... |
KVDDTFYYV | 57,50 | VACVHLA-A*02:01 |
EP11450_1 |
Vaccinia virus Copenhagen Protein G5 18-26 (HLA-A*02:01)
ILDDNLYKV is a linear peptidic epitope (epitope ID26990) studied as part of Putative nuclease G5 from... |
ILDDNLYKV | 57,50 | VACVHLA-A*02:01 |
EP11448_1 |
USP9Y (HLA-A*01:01)
IVDCLTEMY is a linear peptidic epitope (epitope ID29227) studied as part of Probable ubiquitin... |
IVDCLTEMY | 57,50 | AIDS (HIV)HLA-A*01:01BK polyomavirus, Epstein-Barr virus (HHV-4), Hepatitis B virus, Hepatitis C virus, Homo sapiens (Human), Human adenovirus, Human cytomegalovirus (HHV-5), Human immunodeficiency virus (HIV), Human papillomavirus, Human respiratory syncytial virus, Influenza A. M. tuberculosis, Mus musculus (mouse), Vaccinia virus, Yellow fever virus Immune monitoring, Immunohistochemistry, T-cell assays |
EP11447_1 |
Tyrosinase 208-216 (HLA-B*07:02)
LPWHRLFLL is a linear peptidic epitope (epitope ID38770) studied as part of Tyrosinase from Homo sapiens... |
LPWHRLFLL | 57,50 | HumanHLA-B*07:02AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1Molecular Weight: 1194.60AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1Molecular Weight: 1194.60AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1Molecular Weight: 1194.60 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11446_1 |
Tyrosinase 206-214 (HLA-A*24:02)
AFLPWHRLF is a tyrosinase epitope recognized by HLA-A24 restricted, tumor-infiltrating lymphocytes (TIL).... |
AFLPWHRLF | 57,50 | HumanHLA-A*24:02 |
EP11445_1 |
Tyrosinase 425-434 (HLA-A*03:01) (HLA-A*11:01)
YMVPFIPLYR is a linear peptidic epitope (epitope ID75117) studied as part of Tyrosinase from Homo sapiens... |
YMVPFIPLYR | 57,50 | HumanHLA-A*03:01 HLA-A*11:01 |
EP11444_1 |
Tyrosinase 146-156 (HLA-A*01:01)
# |
SSDYVIPIGTY | 57,50 | HumanHLA-A*01:01BK polyomavirus, Epstein-Barr virus (HHV-4), Hepatitis B virus, Hepatitis C virus, Homo sapiens (Human), Human adenovirus, Human cytomegalovirus (HHV-5), Human immunodeficiency virus (HIV), Human papillomavirus, Human respiratory syncytial virus, Influenza A, M. tuberculosis, Mus musculus (mouse), Vaccinia virus, Yellow fever virus Immune monitoring, Immunohistochemistry, T-cell assays, |
EP11443_1 |
Tyrosinase 243-251 mutant (HLA-A*01:01) 244S
Antigen Peptide TTyrosinase 243-251 mutant (HLA-A*01:01) 244S KSDICTDEY for stimulation of antigen-specific... |
KSDICTDEY | 57,50 | HumanHLA-A*01:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1Molecular Weight: 1194.60AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1Molecular Weight: 1194.60AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1Molecular Weight: 1194.60 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11442_1 |
TTK-567 (HLA-A*24:02)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
SYRNEIAYL | 57,50 | HumanHLA-A*24:02AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11441_1 |
TRAG3 57-66 (HLA-A*02:01)
# |
SILLRDAGLV | 57,50 | HumanHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11440_1 |
TRAG3 4-12 (HLA-A*02:01)
# |
GLIQLVEGV | 57,50 | HumanHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11439_1 |
Uty 566–573 (HLA-B*08:01)
LPHNHTDL is a linear peptidic epitope (epitope ID138875) studied as part of Histone demethylase UTY from... |
LPHNHTDL | 57,50 | HumanHLA-B*08:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11438_1 |
MAGE-C1 1087-1095 (HLA-A*02:01)
# |
FLAMLKNTV | 57,50 | HumanHLA-A*02:01Cancer;Melanoma Flow Cytometry |
EP11437_1 |
topII 828-836 (HLA-A*02:01)
FLYDDNQRV is a linear peptidic epitope (epitope ID193822) studied as part of DNA topoisomerase 2-beta from... |
FLYDDNQRV | 57,50 | HumanHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11436_1 |
TGF-b 131-139 (HLA-A*02:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
RLSSCVPVA | 57,50 | HumanHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11435_1 |
hTRT 865-873 (HLA-A*02:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
RLVDDFLLV | 57,50 | HumanHLA-A*02:01Cancerother name: Telomerase Reverse Transcriptase (hTRT) 615-624 Flow Cytometry |
EP11434_1 |
hTRT 988-997 (HLA-A*02:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
YLQVNSLQTV | 57,50 | HumanHLA-A*02:01Cancerother name: Telomerase Reverse Transcriptase (hTRT) 674-683 Flow Cytometry |
EP11433_1 |
hTERT 653-661 (HLA-A*02:01)
Telomerase Reverse Transcriptase (hTRT) 653-661 |
RLTSRVKAL | 57,50 | HumanHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Flow Cytometry Immunohistochemistry |
EP11432_1 |
hTRT 540-548 (HLA-A*02:01)
LAKFLHWL is a linear peptidic epitope (epitope ID179820) studied as part of Telomerase reverse... |
ILAKFLHWL | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry |
EP11431_1 |
hTRT 674-683 (HLA-A*02:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
GLLGASVLGL | 57,50 | HumanHLA-A*02:01Cancerother name: Telomerase Reverse Transcriptase (hTRT) 540-548 Flow Cytometry |
EP11429_1 |
TARP 5-13 mutant (HLA-A*02:01) 9P
FLPSPLFFFL is a linear peptidic epitope (epitope ID16854), tested in T cell assays and MHC ligand assays |
FLPSPLFFFL | 57,50 | HumanHLA-A*02:01 Flow Cytometry Immunohistochemistry |
EP11428_1 |
TARP 27-35 mutant (HLA-A*02:01) 28L
FLFLRNFSL is a linear peptidic epitope (epitope ID16597), tested in T cell assays and MHC ligand assays |
FLFLRNFSL | 57,50 | HumanHLA-A*02:01 Flow Cytometry Immunohistochemistry |
EP11427_1 |
TACE 250-258 (HLA-A*02:01)
YLIELIDRV is a linear peptidic epitope (epitope ID450202) studied as part of Disintegrin and... |
YLIELIDRV | 57,50 | HumanHLA-A*02:01 Flow Cytometry Immunohistochemistry |
EP11426_1 |
Survivin 3a 51-59 mutant (HLA-B*35:01) 59Y
Antigen Peptide Baculoviral IAP repeat-containing protein 5 HLA-B*35:01 (EPDLAQCFY) for stimulation of... |
EPDLAQCFY | 57,50 | HumanHLA-B*35:01Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11425_1 |
Survivin 3A 18-27 mutant (HLA-A*03:01) 27K
Antigen Peptide Baculoviral IAP repeat-containing protein 5 HLA-A*03:01 (RISTFKNWPK) for stimulation of... |
RISTFKNWPK | 57,50 | HumanHLA-A*03:01Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11424_1 |
Survivin 3A 96-104 (HLA-A*02:01)
LTLGEFLKL is a linear peptidic epitope (epitope ID237188) studied as part of Baculoviral IAP... |
LTLGEFLKL | 57,50 | HumanHLA-A*02:01Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11423_1 |
Survivin 80-88 (HLA-A*24:02)
# |
AYACNTSTL | 57,50 | HumanHLA-A*24:02Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11422_1 |
Survivin 96-104 (HLA-A*02:01)
LMLGEFLKL is a linear peptidic epitope (epitope ID38060), tested in T cell assays. The vector of... |
LMLGEFLKL | 57,50 | HumanHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11421_1 |
Survivin 93–101 mutant (HLA-A*01:01) 94T
# |
FTELTLGEF | 57,50 | HumanHLA-A*01:01Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11420_1 |
STEAP 292-300 mutant (HLA-A*02:01) 293L
# |
MLAVFLPIV | 57,50 | HumanHLA-A*02:01 Flow Cytometry Immunohistochemistry |
EP11419_1 |
Spike GP 77–85 (HLA-A*02:01)
LLLNCLWSV is a linear peptidic epitope (epitope ID37536) studied as part of Spike glycoprotein from Human... |
LLLNCLWSV | 57,50 | HLA-A*02:01 Flow Cytometry Immunohistochemistry |
EP11418_1 |
SMCY (HLA-B*07:02)
SPSVDKARAEL is a linear peptidic epitope (epitope ID137455) studied as part of Lysine-specific demethylase... |
SPSVDKARAEL | 92,00 | HumanHLA-B*07:02 |
EP11417_1 |
SART3 309-317 (HLA-A*02:01)
# |
RLAEYQAYI | 57,50 | HumanHLA-A*02:01 Flow Cytometry Immunohistochemistry |
EP11416_1 |
SSA protein SS-56 55-64 (HLA-A*02:01)
YTCPLCRAPV is a linear peptidic epitope (epitope ID117120) studied as part of E3 ubiquitin-protein ligase... |
YTCPLCRAPV | 57,50 | HumanHLA-A*02:01 |
EP11415_1 |
HIV-1 RT 273-282 (HLA-B*35:01)
# |
VPLDEDFRKY | 57,50 | HIV-1HLA-B*35:01AIDS (HIV) Flow Cytometry |
EP11414_1 |
RNF43 721-729 mutant (HLA-A*24:02) 272Y
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
NYQPVWLCL | 57,50 | HumanHLA-A*24:02 Flow Cytometry |
EP11413_1 |
RNF43 11-20 (HLA-A*02:01)
# |
ALWPWLLMAT | 57,50 | HumanHLA-A*02:01 Flow Cytometry Immunohistochemistry |
EP11412_1 |
RhoC 176-185 mutant (HLA-A*03:01) 177L
# |
RLGLQVRKNK | 57,50 | HumanHLA-A*03:01 Flow Cytometry Immunohistochemistry |
EP11411_1 |
PTLV-1 bZIP factor 10-18 (HLA-B*07:02)
LPVSCPEDL is a linear peptidic epitope (epitope ID175259) studied as part of HTLV-1 basic zipper factor... |
LPVSCPEDL | 57,50 | Humanes T-lymphotropes Virus 1HLA-B*07:02Humanes T-lymphotropes Virus 1 (HTLV) Flow Cytometry Immunohistochemistry |
EP11410_1 |
PTLV-1 bZIP factor 26-34 (HLA-A*02:01)
GLLSLEEEL is a linear peptidic epitope (epitope ID175186) studied as part of HTLV-1 basic zipper factor... |
GLLSLEEEL | 57,50 | Humanes T-lymphotropes Virus 1HLA-A*02:01Humanes T-lymphotropes Virus 1 (HTLV) Flow Cytometry Immunohistochemistry |
EP11409_1 |
PTLV-1 bZIP factor 22-30 (HLA-A*02:01)
ELVDGLLSL is a linear peptidic epitope (epitope ID175148) studied as part of HTLV-1 basic zipper factor... |
ELVDGLLSL | 57,50 | Humanes T-lymphotropes Virus 1HLA-A*02:01Humanes T-lymphotropes Virus 1 (HTLV) Flow Cytometry Immunohistochemistry |
EP11408_1 |
PTLV-1 bZIP factor 42-50 (HLA-A*02:01)
AVLDGLLSL is a linear peptidic epitope (epitope ID175124) studied as part of HTLV-1 basic zipper factor... |
AVLDGLLSL | 57,50 | Humanes T-lymphotropes Virus 1HLA-A*02:01Humanes T-lymphotropes Virus 1 (HTLV) Flow Cytometry Immunohistochemistry |
EP11406_1 |
PSMA 27-38 (HLA-A*02:01)
# |
VLAGGFFLL | 57,50 | HumanHLA-A*02:01 Flow Cytometry |
EP11403_1 |
PSM P2 (prostate) (HLA-A*02:01)
ALFDIESKV is a linear peptidic epitope (epitope ID442279) studied as part of Glutamate carboxypeptidase 2... |
ALFDIESKV | 57,50 | HLA-A*02:01 Flow Cytometry |
EP11402_1 |
PSCA 44-51 (51A) (HLA-A*02:01)
# |
QLGEQCWTV | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry Immunohistochemistry |
EP11401_1 |
PSCA 14-22 (HLA-A*02:01)
# |
ALQPGTALL | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry Immunohistochemistry |
EP11399_1 |
PSA-1 153-161 (HLA-A*24:02)
# |
CYASGWGSI | 57,50 | |
EP11398_1 |
Prominin1 744-752 (HLA-A*02:01)
# |
YLQWIEFSI | 57,50 | HumanHLA-A*02:01 Flow Cytometry Immunohistochemistry |
EP11397_5 |
PRAME 300–309 (HLA-A*02:01)
ALYVDSLFFL is a linear peptidic epitope (epitope ID225231) studied as part of Melanoma antigen... |
ALYVDSLFFL | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry |
EP11396_1 |
Pol 502-510 (HLA-A*02:01)
KLHLYSHPI is a linear peptidic epitope (epitope ID31898) studied as part of Protein P from Hepatitis B... |
KLHLYSHPI | 57,50 | HBVHLA-A*02:01Hepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11395_1 |
Pol 455-463 (HLA-A*02:01)
GLSRYVARL is a linear peptidic epitope (epitope ID21145) studied as part of Protein P from Hepatitis B... |
GLSRYVARL | 57,50 | HBVHLA-A*02:01Hepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11394_1 |
Plasmodium falciparum CSP 334-342 (HLA-A*02:01)
YLNKIQNSL is a linear peptidic epitope (epitope ID74841) studied as part of Circumsporozoite (CS) protein... |
YLNKIQNSL | 57,50 | Plasmodium falciparumHLA-A*02:01Malaria tropicaother name: Myelin Proteolipid Protein (57-70), Myelin PLP (57-70) Flow Cytometry |
EP11393_1 |
PLAC1 p31-39 (HLA-A*02:01)
# |
SIDWFMVTV | 57,50 | HumanHLA-A*02:01other name: Myelin Proteolipid Protein (56-70), Myelin PLP (56-70) Flow Cytometry Immunohistochemistry |
EP11392_1 |
PAX-5 311-319 (HLA-A*02:01)
# |
TLPGYPPHV | 57,50 | HLA-A*02:01other name: Myelin Proteolipid Protein (48-70), Myelin PLP (48-70) |
EP11391_1 |
PASD1 167-175 (HLA-A*02:01)
YLVGNVCIL is a linear peptidic epitope (epitope ID460883) studied as part of Circadian clock protein PASD1... |
YLVGNVCIL | 57,50 | HumanHLA-A*02:01other name: Myelin Proteolipid Protein (178-191), Myelin PLP (178-191) Flow Cytometry Immunohistochemistry |
EP11390_1 |
p53 139-147 (HLA-A*02:01)
p53-derived peptide of KLCPVQLWV sequence covering 139-147 and HLA-A*02:01 molecule. The peptide p53... |
KLCPVQLWV | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry |
EP11389_1 |
PASD1 694-702 (HLA-A*02:01)
ELSDSLGPV is a linear peptidic epitope (epitope ID453533) studied as part of Circadian clock protein PASD1... |
ELSDSLGPV | 57,50 | HumanHLA-A*02:01other name: Myelin Proteolipid Protein (190-209), Myelin PLP (190-209) Flow Cytometry Immunohistochemistry |
EP11387_1 |
PAP-3 11-19 (HLA-A*02:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
FLGYLILGV | 57,50 | HumanHLA-A*02:01Humane Papillomviren (HPV) Flow Cytometry |
EP11386_1 |
p53 103-111 (HLA-A*02:01)
YLGSYGFRL is a linear peptidic epitope (epitope ID74682), tested in T cell assays. The peptide p53 103-111... |
YLGSYGFRL | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry |
EP11383_1 |
p53 149–157 mutant (HLA-A*02:01) 150T
STPPPGTRV is a linear peptidic epitope (epitope ID61832) studied as part of Cellular tumor antigen p53 from... |
STPPPGTRV | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry |
EP11382_1 |
p53 149-157 (HLA-A*02:01)
SLPPPGTRV is a linear peptidic epitope (epitope ID59401). This epitope has been studied for immune... |
SLPPPGTRV | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry |
EP11381_1 |
p53 65-73 (HLA-A*02:01)
RMPEAAPPV is a linear peptidic epitope (epitope ID54934) studied as part of Cellular tumor antigen p53 from... |
RMPEAAPPV | 57,50 | HumanHLA-A*02:01Cancerother name: Prostatic Acid Phosphatase-3 11-19 (HLA-A*02:01) Flow Cytometry |
EP11380_1 |
PASD1 39-48 (HLA-A*02:01)
QLLDGFMITL is a linear peptidic epitope (epitope ID457766) studied as part of Circadian clock protein PASD1... |
QLLDGFMITL | 57,50 | HumanHLA-A*02:01other name: Myelin Proteolipid Protein (180-199), Myelin PLP (180-199) Flow Cytometry Immunohistochemistry |
EP11379_1 |
p53 187-197 (HLA-A*02:01)
p53-derived peptide of GLAPPQHLIRV sequence covering 187-197 and HLA-A*02:01) molecule. The peptide p53... |
GLAPPQHLIRV | 92,00 | HumanHLA-A*02:01Cancer Flow Cytometry |
EP11378_1 |
P2X5a (HLA-B*07:02)
The nonapeptide P2X5a (HLA-B*07:02) TPNQRQNVC peptide is the naturally presented epitope at the cell... |
TPNQRQNVC | 57,50 | HumanHLA-B*07:02 Flow Cytometry Immunohistochemistry |
EP11377_1 |
CDH3 807-816 (HLA-A*24:02)
YLNEWGSRF is a linear peptidic epitope (epitope ID477138) studied as part of Cadherin-3 from Homo sapiens... |
DYLNEWGSRF | 57,50 | HumanHLA-A*24:02AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11376_1 |
NY-ESO-1 94-102 (HLA-B*35:01) (HLA-B*51:01)
NY-ESO-1-derived peptide of MPFATPMEA sequence covering 94-102 and HLA-B*35:01 HLA-B*51:01 molecule. The... |
MPFATPMEA | 57,50 | HumanHLA-B*35:01 HLA-B*51:01 Flow Cytometry |
EP11375_1 |
NY-ESO-1 127-136 (HLA-A*68:01)
# |
TVSGNILTIR | 57,50 | HumanHLA-A*68:01 Flow Cytometry Immunohistochemistry |
EP11374_1 |
NY-ESO-1 157-165 mutant (HLA-A*02:01) 165C
SLLMWITQC is a linear peptidic epitope (epitope ID59278) studied as part of Cancer/testis antigen 1 from... |
SLLMWITQC | 57,50 | HumanHLA-A*02:01 Flow Cytometry |
EP11373_1 |
Nuf2 56–64 (HLA-A*24:02)
VYGIRLEHF is a linear peptidic epitope (epitope ID473138) studied as part of Kinetochore protein Nuf2... |
VYGIRLEHF | 57,50 | HLA-A*24:02 |
EP11372_1 |
Nucleocapsid 327-335 (HLA-A*02:01)
LVWMACHSA is a linear peptidic epitope (epitope ID548768) studied as part of Nucleoprotein from Influenza A... |
LVWMACHSA | 57,50 | InfluenzaHLA-A*02:01 Flow Cytometry Immunohistochemistry |
EP11371_1 |
HCV NS3 1073-1081 (HLA-A*02:01)
CINGVCWTV is a linear peptidic epitope (epitope ID6435) studied as part of Genome polyprotein from... |
CINGVCWTV | 57,50 | HCVHLA-A*02:01Hepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11370_1 |
NRP-1 433–441 (HLA-A*02:01)
# |
GMLGMVSGL | 57,50 | HumanHLA-A*02:01Cancerother name: West Nile Virus NY-99 polyprotein precursor (1452-1461) Flow Cytometry Immunohistochemistry |
EP11369_1 |
MYH9 741-749 (HLA-A*02:01)
Human MYH9 of peptide VLMIKALEL covering 741-749 and HLA-A*02:01 molecule. The peptide recognizes CD8 T... |
VLMIKALEL | 57,50 | HumanHLA-A*02:01 Flow Cytometry |
EP11368_1 |
MYH9 478-486 (HLA-A*02:01)
Human MYH9 of peptide QLFNHTMFI covering 478-486 and HLA-A*02:01 molecule. The peptide recognizes CD8 T... |
QLFNHTMFI | 57,50 | HumanHLA-A*02:01 Flow Cytometry |
EP11367_1 |
Myelin basic protein 110-118 (HLA-A*02:01)
SLSRFSWGA is a linear peptidic epitope (epitope ID59472) studied as part of Myelin basic protein... |
SLSRFSWGA | 57,50 | HumanHLA-A*02:01 Flow Cytometry |
EP11366_1 |
Mycobacterium bovis antigen 85-A 200-208 (HLA-A*02:01)
KLIANNTRV is a linear peptidic epitope (epitope ID31902) studied as part of Diacylglycerol... |
KLIANNTRV | 57,50 | Mycobacterium bovisHLA-A*02:01other name: Non-muscle Myosin 478-486 ï¾ T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11365_1 |
Mycobacterium bovis antigen 85-A 6-14 ( HLA-A*02:01)
GLPVEYLQV is a linear peptidic epitope (epitope ID21078) studied as part of Diacylglycerol... |
GLPVEYLQV | 57,50 | Mycobacterium bovis HLA-A*02:01other name: Non muscle Myosin-9 741-749 ï¾ T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11364_1 |
MUC-1 7-15 (HLA-B*07:02)
# |
SPFFLLLLL | 57,50 | HumanHLA-B*07:02Breast cancer;Cancer;Epithelium ï¾ T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11360_1 |
Mesothelin 530–538 (HLA-A*02:01)
VLPLTVAEV is a linear peptidic epitope (epitope ID472635) studied as part of Mesothelin from Homo sapiens... |
VLPLTVAEV | 57,50 | HumanHLA-A*02:01 Flow Cytometry Immunohistochemistry |
EP11358_1 |
Mesothelin 429-437 (HLA-A*01:01)
# |
TLDTLTAFY | 57,50 | HumanHLA-A*01:01 Flow Cytometry Immunohistochemistry |
EP11357_1 |
Midkine 110-119 (HLA-A*24:02)
# |
RYNAQCQETI | 57,50 | HumanHLA-A*24:02 Flow Cytometry Immunohistochemistry |
EP11356_1 |
Midkine 114–122 (HLA-A*02:01)
# |
AQCQETIRV | 57,50 | HumanHLA-A*02:01 Flow Cytometry Immunohistochemistry |
EP11355_1 |
Mena protein (overexpressed in breast cancer) (HLA-A*02:01)
# |
GLMEEMSAL | 57,50 | HumanHLA-A*02:01other name: MSLN 530ï¾–538 (HLA-A*02:01) |
EP11354_1 |
MELK 87-95 (HLA-A*24:02) 93N
# |
EYCPGGNLF | 57,50 | Humanother name: MSLN 429-437 (HLA-A*01:01) Flow Cytometry |
EP11353_1 |
Mcl-1 95-103 (HLA-A*03:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
RLLFFAPTR | 57,50 | HumanHLA-A*03:01 Flow Cytometry |
EP11352_1 |
MART-1 26-35 (HLA-B*35:01)
# |
EAAGIGILTY | 57,50 | HumanHLA-B*35:01 Flow Cytometry Immunohistochemistry |
EP11351_1 |
MAGE-A3 112-120 mutant (HLA-A*02:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
KVAEELVHFL | 57,50 | HumanHLA-A*02:01Cancer;Melanomaother name: MAGE-3 168-176 (HLA-A*01:01) Flow Cytometry |
EP11350_1 |
MAGE-A3 97-105 (HLA-A*24:02)
# |
TFPDLESEF | 57,50 | HLA-A*24:02Cancer;Melanoma Flow Cytometry |
EP11349_1 |
MAGE-A2 156-164 (HLA-A*24:02)
EYLQLVFGI is a linear peptidic epitope (epitope ID15058) studied as part of Melanoma-associated antigen 2... |
EYLQLVFGI | 57,50 | HumanHLA-A*24:02Cancer;Melanoma Flow Cytometry |
EP11347_1 |
MAGE-A3 112-120 (HLA-A*02:01)
KVAELVHFL is a linear peptidic epitope (epitope ID33943) studied as part of Melanoma-associated antigen 9... |
KVAELVHFL | 57,50 | HumanHLA-A*02:01Cancer;Melanoma Flow Cytometry |
EP11346_1 |
MAGE-A2 157-166 (HLA-A*02:01)
YLQLVFGIEV is a linear peptidic epitope (epitope ID74881) studied as part of Melanoma-associated antigen 12... |
YLQLVFGIEV | 57,50 | HumanHLA-A*02:01Cancer;Melanoma Flow Cytometry |
EP11345_1 |
MAGE-A1 289-298 (HLA-B*07:02)
RVRFFFPSL is a linear peptidic epitope (epitope ID179897) studied as part of Melanoma-associated antigen 1... |
RVRFFFPSL | 57,50 | HumanHLA-B*07:02Cancer;Melanomaother name: MAGE-10 254-262 (HLA-A*02:01) T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11344_1 |
MAGE-A1 278-286 (HLA-A*02:01)
KVLEYVIKV is a linear peptidic epitope (epitope ID34095) studied as part of Melanoma-associated antigen 1... |
KVLEYVIKV | 57,50 | HumanHLA-A*02:01Cancer;Melanoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11343_5 |
MAGE-A4 230–239 (HLA-A*02:01)
GVYDGREHTV is a linear peptidic epitope (epitope ID95091) studied as part of Melanoma-associated antigen 4... |
GVYDGREHTV | 57,50 | HumanHLA-A*02:01Cancer;Melanoma Flow Cytometry |
EP11341_1 |
MAGEA-10 254-262 (HLA-A*02:01)
GLYDGMEHL is a linear peptidic epitope (epitope ID189401) studied as part of Melanoma-associated antigen 10... |
GLYDGMEHL | 57,50 | HumanHLA-A*02:01Cancer;Melanoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11340_1 |
LY6K 177-186 (HLA-A*24:02)
# |
RYCNLEGPPI | 57,50 | HumanHLA-A*24:02 Flow Cytometry Immunohistochemistry |
EP11339_1 |
LY6K (HLA-A*02:01)
# |
LLLASIAAGL | 57,50 | HumanHLA-A*02:01other name: Lymphocyte antigen 6 complex locus K (LY6K) 177-186 Flow Cytometry Immunohistochemistry |
EP11335_1 |
Livin 175-184 (HLA-A*02:01)
QLCPICRAPV is a linear peptidic epitope (epitope ID117066) studied as part of Baculoviral IAP... |
QLCPICRAPV | 57,50 | HumanHLA-A*02:01 Flow Cytometry |
EP11334_1 |
Lengsin 206-215 (HLA-A*02:01)
# |
FIYDFCIFGV | 57,50 | HumanHLA-A*02:01 Flow Cytometry Immunohistochemistry |
EP11333_1 |
LANA 1116-1124 (HLA-A*02:01)
QMARLAWEA is a linear peptidic epitope (epitope ID51597) studied as part of Protein ORF73 from Human... |
QMARLAWEA | 57,50 | HSVHLA-A*02:01 Flow Cytometry |
EP11332_1 |
LANA 281-289 (HLA-A*02:01)
AMLVLLAEI is a linear peptidic epitope (epitope ID142528) studied as part of Protein ORF73 from Human... |
AMLVLLAEI | 57,50 | HHV-8HLA-A*02:01 Flow Cytometry Immunohistochemistry |
EP11331_1 |
PSA-1 154-163 (HLA-A*02:01)
# |
VISNDVCAQV | 57,50 | HLA-A*02:01 |
EP11330_1 |
KIF20A 67-75 (HLA-A*24:02)
# |
VYLRVRPLL | 57,50 | HumanHLA-A*24:02 Flow Cytometry Immunohistochemistry |
EP11329_1 |
KIF20A (HLA-A*24:02)
# |
KYYLRVRPLL | 57,50 | HumanHLA-A*24:02 Flow Cytometry Immunohistochemistry |
EP11328_1 |
K8.1 135–143 (HLA-A*02:01)
ALISAFSGS is a linear peptidic epitope (epitope ID142525) studied as part of Protein K8.1 from Human... |
ALISAFSGS | 57,50 | HSVHLA-A*02:01 Flow Cytometry Immunohistochemistry |
EP11327_1 |
ITGB8 662-670 (HLA-A*02:01)
# |
ALMEQQHYV | 57,50 | HumanHLA-A*02:01 Flow Cytometry Immunohistochemistry |
EP11326_1 |
Interferon gamma inducible protein (GILT) 30 27-35 (HLA-A*02:01)
LLDVPTAAV is a linear peptidic epitope (epitope ID37182) studied as part of Gamma-interferon-inducible... |
LLDVPTAAV | 57,50 | HumanHLA-A*02:01other name: Proinsulin precursor 15-24 Flow Cytometry |
EP11324_1 |
Insulin 15-24 (HLA-A*02:01)
ALWGPDPAAA is a linear peptidic epitope (epitope ID103041) studied as part of Insulin (UniProt:P01308) from... |
ALWGPDPAAA | 57,50 | HumanHLA-A*02:01Diabetes Flow Cytometry |
EP11323_1 |
Influenza A NP 44-52 (HLA-A*01:01)
CTELKLSDY is a linear peptidic epitope (epitope ID7136) studied as part of Nucleoprotein from Influenza A... |
CTELKLSDY | 57,50 | Influenza VirusHLA-A*01:01Infection, Influenza, Swine Flu, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11322_1 |
Influenza A MP 59-68 (HLA-A*02:01)
ILGFVFTLTV is a linear peptidic epitope (epitope ID27066) studied as part of Matrix protein 1 from... |
ILGFVFTLTV | 57,50 | Influenza VirusHLA-A*02:01Infection, Influenza, Swine Flu, Respiratory infectionother name: CEF26, Influenza Virus NP (265 - 274) T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11321_1 |
Influenza B BNP 85-94 (HLA-A*02:01)
KLGEFYNQMM is a linear peptidic epitope (epitope ID31880) studied as part of Nucleoprotein from Influenza B... |
KLGEFYNQMM | 57,50 | Influenza Virus BHLA-A*02:01 Flow Cytometry Immunohistochemistry |
EP11320_1 |
Influenza A PB1 329-337 (HLA-B*07:02)
QPEWFRNVL is a linear peptidic epitope (epitope ID51809) studied as part of RNA-directed RNA polymerase... |
QPEWFRNVL | 57,50 | Influenza VirusHLA-B*07:02Infection, Influenza, Swine Flu, Respiratory infectionother name: CEF8, Influenza Virus NP (383 - 391) T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11319_5 |
Influenza A PB1 591-599 (HLA-A*01:01)
VSDGGPNLY is a linear peptidic epitope (epitope ID70898) studied as part of RNA-directed RNA polymerase... |
VSDGGPNLY | 57,50 | Influenza VirusHLA-A*01:01Infection, Influenza, Swine Flu, Respiratory infectionother name: CEF25, Influenza Virus NP (44 - 52) T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11318_1 |
Influenza A NP 383-391 (HLA-B*27:05)
SRYWAIRTR is a linear peptidic epitope (epitope ID60867) studied as part of Nucleoprotein from Influenza A... |
SRYWAIRTR | 57,50 | Influenza VirusHLA-B*27:05Infection, Influenza, Swine Flu, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11317_1 |
Influenza A NP 473-481 (HLA-B*07:02)
SPIVPSFDM is a linear peptidic epitope (epitope ID60089) studied as part of Nucleoprotein from Influenza A... |
SPIVPSFDM | 57,50 | Influenza VirusHLA-B*07:02Infection, Influenza, Swine Flu, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11316_1 |
Influenza A MP2 70-78 (HLA-A*11:01)
KSMREEYRK is a linear peptidic epitope (epitope ID33447) studied as part of Matrix protein 2 from Influenza... |
KSMREEYRK | 57,50 | Influenza VirusHLA-A*11:01Infection, Influenza, Swine Flu, Respiratory infectionother name: CEF3, Influenza Virus MP 13-21 T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11315_1 |
Influenza A MP1 178-187 (HLA-A*11:01)
RMVLASTTAK is a linear peptidic epitope (epitope ID54953) studied as part of Matrix protein 1 from... |
RMVLASTTAK | 57,50 | Influenza VirusHLA-A*11:01Infection, Influenza, Swine Flu, Respiratory infectionother name: Flu MP 58, Influenza Matrix Peptide, Influenza Virus Matrix Protein (58-66), NH2-GILGFVFTL-OH. T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11314_1 |
Influenza A MP 13-21 (HLA-A*11:01)(HLA-A*03:01)(HLA-A*31:01)(HLA-A*68:01)
SIIPSGPLK is a linear peptidic epitope (epitope ID58567) studied as part of Matrix protein 1 from Influenza... |
SIIPSGPLK | 57,50 | Influenza VirusHLA-A*11:01 HLA-A*03:01 HLA-A*31:01 HLA-A*68:01Infection, Influenza, Swine Flu, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11313_1 |
Influenza A (PR8) NP 265-274 (HLA-A*03:01)
ILRGSVAHK is a linear peptidic epitope (epitope ID27283) studied as part of Nucleoprotein from Influenza A... |
ILRGSVAHK | 57,50 | Influenza VirusHLA-A*03:01Infection, Influenza, Swine Flu, Respiratory infection Flow Cytometry |
EP11311_1 |
IL13r 146-154 (HLA-A*24:02)
# |
VYYNWQYLL | 57,50 | HumanHLA-A*24:02AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1other name: T1D Diabetes IGRP 228ï¾–236 Flow Cytometry Immunohistochemistry |
EP11312_1 |
IL13Ra 345-353 (HLA-A*02:01)
# |
ALPFGFILV | 57,50 | HumanHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1other name: T1D Diabetes IGRP 265-273 Flow Cytometry Immunohistochemistry |
EP11310_1 |
IGRP 265–273 (HLA-A*02:01)
VLFGLGFAI is a linear peptidic epitope (epitope ID103705) studied as part of Glucose-6-phosphatase 2 from... |
VLFGLGFAI | 57,50 | HumanHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Flow Cytometry |
EP11308_1 |
IE62 (HLA-A*02:01)
# |
ATGEALWAL | 57,50 | HSVHLA-A*02:01 Flow Cytometry Immunohistochemistry |
EP11307_1 |
IDO199-207 (HLA-A*02:01)
# |
ALLEIASCL | 57,50 | HLA-A*02:01 |
EP11306_1 |
IAPP 5-13 (HLA-A*02:01)
Antigen Peptide Islet amyloid polypeptide IAPP 5-13 (HLA-A*02:01) KLQVFLIVL for stimulation of... |
KLQVFLIVL | 57,50 | HLA-A*02:01Alzheimer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11305_1 |
IA-2 805-813 (HLA-A*02:01)
VIVMLTPLV is a linear peptidic epitope (epitope ID102899) studied as part of Receptor-type tyrosine-protein... |
VIVMLTPLV | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry Immunohistochemistry |
EP11304_1 |
IA-2 797-805 (HLA-A*02:01)
MVWESGCTV is a linear peptidic epitope (epitope ID140054) studied as part of Receptor-type tyrosine-protein... |
MVWESGCTV | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry Immunohistochemistry |
EP11303_1 |
hTRT 461-469 (HLA-A*24:02)
VYGFVRACL is a linear peptidic epitope studied as part of Telomerase reverse transcriptase from Homo... |
VYGFVRACL | 57,50 | HumanHLA-A*24:02Cancer |
EP11302_1 |
hTOM34p (HLA-A*24:02)
# |
KLRGEVKQNL | 57,50 | HumanHLA-A*24:02Cancerother name: Human T-cell lymphotropic virus-1 (HTLV-1) tax 11-19 Flow Cytometry Immunohistochemistry |
EP11301_1 |
HTLV Tax 301-309 (HLA-A*24:02)
SFHSLHLLF is a linear peptidic epitope (epitope ID57790) studied as part of Protein Tax-1 from Primate... |
SFHSLHLLF | 57,50 | HTLV-1HLA-A*24:02 Flow Cytometry |
EP11300_5 |
HTLV Tax 11-19 (HLA-A*02:01)
LLFGYPVYV is a linear peptidic epitope (epitope ID37257) studied as part of Protein Tax-1 from Primate... |
LLFGYPVYV | 57,50 | HTLV-1HLA-A*02:01 Flow Cytometry |
EP11299_1 |
hTERT 663-672 (HLA-A*03:01)
# |
SVLNYERARR | 57,50 | HumanHLA-A*03:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Flow Cytometry Immunohistochemistry |
EP11298_1 |
HSP105 180-188 (HLA-A*24:02)
# |
NYGIYKQDL | 57,50 | HumanHLA-A*24:02AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Flow Cytometry |
EP11297_1 |
HSP105 640–649 (HLA-A*24:02)
# |
EYVYEFRDKL | 57,50 | HumanHLA-A*24:02AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Flow Cytometry Immunohistochemistry |
EP11296_1 |
HSP105 128-136 (HLA-A*02:01)
RLMNDMTAV is a linear peptidic epitope (epitope ID447452) studied as part of Heat shock protein 105 kDa... |
RLMNDMTAV | 57,50 | HumanHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Flow Cytometry |
EP11295_1 |
HSP105 234-243 (HLA-A*02:01)
# |
KLMSSNSTDL | 57,50 | HumanHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Flow Cytometry Immunohistochemistry |
EP11294_1 |
HPV 33 E7 5-13 (HLA-B*07:02)
# |
KPTLKEYVL | 57,50 | HPV HLA-B*07:02AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Flow Cytometry |
EP11293_1 |
HPV 16 E7 11-20 (HLA-A*02:01)
YMLDLQPETT is a linear peptidic epitope (epitope ID75075) studied as part of Protein E7 from... |
YMLDLQPETT | 57,50 | HPV 16HLA-A*02:01Cancer;Malignant genital cancers Flow Cytometry |
EP11292_1 |
HPV 16 E7 12-20 (HLA-A*02:01)
MLDLQPETT is a linear peptidic epitope (epitope ID41919) studied as part of Protein E7 from... |
MLDLQPETT | 57,50 | HPV 16HLA-A*02:01Cancer;Malignant genital cancers Flow Cytometry |
EP11291_1 |
HPV16 E7 82-92 (HLA-A*02:01)
LLMGTLGIVC is a linear peptidic epitope (epitope ID139161) studied as part of Protein E7 from... |
LLMGTLGIVC | 57,50 | HPV 16 HLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Flow Cytometry Immunohistochemistry |
EP11290_1 |
HPV 33 E6 86-94 (HLA-A*11:01)
# |
NTLEQTVKK | 57,50 | HPV HLA-A*11:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Flow Cytometry |
EP11289_1 |
HPV 33 E6 64-72 (HLA-A*03:01)
# |
KLCLRFLSK | 57,50 | HPV HLA-A*03:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Flow Cytometry |
EP11288_1 |
HO-1 212-220 (HLA-A*02:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
QLFEELQEL | 57,50 | HumanHLA-A*02:01 Flow Cytometry Immunohistochemistry |
EP11287_1 |
HMOX1 265-272 (HLA-B*08:01)
APLLRWVL is a linear peptidic epitope (epitope ID442536) studied as part of Heme oxygenase 1... |
APLLRWVL | 57,50 | HumanHLA-B*08:01 Flow Cytometry Immunohistochemistry |
EP11285_1 |
hMena 502-510 (HLA-A*02:01)
# |
TMNGSKSPV | 57,50 | HumanHLA-A*02:01 |
EP11284_1 |
HLA-A2 140-149 (HLA-A*02:01)
YAYDGKDYIA is a linear peptidic epitope (epitope ID128149) studied as part of HLA class I... |
YAYDGKDYIA | 57,50 | HumanHLA-A*02:01 |
EP11283_1 |
HJURP (HLA-A*24:02)
# |
KWLISPVKI | 57,50 | HumanHLA-A*24:02AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1other name: IV9 (476 - 484), HIV - 1 RT Epitope Flow Cytometry Immunohistochemistry |
EP11282_1 |
HIV-1 RT 330-338 (HLA-B*35:01)
NPDIVIYQY is a linear peptidic epitope (epitope ID45315) studied as part of Gag-Pol polyprotein from Human... |
NPDIVIYQY | 57,50 | HIV-1HLA-B*35:01AIDS (HIV) Flow Cytometry |
EP11281_1 |
HIV-1 p17 20-29 (HLA-B*15:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
RLRPGGKKKY | 57,50 | HIV-1HLA-B*15:01AIDS (HIV) Flow Cytometry |
EP11280_1 |
HIV-1 Nef 92-100 (HLA-B*40:01)
KEKGGLEGL is a linear peptidic epitope (epitope ID30464) studied as part of Protein Nef from Human... |
KEKGGLEGL | 57,50 | HIV-1HLA-B*40:01AIDS (HIV) Flow Cytometry |
EP11279_1 |
HIV-1 nef 90-97 (HLA-B*08:01)
FLKEKGGL is a linear peptidic epitope (epitope ID230122) studied as part of Protein Nef from Human... |
FLKEKGGL | 57,50 | HIV-1HLA-B*08:01AIDS (HIV) Flow Cytometry |
EP11278_1 |
HIV-1 Nef 134-143 (HLA-A*24:02)
# |
RYPLTFGWCY | 57,50 | HIV-1HLA-A*24:02AIDS (HIV) Flow Cytometry |
EP11276_1 |
HIV-1 Gag p24 263-272 (HLA-B*27:05)
KRWIIMGLNK is a linear peptidic epitope (epitope ID184136) studied as part of Gag polyprotein from Human... |
KRWIIMGLNK | 57,50 | HIV-1HLA-B*27:05AIDS (HIV) Flow Cytometry |
EP11275_1 |
HIV-1 gag p24 261-269 (HLA-B*08:01)
GEIYKRWII is a linear peptidic epitope (epitope ID19313) studied as part of Gag polyprotein from Human... |
GEIYKRWII | 57,50 | HIV-1HLA-B*08:01AIDS (HIV) Flow Cytometry |
EP11272_1 |
HIV-1 env gp120 843–851 (HLA-B*07:02)
IPRRIRQGL is a linear peptidic epitope (epitope ID28049) studied as part of Envelope glycoprotein gp160... |
IPRRIRQGL | 57,50 | HIV-1HLA-B*07:02AIDS (HIV) Flow Cytometry Immunohistochemistry |
EP11271_1 |
HIV-1 env gp120 90-98 (HLA-A*02:01)
KLTPLCVTL is a linear peptidic epitope (epitope ID32201) studied as part of Envelope glycoprotein gp160... |
KLTPLCVTL | 57,50 | HIV-1HLA-A*02:01AIDS (HIV) Flow Cytometry |
EP11270_1 |
HIV Vpu 66-74 (HLA-A*02:01)
# |
ALVEMGHHA | 57,50 | HIVHLA-A*02:01AIDS (HIV) Flow Cytometry Immunohistochemistry |
EP11269_1 |
HIV-1 Vif 101-109 (HLA-A*02:01)
GLADQLIHL is a linear peptidic epitope (epitope ID126126) studied as part of Virion infectivity factor from... |
GLADQLIHL | 57,50 | HIV-1HLA-A*02:01AIDS (HIV) Flow Cytometry |
EP11268_1 |
HIV Vif 23-31 (HLA-A*02:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
SLVKHHMYI | 57,50 | HIVHLA-A*02:01AIDS (HIV) Flow Cytometry Immunohistochemistry |
EP11267_1 |
HIV Pol (HLA-A*02:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
VIYHYVDDL | 57,50 | HIVHLA-A*02:01AIDS (HIV) Flow Cytometry Immunohistochemistry |
EP11266_1 |
HIV Pol 606–614 (HLA-A*02:01)
# |
KLGKAGYVT | 57,50 | HIVHLA-A*02:01AIDS (HIV) Flow Cytometry Immunohistochemistry |
EP11265_1 |
HIV-1 nef 128-137 (HLA-B*07:02)
TPGPGVRYPL is a linear peptidic epitope (epitope ID110725) studied as part of Protein Nef from Human... |
TPGPGVRYPL | 57,50 | HIV-1HLA-B*07:02AIDS (HIV) Flow Cytometry |
EP11264_1 |
HIV nef 131-140 (HLA-A*24:02)
RYPLTFGWCF is a linear peptidic epitope (epitope ID56620) studied as part of Protein Nef from Human... |
RYPLTFGWCF | 57,50 | HIVHLA-A*24:02AIDS (HIV) Flow Cytometry |
EP11263_1 |
HIV nef 84-92 (HLA-A*11:01)
AVDLSHFLK is a linear peptidic epitope (epitope ID5295) studied as part of Protein Nef from Human... |
AVDLSHFLK | 57,50 | HIVHLA-A*11:01AIDS (HIV) Flow Cytometry Immunohistochemistry |
EP11262_1 |
HIV-1 nef 73-82 (HLA-A*03:01)
QVPLRPMTYK is a linear peptidic epitope (epitope ID52760) studied as part of Protein Nef from Human... |
QVPLRPMTYK | 57,50 | HIV-1HLA-A*03:01AIDS (HIV) Flow Cytometry |
EP11261_1 |
HIV gag p24 223–231 (HLA-B*07:02)
GPGHKARVL is a linear peptidic epitope (epitope ID21635) studied as part of Gag polyprotein from Human... |
GPGHKARVL | 57,50 | HIVHLA-B*07:02AIDS (HIV) Flow Cytometry |
EP11260_1 |
HIV-2 gag 260-269 (HLA-B*27:05)
# |
RRWIQLGLQK | 57,50 | HIV-2HLA-B*27:05AIDS (HIV) Flow Cytometry |
EP11258_1 |
HIV Gag p24 128-136 (HLA-B*08:01)
# |
DIYKRWII | 57,50 | HIVHLA-B*08:01AIDS (HIV) Flow Cytometry Immunohistochemistry |
EP11257_1 |
HIV gag 79-86 (HLA-A*29:02)
LYNTVATLY is a linear peptidic epitope (epitope ID126652) studied as part of Gag-Pol polyprotein from Human... |
LYNTVATLY | 57,50 | HIVHLA-A*29:02AIDS (HIV) Flow Cytometry |
EP11256_1 |
HIV-1 gag p17 20-28 (HLA-A*03:01)
RLRPGGKKK is a linear peptidic epitope (epitope ID54741) studied as part of Gag polyprotein from Human... |
RLRPGGKKK | 57,50 | HIV-1HLA-A*03:01AIDS (HIV) Flow Cytometry Immunohistochemistry |
EP11255_1 |
HIV-1 gag p24 19-27 (HLA-A*02:01)
TLNAWVKVV is a linear peptidic epitope (epitope ID64961) studied as part of Gag polyprotein from Human... |
TLNAWVKVV | 57,50 | HIV-1HLA-A*02:01AIDS (HIV)other name: IV9 (476 - 484), HIV - 1 RT Epitope Flow Cytometry |
EP11254_1 |
HIV-1 p17 Gag 77-86 (HLA-A*02:01)
SLYNTVATLY is a linear peptidic epitope (epitope ID 190980) studied as part of Gag polyprotein from Human... |
SLYNTVATLY | 57,50 | HIV-1HLA-A*02:01AIDS (HIV) Flow Cytometry Immunohistochemistry |
EP11253_1 |
HIV Gag 50-59 (HLA-A*02:01)
SLFNTVATLY is a linear peptidic epitope (epitope ID127083) studied as part of Gag polyprotein from Human... |
SLFNTVATLY | 57,50 | HIVHLA-A*02:01AIDS (HIV) Flow Cytometry |
EP11252_1 |
HIV Gag 77-85 (HLA-A*02:01)
SLFNTVATL is a linear peptidic epitope (epitope ID131070) studied as part of Gag polyprotein from Human... |
SLFNTVATL | 57,50 | HIVHLA-A*02:01AIDS (HIV) Flow Cytometry |
EP11251_1 |
HIV Gag 150-158 (HLA-A*02:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
RTLNAWVKV | 57,50 | HIVHLA-A*02:01AIDS (HIV) Flow Cytometry Immunohistochemistry |
EP11250_1 |
HIV Gag 433-440 (HLA-A*02:01)
Therapeutic vaccination of chronically infected HIV-1 subjects was evaluated as a means of halting disease... |
FLGKIWPS | 57,50 | HIVHLA-A*02:01AIDS (HIV) Flow Cytometry Immunohistochemistry |
EP11249_1 |
HIV Env 314–322 (HLA-B*27:05)
GRAFVTIGK is a linear peptidic epitope (epitope ID302918) studied as part of Envelope glycoprotein gp160... |
GRAFVTIGK | 57,50 | HIVHLA-B*27:05AIDS (HIV) Flow Cytometry Immunohistochemistry |
EP11247_1 |
HIV env 382-391 (HLA-A*29:02)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
SFNCRGEFFY | 57,50 | HIVHLA-A*29:02AIDS (HIV) Flow Cytometry Immunohistochemistry |
EP11246_1 |
HIV env 216-224 (HLA-A*29:02)
HLA class I restricted CD8+ T-cell responses against HIV-1 were analyzed in African patients. Significantly... |
SFDPIPIHY | 57,50 | HIVHLA-A*29:02AIDS (HIV) Flow Cytometry Immunohistochemistry |
EP11245_1 |
HIV env 584–592 (HLA-A*24:02)
RYLRDQQLL is a linear peptidic epitope (epitope ID56585) studied as part of Envelope glycoprotein gp160... |
RYLRDQQLL | 57,50 | HIVHLA-A*24:02AIDS (HIV)other name: HHV-8, glycoprotein B (gB) 492-500 (HLA-A*02:01) Flow Cytometry |
EP11244_1 |
HIV Env gp160 585-593 (HLA-A*24:02)
RYLKDQQLL is a linear peptidic epitope (epitope ID56574) studied as part of Envelope glycoprotein gp160... |
RYLKDQQLL | 57,50 | HIVHLA-A*24:02AIDS (HIV) Flow Cytometry |
EP11242_1 |
HIV Env gp 67-75 (HLA-A*02:01)
NVWATHACV is a linear peptidic epitope (epitope ID126795) studied as part of Envelope glycoprotein gp160... |
NVWATHACV | 57,50 | HIVHLA-A*02:01AIDS (HIV) Flow Cytometry Immunohistochemistry |
EP11241_1 |
LCMV GPC 447-455 (HLA-A*02:01)
YLVSIFLHL is a linear peptidic epitope (epitope ID74978) studied as part of Pre-glycoprotein polyprotein GP... |
YLVSIFLHL | 57,50 | LCMVHLA-A*02:01meningitis, encephalitis ,meningoencephalitis Flow Cytometry Immunohistochemistry |
EP11240_1 |
HHV8 NP 69-77 (HLA-A*02:01)
SLNQTVHSL is a linear peptidic epitope (epitope ID59366) studied as part of Nucleoprotein from Lymphocytic... |
SLNQTVHSL | 57,50 | HSVHLA-A*02:01 Flow Cytometry |
EP11239_1 |
HHV8 ND 17-25 (HLA-A*02:01)
LLNGWRWRL is a linear peptidic epitope (epitope ID37607) studied as part of Protein K12 from Human... |
LLNGWRWRL | 57,50 | HSVHLA-A*02:01 |
EP11237_1 |
EBV BALF-4 276-284 (HLA-A*02:01)
FLDKGTYTL is a linear peptidic epitope (epitope ID16548) studied as part of Envelope glycoprotein B from... |
FLDKGTYTL | 57,50 | EBVHLA-A*02:01Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma Flow Cytometry |
EP11236_1 |
HHV-8 gB 492-500 (HLA-A*02:01)
LMWYELSKI is a linear peptidic epitope (epitope ID38158) studied as part of Envelope glycoprotein B from... |
LMWYELSKI | 57,50 | HSVHLA-A*02:01 Flow Cytometry Immunohistochemistry |
EP11235_1 |
HER-2/neu 85–94 (HLA-A*02:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
LIAHNQVRQV | 57,50 | HumanHLA-A*02:01Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11234_1 |
HER-2 434-443 (HLA-A*02:01)
# |
ILHDGAYSL | 57,50 | HumanHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11233_1 |
HER-2/neu 63-71 (HLA-A*24:02)
TYLPTNASL is a linear peptidic epitope (epitope ID67385) studied as part of Receptor tyrosine-protein... |
TYLPTNASL | 57,50 | HumanHLA-A*24:02Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11230_1 |
HCV NS3 1373–1380 (HLA-B*51:01)
IPFYGKAI is a linear peptidic epitope (epitope ID27847) studied as part of Genome polyprotein from... |
IPFYGKAI | 57,50 | HCVHLA-B*51:01Hepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11226_1 |
HCV NS3 1395-1403 (HLA-B*08:01)
HSKKKCDEL is a linear peptidic epitope (epitope ID24762) studied as part of Genome polyprotein from... |
HSKKKCDEL | 57,50 | HCVHLA-B*08:01Hepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11225_1 |
HCV NS4A 1635-1643 (HLA-A*03:01)
VTLTHPITK is a linear peptidic epitope (epitope ID71412) studied as part of Genome polyprotein from... |
VTLTHPITK | 57,50 | HCVHLA-A*03:01Hepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11224_1 |
HCV NS4B 214-222 (HLA-A*02:01)
LLWNGPMAV is a linear peptidic epitope (epitope ID121572) studied as part of Genome polyprotein from Yellow... |
LLWNGPMAV | 57,50 | HCVHLA-A*02:01Hepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11227_1 |
NS5B 2841-2849 (HLA-B*27:05)
ARMILMTHF is a linear peptidic epitope (epitope ID4197) studied as part of Genome polyprotein from... |
ARMILMTHF | 57,50 | HLA-B*27:05Hepatitis-C-Virusother name: CDCA1 56ï¾–64 |
EP11223_1 |
HCV Polyprotein 1273-1282 (HLA-A*02:01)
GVDPNIRTGV is a linear peptidic epitope (epitope ID97373) studied as part of Genome polyprotein from... |
GVDPNIRTGV | 57,50 | HCVHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11222_1 |
HCV NS3 1073-1081 mutant (HLA-A*02:01) 1074V
CVNGVCWTV is a linear peptidic epitope (epitope ID7292) studied as part of Genome polyprotein from... |
CVNGVCWTV | 57,50 | HCVHLA-A*02:01Hepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11221_1 |
HCV NS3 1436-1444 mutant (HLA-A*01:01) 1444Y
ATDALMTGY is a linear peptidic epitope (epitope ID4917) studied as part of Genome polyprotein from... |
ATDALMTGY | 57,50 | HCVHLA-A*01:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11220_1 |
HCV NS5B 2588-2596 (HLA-A*03:01)
RVCEKMALY is a linear peptidic epitope (epitope ID56247) studied as part of Genome polyprotein from... |
RVCEKMALY | 57,50 | HCVHLA-A*03:01Hepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11219_1 |
HCV NS5B 2727-2735 (HLA-A*02:01)
# |
GLQDCTMLV | 57,50 | HCVHLA-A*02:01Hepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11218_1 |
HCV NS5a 2266-2275 (HLA-B*40:01)
REISVPAEIL is a linear peptidic epitope (epitope ID53541) studied as part of Genome polyprotein from... |
REISVPAEIL | 57,50 | HCVHLA-B*40:01Hepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11217_1 |
HCV NS5a 1992-2200 (HLA-A*02:01)
VLSDFKTWL is a linear peptidic epitope (epitope ID69751) studied as part of Genome polyprotein from... |
VLSDFKTWL | 57,50 | HCVHLA-A*02:01Hepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11214_1 |
EBV BZLF1 44-52 (HLA-B*07:02)
LPCVLWPVL is a linear peptidic epitope studied as part of Trans-activator protein BZLF1 from Human... |
LPCVLWPVL | 57,50 | HLA-B*07:02 |
EP11213_1 |
PSA-1 146-154 (HLA-A*02:01)
# |
KLQCVDLHV | 57,50 | HLA-A*02:01 |
EP11212_1 |
PSA-1 141-150 (HLA-A*02:01)
# |
FLTPKKLQCV | 57,50 | HLA-A*02:01 |
EP11208_1 |
HCV NS3 1359-1367 (HLA-B*35:01)
HPNIEEVAL is a linear peptidic epitope (epitope ID24479) studied as part of Genome polyprotein from... |
HPNIEEVAL | 57,50 | HCVHLA-B*35:01Hepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11207_1 |
HCV NS3 1031-1039 (HLA-A*24:02)
AYSQQTRGL is a linear peptidic epitope (epitope ID5934) studied as part of Genome polyprotein from... |
AYSQQTRGL | 57,50 | HCVHLA-A*24:02Hepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11206_1 |
HCV NS3 1406-1415 (HLA-A*02:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
KLSGLGINAV | 57,50 | HCVHLA-A*02:01Hepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11205_1 |
HCV NS3 1436-1444 (HLA-A*01:01)
ATDALMTGF is a linear peptidic epitope (epitope ID4916) studied as part of Genome polyprotein from... |
ATDALMTGF | 57,50 | HCVHLA-A*01:01Hepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11204_1 |
HCV E1 207-214 (HLA-B*35:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
CPNSSIVY | 57,50 | HCVHLA-B*35:01HepatitisHBV pol; Hepatitis B virus polymerase T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11203_1 |
HCV core 41-49 (HLA-B*07:02)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
GPRLGVRAT | 57,50 | HCVHLA-B*07:02Hepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11202_1 |
HCV core 111-119 (HLA-B*07:02)
DPRRRSRNL is a linear peptidic epitope (epitope ID9746) studied as part of Genome polyprotein from... |
DPRRRSRNL | 57,50 | HCVHLA-B*07:02Hepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11201_5 |
HCV core 35-44 (HLA-A*02:01)
YLLPRRGPRL is a linear peptidic epitope (epitope ID74798) studied as part of Genome polyprotein from... |
YLLPRRGPRL | 57,50 | HVCHLA-A*02:01Hepatitisother name: HLA-G peptide T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11200_1 |
HCV core 132-140 mutant (HLA-A*02:01) 139L
DLMGYIPLV is a linear peptidic epitope (epitope ID9203) studied as part of Genome polyprotein from... |
DLMGYIPLV | 57,50 | HVCHLA-A*02:01Hepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11199_1 |
HCV core 132-140 (HLA-A*02:01)
DLMGYIPAV is a linear peptidic epitope (epitope ID9199) studied as part of Genome polyprotein from... |
DLMGYIPAV | 57,50 | HCVHLA-A*02:01Hepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11198_1 |
HCMV pp65 363-373 (HLA-A*01:01)
YSEHPTFTSQY is a linear peptidic epitope (epitope ID75718) studied as part of 65 kDa phosphoprotein from... |
YSEHPTFTSQY | 57,50 | HCMVHLA-A*01:01Infection, Control, Cancer, TORCH, Infectious mononucleosis, CMV hepatitis, Retinitis, Colitis, Pneumonitis, Esophagitis, AIDS, Cancer chemotherapy, Transplantation T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11197_1 |
HCMV IE1 81-89 (HLA-A*02:01)
VLAELVKQI is a linear peptidic epitope (epitope ID69363) studied as part of 55 kDa immediate-early protein... |
VLAELVKQI | 57,50 | HCMVHLA-A*02:01Infection, Control, Cancer, TORCH, Infectious mononucleosis, CMV hepatitis, Retinitis, Colitis, Pneumonitis, Esophagitis, AIDS, Cancer chemotherapy, Transplantation T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11196_1 |
HBV envelope 335-343 (HLA-A*02:01)
Antigen Peptide HBV envelope 335-343 (HLA-A*02:01) GLSPTVWLSV for stimulation of antigen-specific T cells... |
WLSLLVPFV | 57,50 | HBVHLA-A*02:01Hepatitis Flow Cytometry |
EP11195_1 |
HBV envelope 348-357 (HLA-A*02:01)
Antigen Peptide HBV envelope 348-357 (HLA-A*02:01) GLSPTVWLSV for stimulation of antigen-specific T cells... |
GLSPTVWLSV | 57,50 | HBVHLA-A*02:01Hepatitis Flow Cytometry |
EP11194_1 |
HBV envelope 183-191 (HLA-A*02:01)
FLLTRILTI is a linear peptidic epitope (epitope ID16755) studied as part of Large envelope protein from... |
FLLTRILTI | 57,50 | HBVHLA-A*02:01other name: gp100 (pmel17) 17-25 (HLA-A*03:01) Flow Cytometry |
EP11193_1 |
HBV polymerase 756-764 (HLA-A*24:02)
KYTSFPWLL is a linear peptidic epitope (epitope ID34616) studied as part of Protein P from Hepatitis B... |
KYTSFPWLL | 57,50 | HBVHLA-A*24:02 Flow Cytometry |
EP11192_1 |
HBV polymerase 575 - 583 (HLA-A*02:01)
FLLSLGIHL is a linear peptidic epitope (epitope ID16751) studied as part of Protein P from Hepatitis B... |
FLLSLGIHL | 57,50 | HBVHLA-A*02:01 Flow Cytometry |
EP11191_1 |
HBV core 19-27 (HLA-B*35:01) (HLA-B*51:01)
LPSDFFPSV is a linear peptidic epitope (epitope ID38701) studied as part of Capsid protein from Hepatitis B... |
LPSDFFPSV | 57,50 | HBVHLA-B*35:01 HLA-B*51:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Flow Cytometry |
EP11190_1 |
HBV core antigen 88-96 (HLA-A*11:01)
YVNVNMGLK is a linear peptidic epitope (epitope ID76370) studied as part of Capsid protein from Hepatitis B... |
YVNVNMGLK | 57,50 | HBVHLA-A*11:01other name: gp100 (pmel17) 154-162 (HLA-A*02:01) Flow Cytometry |
EP11189_1 |
HBV core 18-27 (subtype ADR4) (HLA-A*02:01)
FLPSDFFPSI is a linear peptidic epitope (epitope ID16832) studied as part of External core antigen from... |
FLPSDFFPSI | 57,50 | HBVHLA-A*02:01Hepatitisother name: GILT 30 27-35 (HLA-A*02:01) Flow Cytometry |
EP11188_1 |
miHAg HA-8 (HLA-A*02:01)
# |
RTLDKVLEV | 57,50 | HumanHLA-A*02:01 Flow Cytometry |
EP11187_1 |
HBV core 117-125 (HLA-A*24:02)
EYLVSFGVW is a linear peptidic epitope (epitope ID15061) studied as part of Capsid protein from Hepatitis B... |
EYLVSFGVW | 57,50 | HBVHLA-A*24:02Hepatitis Flow Cytometry |
EP11186_1 |
H250 (HLA-A*02:01)
SMYRVFEVGV is a linear peptidic epitope (epitope ID 59787) studied as part of Hemagglutinin glycoprotein... |
SMYRVFEVGV | 57,50 | InfluenzaHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1other name: G250 (renal cell carcinoma) 217-225 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11185_1 |
miHAg H-Y (human SMCY) 311-319 (HLA-A*02:01)
FIDSYICQV is a linear peptidic epitope (epitope ID 137402) studied as part of Lysine-specific demethylase... |
FIDSYICQV | 57,50 | HumanHLA-A*02:01 Flow Cytometry |
EP11184_1 |
gp100 (pmel17) 476-485 (HLA-A*02:01)
# |
VLYRYGSFSV | 57,50 | HumanHLA-A*02:01 Flow Cytometry |
EP11181_1 |
gp100 280-288 mutant (HLA-A*02:01) 288V
Antigen Peptide gp100 280-288 mutant (HLA-A*02:01) 288V YLEPGPVTV for stimulation of antigen-specific T... |
YLEPGPVTV | 57,50 | HumanHLA-A*02:01Cancer, Epithelium, Melanoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11180_5 |
gp100 154-162 (HLA-A*02:01)
KTWGQYWQV is a linear peptidic epitope (epitope ID 33915) studied as part of Melanocyte protein PMEL from... |
KTWGQYWQV | 57,50 | HumanHLA-A*02:01 Flow Cytometry |
EP11179_1 |
GPC3 298-306 (HLA-A*24:02)
# |
EYILSLEEL | 57,50 | HumanHLA-A*24:02CancerForkhead Box M1; M-Phase Phosphoprotein 2; Hepatocyte Nuclear Factor 3 Forkhead Homolog 11; Winged-Helix Factor From INS-1 Cells; Forkhead-Related Protein FKHL16; MPM-2 Reactive Phosphoprotein 2; Transcription Factor Trident; HNF-3/Fork-Head Homolog 11; FKHL16; HFH-11; HFH11; MPP2; Flow Cytometry |
EP11178_1 |
GPC3 144-152 (HLA-A*02:01)
# |
FVGEFFTDV | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry |
EP11177_1 |
GAD65 114-123 (HLA-A*02:01)
Antigen Peptide GAD65 114-123 (HLA-A*02:01) (VMNILLQYVV) for stimulation of antigen-specific T cells in T... |
VMNILLQYVV | 57,50 | HumanHLA-A*02:01Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11176_1 |
GAD65 114–122 (HLA-A*02:01)
VMNILLQYV is a linear peptidic epitope (epitope ID 104336) studied as part of Glutamate decarboxylase 2... |
VMNILLQYV | 57,50 | HumanHLA-A*02:01 Flow Cytometry |
EP11175_1 |
G250 217-225 (HLA-A*02:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
HLSTAFARV | 57,50 | HumanHLA-A*02:01other name: Ewing Tumor EZH2 666-674 (HLA-A*02:01) Flow Cytometry |
EP11172_1 |
FOXM1 262-270 (HLA-A*24:02)
IYTWIEDHF is a linear peptidic epitope (epitope ID 467143) studied as part of Forkhead box protein M1 from... |
IYTWIEDHF | 57,50 | HumanHLA-A*24:02 Flow Cytometry Immunohistochemistry |
EP11171_1 |
FOLR1 191-199 (HLA-A*02:01)
# |
EIWTHSYKV | 57,50 | HumanHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11170_1 |
FLT1 (HLA-A*02:01)
# |
TLFWLLTL | 57,50 | HumanHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11169_1 |
FAP alpha 639-647 (HLA-A*02:01)
# |
GLFKCGIAV | 57,50 | HumanHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 2 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11168_1 |
FAP alpha 463-471 (HLA-A*02:01)
# |
ALVCYGPGI | 57,50 | HumanHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11167_1 |
EZH2 666-674 (HLA-A*02:01)
# |
YMCSFLFNL | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry |
EP11166_1 |
EZH2 729-737 (HLA-A*02:01)
# |
SQADALKYV | 57,50 | HumanHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11164_1 |
EphA2 883-891 (HLA-A*02:01)
# |
TLADFDPRV | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry |
EP11163_1 |
Endosialin 691-700 (HLA-A*02:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
LLVPTCVFLV | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry Immunohistochemistry |
EP11162_1 |
EGF-R-479 350-359 (HLA-A*02:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
KLFGTSGQKT | 57,50 | HumanHLA-A*02:01 |
EP11161_1 |
EGF-R 1138-1147 (HLA-A*02:01)
# |
YLNTVQPTCV | 57,50 | HumanHLA-A*02:01 Flow Cytometry |
EP11160_1 |
EDDR1 867-876 (HLA-A*02:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
FLAEDALNTV | 57,50 | HumanHLA-A*02:01 |
EP11159_1 |
EBV LMP2 200-208 (HLA-B*40:01)
IEDPPFNSL is a linear peptidic epitope (epitope ID 25756) studied as part of Latent membrane protein 2 from... |
IEDPPFNSL | 57,50 | EBVHLA-B*40:01 Flow Cytometry |
EP11158_1 |
EBV LMP2 419-427 (HLA-A*24:02)
# |
TYGPVFMSL | 57,50 | EBVHLA-A*24:02 |
EP11157_1 |
EBV LMP-2 419-427 (HLA-A*24:02)
Antigen Peptide EBV LMP-2 419-427 (HLA-A*24:02) TYGPVFMCL for stimulation of antigen-specific T cells in T... |
TYGPVFMCL | 57,50 | EBVHLA-A*24:02Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11156_1 |
EBV LMP-2 340-349 (HLA-A*11:01)
SSCSSCPLSK is a linear peptidic epitope (epitope ID60930) studied as part of Latent membrane protein 2 from... |
SSCSSCPLSK | 57,50 | EBVHLA-A*11:01Infectious mononucleosis, Burkitt's lymphoma, Hodgkin's lymphoma,gastric cancer,nasopharyngeal carcinoma, multiple sclerosis, and lymphomatoid granulomatosis |
EP11155_1 |
EBV LMP1 159-167 (HLA-A*02:01)
Antigen Peptide EBV LMP1 159-167 (HLA-A*02:01) YLQQNWWTL for stimulation of antigen-specific T cells in T... |
YLQQNWWTL | 57,50 | EBVHLA-A*02:01Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma ï¾ T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11154_1 |
EBV LMP-1 125-133 (HLA-A*02:01)
Antigen Peptide EBV LMP-1 125-133 (HLA-A*02:01) YLLEMLWRL for stimulation of antigen-specific T cells in T... |
YLLEMLWRL | 57,50 | EBVHLA-A*02:01Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma ï¾ T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11153_1 |
EBV EBNA3A 158-166 (HLA-B*08:01)
QAKWRLQTL is a linear peptidic epitope (epitope ID50298) studied as part of Epstein-Barr nuclear antigen 3... |
QAKWRLQTL | 57,50 | EBVHLA-B*08:01 |
EP11152_1 |
EBV EBNA-3C 881-889 (HLA-B*07:02)
QPRAPIRPI is a linear peptidic epitope (epitope ID 51946) studied as part of Epstein-Barr nuclear antigen 6... |
QPRAPIRPI | 57,50 | EBVHLA-B*07:02 |
EP11151_1 |
EBV EBNA3B 416-424 (HLA-A*11:01; HLA-A*68:01)
|
IVTDFSVIK | 57,50 | EBVHLA-A*11:01 HLA-A*68:01Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11149_1 |
EBV EBNA-3C 284-293 (HLA-A*02:01)
LLDFVRFMGV is a linear peptidic epitope (epitope ID 37153) studied as part of Epstein-Barr nuclear antigen... |
LLDFVRFMGV | 57,50 | EBVHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11148_1 |
EBV EBNA-3A 458-466 (HLA-B*35:01)
HLA-B35-restricted epitope from Epstein-Barr Virus latent nuclear antigen 3A (458-466) for stimulation of... |
YPLHEQHGM | 57,50 | EBVHLA-B*35:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11147_1 |
EBV EBNA 3A 246-253 (HLA-A*24:02)
RYSIFFDY is a linear peptidic epitope (epitope ID 56650) studied as part of Epstein-Barr nuclear antigen 3... |
RYSIFFDY | 57,50 | EBVHLA-A*24:02 |
EP11144_1 |
EBV BZLF-1 54-64 mutant (HLA-B*35:01)
# |
EPLSQSQITAY | 115,00 | EBVHLA-B*35:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11143_1 |
EBV BZLF-1 54-64 (HLA-B*35:01)
Antigen Peptide EBV BZLF1 HLA-B*3501 (EPLPQGQLTAY) for stimulation of antigen-specific T cells in T cell... |
EPLPQGQLTAY | 115,00 | EBVHLA-B*35:01Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11142_1 |
EBV BRLF1 101-109 (HLA-A*29:02)
# |
IACPIVMRY | 57,50 | EBVHLA-A*29:02AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11141_1 |
EBV BRLF1 28-37 (HLA-A*24:02)
Antigen Peptide EBV BRLF1 28-37 (HLA-A*24:02) DYCNVLNKEF for stimulation of antigen-specific T cells in T... |
DYCNVLNKEF | 57,50 | EBVHLA-A*24:02Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11140_5 |
EBV BRLF1 134-142 (HLA-A*11:01)
HLA-A11 restricted epitope from Epstein-Barr Virus BRLF1 (134-142) is a linear peptidic epitope (epitope ID... |
ATIGTAMYK | 57,50 | EBVHLA-A*11:01 |
EP11139_1 |
BRLF1 109-117 (HLA-A*02:01)
Antigen Peptide BRLF1 109–117 HLA-A*02:01 (YVLDHLIVV) for stimulation of antigen-specific T cells in T cell... |
YVLDHLIVV | 57,50 | HumanHLA-A*02:01Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11138_1 |
EBV BMRF1 116-128 (HLA-B*07:02)
RPQGGSRPEFVKL is a linear peptidic epitope (epitope ID 55295) studied as part of DNA polymerase... |
RPQGGSRPEFVKL | 115,00 | EBVHLA-B*07:02AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11127_1 |
EBV BMRF1 208-216 (HLA-A*02:01)
TLDYKPLSV is a linear peptidic epitope (epitope ID 64763) studied as part of DNA polymerase processivity... |
TLDYKPLSV | 57,50 | EBVHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11125_1 |
DEP DC1 294-302 (HLA-A*24:02)
For sensitive and specific detection of antigen-specific T cells using flow cytometry. |
EYYELFVNI | 57,50 | HumanHLA-A*24:02AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11126_1 |
DLK1 309-317 (HLA-A*02:01)
# |
ILGVLTSLV | 57,50 | HumanHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11124_1 |
Cytochrome p450 1B1 239-248 (HLA-A*02:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
SLVDVMPWL | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry |
EP11123_1 |
HCMV UL138 (HLA-B*35:01)
LPLNVGLPIIGVM is a linear peptidic epitope (epitope ID 188912) studied as part of Protein UL138 from Human... |
LPLNVGLPIIGVM | 115,00 | HCMVHLA-B*35:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11122_1 |
HCMV pp65 123-131 (HLA-B*35:01)
CMV-derived peptide of IPSINVHHY sequence covering 123-131 and B*35:01 molecule. IPSINVHHY is a linear... |
IPSINVHHY | 57,50 | HCMVHLA-B*35:01Infection, Control, Cancer, TORCH, Infectious mononucleosis, CMV hepatitis, Retinitis, Colitis, Pneumonitis, Esophagitis, AIDS, Cancer chemotherapy, Transplantation T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11121_1 |
HCMV pp65 113-121 (HLA-A*24:02)
Antigen Peptide HCMV pp65 (113-121) HLA-A*24:02 (VYALPLKML) for stimulation of antigen-specific T cells in... |
VYALPLKML | 57,50 | HCMVHLA-A*24:02Infection, Control, Cancer, TORCH, Infectious mononucleosis, CMV hepatitis, Retinitis, Colitis, Pneumonitis, Esophagitis, AIDS, Cancer chemotherapy, Transplantation T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11120_5 |
HCMV IE-1 199-207 (HLA-B*08:01)
ELRRKMMYM is a linear peptidic epitope (epitope ID 13133) studied as part of 55 kDa immediate-early protein... |
ELRRKMMYM | 57,50 | HumanHLA-B*08:01Infection, Control, Cancer, TORCH, Infectious mononucleosis, CMV hepatitis, Retinitis, Colitis, Pneumonitis, Esophagitis, AIDS, Cancer chemotherapy, Transplantation T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11119_1 |
HCMV IE1 51-59 (HLA-B*08:01)
CMV IE1-derived peptide of ELNRKMIYM covering 51-59 and B*08:01 molecule is a linear peptidic epitope... |
ELNRKMIYM | 57,50 | HumanHLA-B*08:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11118_1 |
HCMV IE-1 199-207 mutant (HLA-B*08:01) 201K, 205I
ELKRKMIYM is a linear peptidic epitope (epitope ID 13133) studied as part of 55 kDa immediate-early protein... |
ELKRKMIYM | 57,50 | HumanHLA-B*08:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1Hemagglutinin protein Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11117_1 |
HCMV IE-1 248-256 (HLA-A*24:02)
AYAQKIFKI is a linear peptidic epitope (epitope ID140986) studied as part of 55 kDa immediate-early protein... |
AYAQKIFKI | 57,50 | HumanHLA-A*24:02AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1other name: Human influenza hemagglutinin Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11116_1 |
HCMV IE1 184-192 (HLA-A*03:01)
CMV IE1 (184-192) is a linear peptidic epitope (epitope ID 31883) studied as part of 55 kDa immediate-early... |
KLGGALQAK | 57,50 | HCMVHLA-A*03:01Infection, Control, Cancer, TORCH, Infectious mononucleosis, CMV hepatitis, Retinitis, Colitis, Pneumonitis, Esophagitis, AIDS, Cancer chemotherapy, Transplantationother name: GPC3 144-152 (overexpressed in hepatocellular carcinoma) T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP11115_1 |
Chondromodulin-I 319-327 (HLA-A*02:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
VIMPCSWWV | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry |
EP11114_1 |
Chlamydia trachomatis MOMP 258-266 (HLA-A*02:01)
RLNMFTPYI is a linear peptidic epitope (epitope ID54686) studied as part of Chlamydia trachomatis and Major... |
RLNMFTPYI | 57,50 | Chlamydia trachomatisHLA-A*02:01 Flow Cytometry |
EP11113_1 |
CEACAM 185-193 (HLA-B*07:02)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
LPVSPRLQL | 57,50 | HumanHLA-B*07:02AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11111_1 |
CEA 652-660 (HLA-A*24:02)
Carcinogenic Embryonic Antigen (CEA) 652-660 is a linear peptidic epitope (epitope ID 67308) studied as... |
TYACFVSNL | 57,50 | HumanHLA-A*24:02 Flow Cytometry |
EP11110_1 |
CEA 694-702 (HLA-A*02:01)
GVLVGVALI is a linear peptidic epitope (epitope ID137754) studied as part of Carcinoembryonic... |
GVLVGVALI | 57,50 | HumanHLA-A*02:01 Flow Cytometry |
EP11109_1 |
CD59 glycoprotein precursor 106-114 (HLA-A*02:01)
SLSEKTVLL is a linear peptidic epitope (epitope ID 59453) studied as part of CD59 glycoprotein from Homo... |
SLSEKTVLL | 57,50 | HumanHLA-A*02:01 Flow Cytometry |
EP11108_1 |
CD33 65-73 mutant (HLA-A*02:01) 65Y, 66L
YLISGDSPV is a linear peptidic epitope (epitope ID74719), tested in T cell assays and MHC ligand assay |
YLISGDSPV | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry Immunohistochemistry |
EP11107_1 |
CB9L2 (HLA-A*02:01)
# |
ALYLMELTM | 57,50 | HLA-A*02:01 Flow Cytometry Immunohistochemistry |
EP11106_1 |
Carbonic anhydrase 219-227 (HLA-A*24:02)
This peptide is used for the detection of antigen-specific T-cell populations. MHC-peptide tetramer... |
EYRALQLHL | 57,50 | HumanHLA-A*24:02Cancer Flow Cytometry |
EP11105_1 |
ORF2 46-54
# |
APRGVRMAV | 92,00 | |
EP11104_1 |
ORF2 1-11
# |
MLMAQEALAFL | 92,00 | |
EP11102_1 |
BRAF 594-601 mutant (HLA-B*27:05) 600V
# |
GRFGLATVK | 57,50 | HumanHLA-B*27:05Cancer Flow Cytometry Immunohistochemistry |
EP11101_1 |
BRAF 594-601 mutant (HLA-B*27:05) 600E
Tis peptide has high avidity for CD8 T cells, and can be used in the analysis of individual... |
GRFGLATEK | 57,50 | HumanHLA-B*27:05AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11100_1 |
BMI1 (74-82) (HLA-A*02:01)
TLQDIVYKL is a linear peptidic epitope (epitope ID 459976) studied as part of Polycomb complex protein... |
TLQDIVYKL | 57,50 | HumanHLA-A*02:01 Flow Cytometry Immunohistochemistry |
EP11099_1 |
BMI1 (271-279) (HLA-A*02:01)
# |
CLPSPSTPV | 57,50 | HumanHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11094_1 |
BKV Large T antigen 406-414 (HLA-A*02:01)
VIFDFLHCI is a linear peptidic epitope (epitope ID 68945 ) studied as part of Human polyomavirus 1 protein... |
VIFDFLHCI | 57,50 | BK polyomavirus (BKPyV) (Human polyomavirus 1)HLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Flow Cytometry Immunohistochemistry |
EP11093_1 |
BKV Large T antigen 579-587 (HLA-A*02:01)
BKV LT-ag peptide LLLIWFRPV (HLA-A*02:01) for stimulation of human BKV LT-ag(579-587)-specific CD8+... |
LLLIWFRPV | 57,50 | BK polyomavirus (BKPyV) (Human polyomavirus 1)HLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Flow Cytometry Immunohistochemistry |
EP11092_1 |
BGLAP (HLA-A*24:02)
# |
LYQWLGAPV | 57,50 | HumanHLA-A*24:02Cancer Flow Cytometry Immunohistochemistry |
EP11091_1 |
BGLAP 1-10 (HLA-A*02:01)
# |
YLYQWLGAPV | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry Immunohistochemistry |
EP11090_1 |
BCR-ABL 19-27 (HLA-B*27:01)
Tumor Antigen-derived Peptide. GFKQSSKAL is a linear peptidic epitope (epitope ID19558) studied as part of... |
GFKQSSKAL | 57,50 | HumanHLA-B*27:01Cancer Flow Cytometry |
EP11089_1 |
BCR/ABL 210 kD fusion protein 21-29 (HLA-A*03:01)
|
KQSSKALQR | 57,50 | HumanHLA-A*03:01Cancer Flow Cytometry |
EP11088_1 |
BCR/ABL 210 kD fusion protein 259-269 (HLA-A*03:01) (HLA-A*11:01)
This peptide has high avidity for CD8 T cells, and can be used in the analysis of individual... |
ATGFKQSSK | 57,50 | HumanHLA-A*03:01 HLA-A*11:01Cancer Flow Cytometry |
EP11086_1 |
BCL2-like 1 173-182 (HLA-A*02:01)
This peptides has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
YLNDHLEPWI | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry |
EP11085_1 |
BCL-2L1 165-173 (HLA-A*03:01)
# |
RIAAWMATY | 57,50 | HumanHLA-A*03:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP11084_1 |
BCL-2A1 15-23 (HLA-A*24:02)
This peptides are used for the detection of antigen-specific T-cell populations. MHC-peptide tetramer... |
DYLQYVLQI | 57,50 | HumanHLA-A*24:02cancer, infectious diseases, and autoimmune diseases Flow Cytometry Immunohistochemistry |
EP11083_1 |
BCL-2 180-189 (HLA-A*02:01)
This peptide has high avidity for CD8 T cells, and can be used in the analysis of individual... |
YLNRHLHTWI | 57,50 | HumanHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Flow Cytometry Immunohistochemistry |
EP11081_1 |
BCL-2 208-217 (HLA-A*02:01)
This peptide has high avidity for CD8 T cells, and can be used in the analysis of individual... |
PLFDFSWLSL | 57,50 | HumanHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Flow Cytometry |
EP11080_1 |
BCL-2 85-93 (HLA-A*02:01)
# |
ALSPVPPVV | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry Immunohistochemistry |
EP11079_1 |
BAP31 167-175 (HLA-A*02:01)
KLDVGNAEV is a linear peptidic epitope (epitope ID445492) studied as part of B-cell receptor-associated... |
KLDVGNAEV | 57,50 | HumanHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Flow Cytometry Immunohistochemistry |
EP11078_1 |
BA46 194-202 (HLA-A*02:01)
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual... |
NLFETPVEA | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry Immunohistochemistry |
EP11077_1 |
BA46 97-106 (HLA-A*02:01)
This gene encodes a preproprotein that is proteolytically processed to form multiple protein products. The... |
GLQHWVPEL | 57,50 | HumanHLA-A*02:01AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Flow Cytometry |
EP11075_1 |
ABL1 (HLA-A*02:01)
This gene is a protooncogene that encodes a protein tyrosine kinase involved in a variety of cellular... |
CLWCVPQLR | 57,50 | Homo sapiens (Human)HLA-A*02:01 |
EP11074_1 |
ABI2 145-153 (HLA-A*02:01)
control peptide |
ILDDIGHGV | 57,50 | Homo sapiens (Human)HLA-A*02:01 |
EP10789_1 |
EBNA 3a (596-604)
This peptide represents an HLA-A2-restricted epitope of the Epstein-Barr virus nuclear antigen 3 (EBNA 3).... |
SVRDRLARL | 57,50 | |
EP10788_1 |
gB2 498-505 (H-2 Kb)
This is the immunodominant epitope gB-8p from herpes simplex virus (HSV) glycoprotein B (gB), amino acids... |
SSIEFARL | 57,50 | HumanH-2 KbAIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 3 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP10774_1 |
ADV hexon 886-894 (HLA-A*01:01)
ADV hexon peptide TDLGQNLLY (HLA-A*01:01) for stimulation of T-cells. Single peptide (TDLGQNLLY) for... |
TDLGQNLLY | 57,50 | Human adenovirus C serotype 5 (HAdV-5) (Human adenovirus 5)HLA-A*01:01 |
EP10769_1 |
PAP 299-307
ALDVYNGLL is a linear peptidic epitope studied as part of Prostatic acid phosphatase from Homo sapiens (human) |
ALDVYNGLL | 57,50 | HumanHumane Papillomviren (HPV) Flow Cytometry |
EP10768_1 |
RSV NP 137-145 (HLA-A*02:01)
KMLKEMGEV is a linear peptidic epitope (epitope ID32357) studied as part of Nucleoprotein from Human... |
KMLKEMGEV | 57,50 | Human immunodeficiency virus HLA-A*02:01 Flow Cytometry |
EP10707_1 |
HPV E6 48-57 (H-2 Kb)
Source: BK polyomavirus,Epstein-Barr virus (HHV-4),Hepatitis B virus,Hepatitis C virus,Homo sapiens... |
EVYDFAFRDL | 57,50 | HPVH-2 Kb AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 |
EP10273_1 |
HBV_Polymerase_171
SPYSWEQEL is a linear peptidic epitope studied as part of Protein P from Hepatitis B virus. This epitope... |
SPYSWEQEL | 57,50 | HBV |
EP10272_1 |
HBVcore14, (HBA31)
STLPETTVVRR is a linear peptidic epitope studied as part of Capsid protein from Hepatitis B virus and... |
STLPETTVVRR | 115,00 | HBVHBA31 Flow Cytometry |
EP10165_1 |
MAGE - A2 mutant (157-166) 161I
# |
YLQLIFGIEV | 57,50 | |
EP10116_1 |
HCMV IE-1 88-96 (HLA-B*08:01)
Antigen Peptide CMV IE-1(88-96) p (HLA-B*0801) for stimulation of T-cells. Single peptide (QIKVRVDMV) for... |
QIKVRVDMV | 57,50 | HCMVHLA-B*08:01Infection, Control, Cancer, TORCH, Infectious mononucleosis, CMV hepatitis, Retinitis, Colitis, Pneumonitis, Esophagitis, AIDS, Cancer chemotherapy, Transplantation T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP10115_1 |
Melan A 27-35
This native Melan-A (27-35) nonapeptide is an immunodominant antigen from melanocyte/melanoma... |
AAGIGILTV | 57,50 | Humanother name: MSLN 20-28 (HLA-A*02:01) Flow Cytometry |
EP10059_1 |
[beta]-Amyloid (1-40)
A number of Aß protein variants, differing only at their carboxy terminus (1-39, 1-40, 1-42 and 1-43), are... |
DAEFGHDSGFEVRHQKLVFFAEDVGSNKGAIIGLMVGGVV | 345,00 | RatAlzheimer's Disease Neuroscience |
EP10054_1 |
[beta]-Amyloid (22-35)
Aβ (22-35), EDVGSNKGAIIGLM, forms amyloid fibrils in vitro resembling those of the β-amyloid protein in... |
EDVGSNKGAIIGLM | 80,50 | Human, Mouse, RatAlzheimer Desease |
EP10048_1 |
[beta]-Amyloid (16-23)
This octapeptide beta-Amyloid 16 to 23 was used in exploring the design of potential inhibitors of... |
KLVFFAED | 57,50 | Human, Mouse, RatAlzheimer Desease |
EP10043_1 |
[beta]-Amyloid (1-39)
A number of Aß protein variants, differing only at their carboxy terminus (1-39, 1-40, 1-42 and 1-43), are... |
DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGV | 345,00 | HumanAlzheimer's Disease Neuroscience |
EP10028_1 |
[beta]-Amyloid (13-27)
This β-Amyloid peptide 13 to 27 amino acid residues was used to study the kinetics of β-amyloid formation. |
HHQKLVFFAEDVGSNK | 80,50 | HumanAlzheimer's Disease Neuroscience |
EP10027_1 |
[beta]-Amyloid (1-28)
The three-dimensional solution structure of Aß (1-28) reveals the folding of the peptide to form a... |
DAEFRHDSGYEVHHQKLVFFAEDVGSNK | 172,50 | HumanAlzheimer's Disease Neuroscience |
EP10025_1 |
[beta]-Amyloid (12-28)
Injection of the amyloid ?-protein fragment VHHQKLVFFAEDVGSNK into different limbic system structures in... |
VHHQKLVFFAEDVGSNK | 80,50 | HumanAlzheimer's Disease Neuroscience |
EP10023_1 |
[beta]-Amyloid (1-16)
The Cu²⁺ complex of this soluble amyloid β-protein fragment showed significant oxidative activities toward... |
DAEFRHDSGYEVHHQK | 80,50 | HumanAlzheimer's Disease Neuroscience |
EP10022_1 |
[beta]-Amyloid (1-15)
Aβ (1-15) was used in a study investigating the presence of conformational epitope/s (mimotope/s) on... |
DAEFRHDSGYEVHHQ | 80,50 | HumanAlzheimer's Disease Neuroscience |
EP10016_1 |
[beta]-Amyloid (1-14)
Beta-amyloid peptide (Abeta), the major constituent of amyloid plaques in the brains of Alzheimer’s... |
DAEFGHDSGFEVRH | 80,50 | HumanAlzheimer's Disease Neuroscience |
EP10015_1 |
[beta]-Amyloid (11-22)
Beta-amyloid peptide (Abeta), the major constituent of amyloid plaques in the brains of Alzheimer’s... |
EVHHQKLVFFAE | 80,50 | HumanAlzheimer's Disease Neuroscience |
EP10013_5 |
[beta]-Amyloid (11- 40)
Post-mortem Alzheimer’s diseased brain specimens reveals significant levels of Aß (11-40/42) within... |
EVHHQKLVFFAEDVGSNKGAIIGLMVGGVV | 230,00 | HumanAlzheimer's Disease Neuroscience |
EP10012_1 |
[beta]-Amyloid (10-35)
Amyloid β-protein (10-35), YEVHHQKLVFFAEDVGSNKGAIIGLM, was used as a truncated peptide model for the... |
YEVHHQKLVFFAEDVGSNKGAIIGLM | 138,00 | HumanAlzheimer's Disease Neuroscience |
EP09933_1 |
[alpha]-Casein (90-95)
bioactive peptide |
RYLGYL | 57,50 | |
EP09931_1 |
[alpha]-Bag Cell Peptide (1 - 8)
The octapeptide APRLRFYS from Aplysia parvula acts as a neurotransmitter locally, upon neurons of the... |
APRLRFYS | 51,75 | |
EP09932_1 |
[alpha]-Bag Cell Peptide (1 - 9)
The nonapeptide APRLRFYSL from Aplysia parvula acts as a neurotransmitter locally, upon neurons of the... |
APRLRFYSL | 51,75 | |
EP09930_1 |
[alpha]-Bag Cell Peptide (1 - 7)
The heptapeptide APRLRFY from Aplysia parvula acts as a neurotransmitter locally, upon neurons of the... |
APRLRFY | 51,75 | |
EP09928_1 |
Ala13 - Apelin - 13
Apelin -13 is a vasoactive peptide and one of the most potent endogenous inotropic agents known. It is one... |
QRPRLSHKGPMPA | 92,00 | Cardiovascular System & Diseases |
EP09925_1 |
Autocamtide 2; Autocamtide-2-Related Inhibitory Peptide [Ala9]
This is a myristoylated form of Autocamtide-2-Related Inhibitory Peptide (AIP), a highly potent and... |
KKALRRQEAVDAL | 103,50 | Cell Signaling |
EP09923_1 |
[Ala8] - Humanin, [Ala8] - HN, Shna
Protection activity of humanin (HN) against neuronal cell death is abrogated in this peptide, where Cys8 is... |
MAPRGFSALLLLTSEIDLPVKRRA | 92,00 | |
EP09920_1 |
PLP (57-70)
# |
YEYLINVIHAFQYV | 103,50 | |
EP09919_1 |
PLP (56-70)
# |
DYEYLINVIHAFQYV | 103,50 | |
EP09918_1 |
PLP (48 - 70)
# |
TYFSKNYQDYEYLINIHAFQYV | 241,50 | |
EP09917_1 |
PLP (190 - 209)
# |
SKTSASIGSLCADARMYGVL | 195,50 | |
EP09916_1 |
PLP (180 - 199)
# |
WTTCQSIAFPSKTSASIGSL | 115,00 | other name: Leukocyte Proteinase-3 (Wegener's autoantigen) 169-177 |
EP09915_1 |
PLP (139-151) mutant 140S
This serine substituted PLP (139-151) causes severe, acute experimental allergic encephalomyelitis in SJL... |
HSLGKWLGHPDKF | 57,50 | other name: Polymerase 455-463 |
EP09911_1 |
PLP (139-151) mutant 144A
PLP (139-151) mutant 144A is the Ala 144 form of Proteolipid protein (PLP), an epitope of immunodominant... |
HSLGKALGHPDKF | 92,00 | H2-IAs multiple sclerosisother name: Polymerase 502-510 Neuroscience |
EP09910_1 |
MBP (273-281), bovine, MBP (138-146), mouse
# |
FSWGAEGQK | 57,50 | mouseMultiple Sclerosis |
EP09909_1 |
MBP (146–170)
# |
AQGTLSKIFKLGGRDSRSGSPMARR | 241,50 | Multiple Sclerosis |
EP09908_1 |
MBP (131–155)
# |
ASDYKSAHKGLKGVDAQGTLSKIFK | 241,50 | Multiple Sclerosis |
EP09907_1 |
MBP (111 - 129)
# |
LSRFSWGAEGQRPGFGYGG | 195,50 | HumanMultiple Sclerosis |
EP09906_1 |
MBP (92 - 111)
# |
VTPRTPPPSQGKGRGLSLSR | 195,50 | Multiple Sclerosis |
EP09903_1 |
MBP (87 - 99), human
# |
VHFFKNIVTPRTP | 115,00 | HumanMultiple Sclerosis |
EP09902_1 |
MBP (84 - 105)
# |
VVHFFKNIVTPRTPPPSQGKGR | 241,50 | Multiple Sclerosis |
EP09900_1 |
MBP (79 - 87)
# |
DENPVVHFF | 57,50 | Multiple Sclerosis |
EP09899_1 |
MBP (74 - 85) mutant 81A
# |
QKSQRSQAENPV | 92,00 | multiple sclerosis Neuroscience, Cell Signaling |
EP09897_1 |
MBP (69-88)
# |
YGSLPQKSQRSQDENPVVHF | 195,50 | Multiple Sclerosis |
EP09896_1 |
MBP (68–86)
# |
YGSLPQKSQRSQDENPV | 149,50 | Multiple Sclerosis |
EP09895_1 |
MBP (65 - 75); Peptide S24
Synthetic peptide S24 (TTHYGSLPQKG) represents residues 65-74 of myelin basic protein (MBP) and contains... |
TTHYGSLPQKG | 92,00 | Multiple Sclerosis |
EP09892_1 |
MBP (14 - 33)
# |
KYLATASTMDHARHGFLPRH | 195,50 | Multiple Sclerosis |
EP09890_1 |
MBP (1-20)
This peptide is a synthetic peptide that is derived from Mouse MBP. This peptide sequence corresponds to... |
ASQKRPSQRSKYLATASTMD | 195,50 | Multiple Sclerosis |
EP09889_1 |
MBP (1 - 17)
# |
ASQKRPSQRSKYLATAS | 149,50 | mouseMultiple Sclerosis |
EP09887_1 |
MBP (1 - 11) mutant 4A
# |
ASQARPSQRHG | 115,00 | multiple sclerosis Neuroscience, Cell Signaling |
EP09886_1 |
MBP (1 - 11) mouse
# |
ASQKRPSQRSK | 57,50 | mouseMultiple Sclerosis |
EP09885_1 |
MOBP 16 - 37, mouse
This is amino acid residues 16-37 of murine myelin oligodendrocyte basic protein (MOBP), a major component... |
QKFSEHFSIHCCPPFTFLNSKR | 195,50 | mouseHLA-A*02:01 |
EP09884_1 |
MOG 101 - 120, human, mouse
Myelin oligodendrocyte glycoprotein (MOG) 101 - 120, a minor component of CNS myelin, is expressed in... |
RDHSYQEEAAMELKVEDPFY | 195,50 | Human, mouse Multiple Sclerosis |
EP09883_1 |
MOG 101 - 108, rat
Myelin oligodendrocyte glycoprotein (MOG) 101 - 108, a minor component of CNS myelin, is expressed in... |
RDHSYQEE | 57,50 | rat Multiple Sclerosis |
EP09882_1 |
MOG 96 - 108, human
Myelin oligodendrocyte glycoprotein (MOG)96 - 108, a minor component of CNS myelin, is expressed in central... |
TCFFRDHSYQSEA | 115,00 | Human Multiple Sclerosis |
EP09880_1 |
MOG 91 - 114, rat
Myelin oligodendrocyte glycoprotein (MOG) 91 - 114, a minor component of CNS myelin, is expressed in... |
SDEGGYTCFFRDHSYQEEAAVELK | 241,50 | rat Multiple Sclerosis |
EP09879_1 |
MOG 89 - 113, human
Myelin oligodendrocyte glycoprotein (MOG) 89 - 113, a minor component of CNS myelin, is expressed in... |
RFSDEGGFTCFFRDHSYQEEAAMEL | 241,50 | Human Multiple Sclerosis |
EP09878_1 |
MOG 76 - 100, human
Myelin oligodendrocyte glycoprotein (MOG) 76 - 100, a minor component of CNS myelin, is expressed in... |
IGEGKVTLRIRNVRFSDEGGFTCFF | 241,50 | Human Multiple Sclerosis |
EP09877_1 |
MOG 67 - 87, rat
Myelin oligodendrocyte glycoprotein (MOG) 67 - 87, a minor component of CNS myelin, is expressed in central... |
GRTELLKESIGEGKVALRIQN | 241,50 | rat Multiple Sclerosis |
EP09876_1 |
MOG 71 - 90, mouse
Myelin oligodendrocyte glycoprotein (MOG) 71 - 90, a minor component of CNS myelin, is expressed in central... |
LLKETISEGKVTLRIQNVRF | 195,50 | Mouse Multiple Sclerosis |
EP09875_1 |
MOG 50 - 74, human
Myelin oligodendrocyte glycoprotein (MOG) 50 - 74, a minor component of CNS myelin, is expressed in central... |
LYRNGKDQDGDAPEYRGRTELLKD | 241,50 | Human Multiple Sclerosis |
EP09874_1 |
MOG 46 - 54
Myelin oligodendrocyte glycoprotein (MOG) 46 - 54, a minor component of CNS myelin, is expressed in central... |
RVVHLYRNG | 57,50 | Mouse, Rat Multiple Sclerosis |
EP09873_1 |
MOG 45 - 54
Myelin oligodendrocyte glycoprotein (MOG) 45 - 54, a minor component of CNS myelin, is expressed in central... |
SRVVHLYRNG | 57,50 | Mouse, Rat Multiple Sclerosis |
EP09872_1 |
MOG 43-54
Myelin oligodendrocyte glycoprotein (MOG) 43-54, a minor component of CNS myelin, is expressed in central... |
PFSRVVHLYRNG | 115,00 | Mouse, Rat Multiple Sclerosis |
EP09871_1 |
MOG 42 - 54
Myelin oligodendrocyte glycoprotein (MOG) 42-54, a minor component of CNS myelin, is expressed in central... |
SPFSRVVHLYRNG | 115,00 | Mouse, Rat Multiple Sclerosis |
EP09870_1 |
MOG 41-54
Myelin oligodendrocyte glycoprotein (MOG) 41-54, a minor component of CNS myelin, is expressed in central... |
RSPFSRVVHLYRNG | 115,00 | Mouse, Rat Multiple Sclerosis |
EP09867_1 |
MOG 38 - 60, human
Myelin oligodendrocyte glycoprotein (MOG) 38 - 60, a minor component of CNS myelin, is expressed in central... |
GWYRPPFSRVVHLYRNGKDQDGD | 241,50 | Human Multiple Sclerosis |
EP09866_1 |
MOG 38 - 55
Myelin oligodendrocyte glycoprotein (MOG) 38 - 55, a minor component of CNS myelin, is expressed in central... |
GWYRSPFSRVVHLYRNGK | 115,00 | Mouse, Rat Multiple Sclerosis |
EP09865_1 |
MOG 38-53
Myelin oligodendrocyte glycoprotein (MOG) 38-53, a minor component of CNS myelin, is expressed in central... |
GWYRSPFSRVVHLYRN | 115,00 | Mouse, Rat Multiple Sclerosis |
EP09864_1 |
MOG 37–54, mouse, rat
Myelin oligodendrocyte glycoprotein (MOG) 37–54, a minor component of CNS myelin, is expressed in central... |
VGWYRSPFSRVVHLYRNG | 115,00 | Mouse, Rat Multiple Sclerosis |
EP09863_1 |
MOG 35 - 53
Myelin oligodendrocyte glycoprotein (MOG) 35-53, a minor component of CNS myelin, is expressed in central... |
MEVGWYRSPFSRVVHLYRN | 195,50 | Mouse, Rat Multiple Sclerosis |
EP09862_1 |
MOG 35-52
Myelin oligodendrocyte glycoprotein (MOG) 35-52, a minor component of CNS myelin, is expressed in central... |
MEVGWYRSPFSRVVHLYR | 195,50 | Mouse, Rat Multiple Sclerosis |
EP09861_1 |
MOG 35 - 51
Myelin oligodendrocyte glycoprotein (MOG) 35-51, a minor component of CNS myelin, is expressed in central... |
MEVGWYRSPFSRVVHLY | 195,50 | Mouse, Rat Multiple Sclerosis |
EP09860_1 |
MOG 27 - 50, human
Myelin oligodendrocyte glycoprotein (MOG) 27-50, a minor component of CNS myelin, is expressed in central... |
SPGKNATGMELGWYRPPFSRVVHL | 264,50 | Human Multiple Sclerosis |
EP09859_1 |
MOG 14 - 39, human
Myelin oligodendrocyte glycoprotein (MOG) 14 - 39, a minor component of CNS myelin, is expressed in central... |
ALVGDEVELPCRISPGKNATGMELGW | 264,50 | Human Multiple Sclerosis |
EP09858_1 |
MOG 8 - 22, rat
Myelin oligodendrocyte glycoprotein (MOG) 8 - 22, a minor component of CNS myelin, is expressed in central... |
PGYPIRALVGDEQED | 115,00 | rat Multiple Sclerosis |
EP09857_1 |
MOG 8 - 21
Myelin oligodendrocyte glycoprotein (MOG) 8 - 21, a minor component of CNS myelin, is expressed in central... |
PGYPIRALVGDEAE | 115,00 | Mouse, Rat Multiple Sclerosis |
EP09856_1 |
MOG 1 - 26, human
Myelin oligodendrocyte glycoprotein (MOG) 1 - 26, a minor component of CNS myelin, is expressed in central... |
GQFRVIGPRHPIRALVGDEVELPCRI | 264,50 | Human Multiple Sclerosis |
EP09855_1 |
MOG 1 - 21, rat
Myelin oligodendrocyte glycoprotein (MOG) 1 - 21, a minor component of CNS myelin, is expressed in central... |
GQFRVIGPGHPIRALVGDEAE | 241,50 | rat Multiple Sclerosis |
EP09848_1 |
CyLoP-1
CyLoP-1 is a cysteine-rich cell-penetrating peptide derived from nuclear localization sequence of snake... |
CRWRWKCCKK | 138,00 | |
EP09843_1 |
Arg9
This is a peptide comprising of 9 arginine residues. It has been shown that poly-Arg peptides composed of 9... |
RRRRRRRRR | 57,50 | Chlamydomonas reinhardtii (Chlamydomonas smithii) Cell Permeable & Penetraiting |
EP09842_1 |
LCMV GP 64-80
# |
GPDIYKGVYQFKSVEFD | 149,50 | LCMVmeningitis, encephalitis ,meningoencephalitis Flow Cytometry |
EP09841_1 |
PLP (178-191)
NTWTTCQSIAFPSK represents a short peptide sequence of the protein lipid portion of the myelin sheath.... |
NTWTTCQSIAFPSK | 97,75 | |
EP09840_1 |
PLP (139-151)
This is amino acid residue 139 to 151 of myelin proteolipid protein (PLP). This peptide is used to induce... |
HCLGKWLGHPDKF | 97,75 | |
EP09837_1 |
MOG 91 - 108, rat
Myelin oligodendrocyte glycoprotein (MOG) 91 - 108, a minor component of CNS myelin, is expressed in... |
SDEGGYTCFFRDHSYQEE | 195,50 | rat Multiple Sclerosis |
EP09836_1 |
MOG 183-191
Myelin oligodendrocyte glycoprotein (MOG) 183-191, a minor component of CNS myelin, is expressed in central... |
FVIVPVLGP | 57,50 | Mouse, Rat Multiple Sclerosis |
EP09834_1 |
MOG 92-106
Myelin oligodendrocyte glycoprotein (MOG)92-106, a minor component of CNS myelin, is expressed in central... |
DEGGYTCFFRDHSYQ | 115,00 | Mouse, Rat Multiple Sclerosis |
EP09833_1 |
MOG 35-55 human
Myelin oligodendrocyte glycoprotein (MOG) 35-55, a minor component of CNS myelin, is expressed in central... |
MEVGWYRPPFSRVVHLYRNGK | 115,00 | Human Multiple Sclerosis |
EP09832_1 |
Melan - A, MART 1 (26 - 35)
This native Melan-A (26-35) decapeptide is an immunodominant antigen from melanocyte/melanoma... |
EAAGIGILTV | 57,50 | Human Flow Cytometry |
EP09831_1 |
MAGE-A3 271-279 (HLA-A*02:01)
FLWGPRALV is a linear peptidic epitope (epitope ID16970) studied as part of Melanoma-associated antigen 3... |
FLWGPRALV | 57,50 | HumanHLA-A*02:01Cancer;Melanoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP09830_1 |
HCV NS5b 2594-2602 mutant (HLA-A*02:01) 2600S
# |
ALYDVVSKL | 57,50 | HLA-A*02:01 |
EP09340_1 |
NS5B 2936-2944 (HLA-B*27:05)
# |
GRAAICGKY | 57,50 | HLA-B*27:05Hepatitis-C-Virus |
EP09213_1 |
Human HLA-A*02, A*24 leader 3-11 (HLA-A*02)
HLA-A leader 3-11-derived peptide of VMAPRTLVL sequence covering 3-11 and HLA-E*01:03 molecule. VMAPRTLVL... |
VMAPRTLVL | 57,50 | HumanHLA-A*02other name: Telomerase Reverse Transcriptase (hTRT) 988-997 Flow Cytometry |
EP09074_1 |
Larazotide (AT-1001)
Larazotide (INN; also known as AT-1001; formulated as the salt with acetic acid, larazotide acetate) is a... |
GGVLVQPG | 80,50 | AT-1001 |
EP08950_1 |
OVA 257-268 (H-2 Kb)
SIIVFEKL is a linear peptidic epitope, tested in T cell assays and MHC ligand assay. |
SIIVFEKL | 57,50 | H-2 Kb AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Flow Cytometry |
EP08851_1 |
B8R 20-27 (H-2 Kb)
This is amino acids 20 to 27 fragment of B8R, a vaccinia virus (VV) gene that encodes a secreted protein... |
TSYKFESV | 57,50 | VACVH-2 Kb Flow Cytometry |
EP08803_1 |
HPV E6 29-38 (HLA-A*02:01)
TIHDIILECV is a linear peptidic epitope (epitope ID64320) studied as part of Protein E6 from... |
TIHDIILECV | 57,50 | HPVHLA-A*02:01Cancer, HPV 16 infection, or HPV-positive premalignancy |
EP08801_1 |
HCV NS5B 2594-2602 (HLA-A*02:01)
ALYDVVTKL is a linear peptidic epitope studied as part of Genome polyprotein from Hepatitis C virus. |
ALYDVVTKL | 57,50 | HCVHLA-A*02:01Hepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP08624_1 |
HCMV IE-1 378-389 (HLA-B18)
HLA-B18-restricted epitope from Cytomegalovirus (378-389) |
SDEEEAIVAYTL | 92,00 | HumanHLA-B*18 |
EP08605_1 |
EBV LMP-2 426-434 (HLA-A*02:01)
EBV LMP-2 426-434 (HLA-A*02:01) CLGGLLTMV for stimulation of antigen-specific T cells in T cell assays such... |
CLGGLLTMV | 57,50 | EBVHLA-A*02:01Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP08274_1 |
EBV EBNA-1 407-417 (HLA-B*35:01)
Antigen Peptide EBV EBNA-1 407-417 (HLA-B*35:01) HPVGEADYFEY for stimulation of antigen-specific T cells in... |
HPVGEADYFEY | 57,50 | EBVHLA-B*35:01Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP08114_1 |
PRAME 425-433 (HLA-A*02:01)
# |
SLLQHLIGL | 57,50 | HumanHLA-A*02:01Cancer, Immunologyother name: Prostate Stem Cell Antigen (PSCA) 14-22 Flow Cytometry |
EP08069_1 |
HCMVlfl
VMAPRTLFL is a linear peptidic epitope (epitope ID99045) studied as part of HLA class I histocompatibility... |
VMAPRTLFL | 57,50 | Human Flow Cytometry |
EP08035_1 |
HIV-1 RT 476-484 (HLA-A*02:01)
ILKEPVHGV is a linear peptidic epitope studied as part of Gag-Pol polyprotein from Human immunodeficiency... |
ILKEPVHGV | 57,50 | HIV-1HLA-A*02:01AIDS (HIV) Flow Cytometry |
EP08010_1 |
CRGDS
GRGDS forms the cell-binding domain of a glycoprotein, Osteopontin (OPN) . Although the native form of OPN... |
CRGDS | 57,50 | |
EP07991_1 |
NS2A 4–13 (HLA-C*03:04)
# |
HAVPFGLVSM | 57,50 | HLA-C*03:04other name: West Nile virus NY-99 polyprotein precursor 2023-2031 |
EP07918_1 |
3x FLAG Peptide
|
DYKDDDDK-DYKDDDDK-DYKDDDDK | 195,50 | |
EP07916_1 |
HCV Polyprotein 1406-1415 (HLA-A*02:01)
KLVALGINAV is a linear peptidic epitope studied as part of Genome polyprotein from Hepatitis C virus.... |
KLVALGINAV | 57,50 | HCVHLA-A*02:01Hepatitis T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07915_1 |
PPI 2-10 (HLA-A*02:01)
ALWMRLLPL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from preproinsulin (PPI)... |
ALWMRLLPL | 57,50 | HLA-A*02:01 |
EP07914_1 |
ADV Hexon 917-925 (HLA-A*02:01)
Single peptide (YVLFEVFDV) for stimulation of human ADV Hexon (917-925)-specific CD8+ T cells. The peptide... |
YVLFEVFDV | 57,50 | Human adenovirus C serotype 5 (HAdV-5) (Human adenovirus 5)HLA-A*02:01Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07912_1 |
Cyclin A1 227-235 (HLA-A*02:01)
Single peptide (FLDRFLSCM) for stimulation of human CyclinA1(227-235)-specific CD8+T cells |
FLDRFLSCM | 57,50 | HumanHLA-A*02:01other name: CM15, CAMEL0, Cecropin A (1-8)-Melittin A (3-9) amide, Cecropin A-melittin hybrid peptide [CA(1-7)M(2-9)NH2] |
EP07911_1 |
HCMV pp65 265-275 (HLA-B*07:02)
RPHERNGFTVL is a linear peptidic epitope (epitope ID55170) studied as part of 65 kDa phosphoprotein from... |
RPHERNGFTVL | 57,50 | HCMVHLA-B*07:02Infection, Control, Cancer, TORCH, Infectious mononucleosis, CMV hepatitis, Retinitis, Colitis, Pneumonitis, Esophagitis, AIDS, Cancer chemotherapy, Transplantation T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07910_1 |
CD79b 52-60 (HLA-A*02:01)
Antigen Peptide CD antigen HLA-A*0203 (TLKDGIIMI) for stimulation of antigen-specific T cells in T cell assays |
TLKDGIIMI | 57,50 | HumanHLA-A*02:01Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07909_1 |
CD22-4 371-379 (HLA-A*02:01)
SARS-CoV-2 peptide LLLDRLNQL (HLA-A*0201) for stimulation of T-cells. Single peptide (LLLDRLNQL) for... |
RLLGKESQL | 57,50 | HLA-A*02:01 |
EP07907_1 |
FAP 735-744 (HLA-A*02:01)
GLSGLSTNHL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from fibroblast... |
GLSGLSTNHL | 57,50 | HumanHLA-A*02:01Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07906_1 |
Fibromodulin F4 226-235 (HLA-A*02:01)
YLLDLSYNHL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from tumor-associated... |
YLLDLSYNHL | 57,50 | HLA-A*02:01Aging Cancerother name: Epithelial Discoidin Domain Receptor 1 (EDDR1) 867-876 (HLA-A*02:01) T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07905_1 |
Fibromodulin F3 250-259 (HLA-A*02:01)
Antigen Peptide Fibromodulin HLA-A*02:01 (YMEHNNVYTV) for stimulation of antigen-specific T cells in T cell... |
YMEHNNVYTV | 57,50 | HLA-A*02:01Aging Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07904_1 |
Fibromodulin F2 206-215 (HLA-A*02:01)
Antigen Peptide Fibromodulin HLA-A*02:01 (YLQHNEIQEV) for stimulation of antigen-specific T cells in T cell... |
YLQHNEIQEV | 57,50 | Scophthalmus maximus (Turbot) (Psetta maxima)HLA-A*02:01Aging Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07903_1 |
Fibromodulin F1 7-17 (HLA-A*02:01)
Antigen Peptide Fibromodulin HLA-A*02:01 (LLLAGLFSL) for stimulation of antigen-specific T cells in T cell... |
LLLAGLFSL | 57,50 | HLA-A*02:01Aging Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07902_1 |
HsPSMA 634-642 (H-2 Db)
SAVKNFTEI (H-2 Db) is a single peptide for stimulation of T cells. The peptide from HsPSMA is synthesized... |
SAVKNFTEI | 57,50 | H-2 Db |
EP07901_1 |
MAGE 212-220 (HLA-C*07:01)
This Peptide MAGE HLA-C*07:01 (EGDCAPEEK) is for stimulation of antigen-specific T cells in T cell assays... |
EGDCAPEEK | 57,50 | HumanHLA-C*07:01Cancer;Melanomaother name: MAGE-3 antigen (271-279) T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07900_1 |
HCMV pp65 341-349 (HLA-A*24:02/HLA-A*23:01)
HCMV pp65 341-349 (HLA-A*24:02/HLA-A*23:01) QYDPVAALF for stimulation of antigen-specific T cells in T cell... |
QYDPVAALF | 57,50 | HCMVHLA-A*24:02 HLA-A*23:01Infection, Control, Cancer, TORCH, Infectious mononucleosis, CMV hepatitis, Retinitis, Colitis, Pneumonitis, Esophagitis, AIDS, Cancer chemotherapy, Transplantation T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07899_1 |
EBV BZLF-1 190-197 (HLA-B*08:01)
Antigen peptide RAKFKQLL for stimulation of human EBV BZLF-1(190-197)-specific CD8+ T-cells. The peptide is... |
RAKFKQLL | 57,50 | EBVHLA-B*08:01Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma ï¾ T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07898_1 |
HERV-K Gag 155-163 (HLA-A*02:01)
Antigen Peptide Gag HLA-A*0201 (VIYPETLKL) for stimulation of antigen-specific T cells in T cell assays... |
VIYPETLKL | 57,50 | HumanHLA-A*02:01Autoimmune disease T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07897_1 |
HERV-K Gag 139-147 (HLA-A*02:01)
Antigen Peptide Gag HLA-A*02:01 (VMAQSTQNV) for stimulation of antigen-specific T cells in T cell assays... |
VMAQSTQNV | 57,50 | HumanHLA-A*02:01Autoimmune disease T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07893_1 |
EBV LMP2 356-364 (HLA-A*02:01)
Antigen Peptide EBV LMP2 HLA-A*0201 (FLYALALLL) for stimulation of human EBV LMP2(356-364)-specific CD8+... |
FLYALALLL | 57,50 | EBVHLA-A*02:01Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07892_1 |
EBV EBNA-3A 603-611 (HLA-A*03:01)
RLRAEAQVK is a linear peptidic epitope (epitope ID54728) studied as part of Epstein-Barr nuclear antigen 3... |
RLRAEAQVK | 57,50 | EBVHLA-A*03:01Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07887_1 |
SIVmag Gag 19-27 (Mamu-A*01)
MHC I-Strep Mamu-A*01; SIVmag Gag (181-189) (CTPYDINQM) is a recombinantly expressed MHC class I molecule... |
CTPYDINQM | 57,50 | Simianes Immundefizienz-Virus |
EP07886_1 |
Bcl-2 214-223 (HLA-A*02:01)
Bcl-2 peptide WLSLKTLLSL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from B... |
WLSLKTLLSL | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry Immunohistochemistry |
EP07885_1 |
CD22 antigen (HLA-A*02:01)
Antigen Peptide CD antigen HLA- A*0201 (PLSEGPHSL) for stimulation of antigen-specific T cells in T cell... |
PLSEGPHSL | 57,50 | HumanHLA-A*02:01Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07884_1 |
CD22 antigen 459-467 (HLA-A*02:01)
D22 antigen(459-467) peptide SLPYHSQKL (HLA- A*02:01) for stimulation of T-cells. Single peptide... |
SLPYHSQKL | 57,50 | HumanHLA-A*02:01Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07882_1 |
ADV hexon (HLA-B*35:01)
ADV hexon peptide MPNRPNYIAF (HLA-B*35:01) for stimulation of T-cells. Single peptide (MPNRPNYIAF) for... |
MPNRPNYIAF | 57,50 | Human adenovirus C serotype 5 (HAdV-5) (Human adenovirus 5)HLA-B*35:01Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07881_1 |
ADV hexon 114 -124 (HLA-B*07:02)
Single peptide (KPYSGTAYNAL) for stimulation of human ADV Hexon (114-124)-specific CD8+ T cells. The... |
KPYSGTAYNAL | 57,50 | Human adenovirus C serotype 5 (HAdV-5) (Human adenovirus 5)HLA-B*07:02Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07880_1 |
ADV hexon 37-45 (HLA-A*24:02)
Single peptide (TYFSLNNKF) for stimulation of human ADV Hexon (37-45)-specific CD8+ T cells. The peptide is... |
TYFSLNNKF | 57,50 | Human adenovirus C serotype 5 (HAdV-5) (Human adenovirus 5) HLA-A*24:02Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07877_1 |
OVA-Q4H7 (H-2 Kb)
Q4H7 peptide SIIQFEHL (H-2 Kb) for stimulation of T cells. Single peptide (SIIQFEHL) for stimulation of... |
SIIQFEHL | 57,50 | H-2 Kb Flow Cytometry |
EP07876_1 |
Uty (H-2 Db)
Antigen peptide WMHHNMLDI for stimulation of murine Uty-specific CD8+T-cells. The peptide is synthesised as... |
WMHHNMLDI | 57,50 | |
EP07875_1 |
MAGE-A1 161-169 (HLA-A*01:01)
EADPTGHSY is a linear peptidic epitope (epitope ID11010) studied as part of Melanoma-associated antigen 1... |
EADPTGHSY | 57,50 | HumanHLA-A*01:01Cancer;Melanoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07873_1 |
Survivin 95-104 (HLA-A*02:01)
Survivin-derived peptide of ELTLGEFLKL sequence covering 95ï¾–104 and A*02:01 molecule.Single peptide... |
ELTLGEFLKL | 57,50 | HumanHLA-A*02:01CancerTGF-beta receptor type-2 131-139 T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07872_1 |
WT1 235-243 (HLA-A*24:02)
Antigen peptide WT1 235-243 (HLA-A*24:02) CMTWNQMNL for stimulation of antigen-specific T cells in T cell... |
CMTWNQMNL | 57,50 | HumanHLA-A*24:02Cancer;Wilms tumor 1 T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07871_1 |
gp100 280-288 (HLA-A*02:01)
YLEPGPVTA is a linear peptidic epitope studied as part of Melanocyte protein PMEL from Homo sapiens... |
YLEPGPVTA | 57,50 | HumanHLA-A*02:01Cancer, Epithelium, Melanoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07869_1 |
MUC1 (HLA-B*07:02)
MUC1 peptide VPGWGIALL (HLA-B*0702) is a single peptide for stimulation of T cells. The peptide from Mucin... |
VPGWGIALL | 57,50 | HumanHLA-B*07:02Breast cancer;Cancer;Epithelium ï¾ T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07868_1 |
MUC1 950-958 (HLA-A*02:01)
MUC1 peptide STAPPVHNV (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from Mucin... |
STAPPVHNV | 57,50 | HumanHLA-A*02:01Breast cancer;Cancer;Epitheliumother name: Tumor Mucin antigen 7-15 ï¾ T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07867_1 |
HM1.24 126-134 (HLA-A*02:01)
KLQDASAEV is a linear peptidic epitope (epitope ID455519) studied as part of Bone marrow stromal antigen 2... |
KLQDASAEV | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry |
EP07861_1 |
gp100 209-217 (HLA-A*02:01)
ITDQVPFSV is a linear peptidic epitope studied as part of Melanocyte protein PMEL from Homo sapiens (human)... |
ITDQVPFSV | 57,50 | HumanHLA-A*02:01Cancer, Epithelium, Melanoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07860_1 |
gp100 209-217 mutant (HLA-A*02:01) 210M
gp100 209-217 Pos. 210M (HLA-A*02:01) IMDQVPFSV is a linear peptidic epitope studied as part of Melanoma... |
IMDQVPFSV | 57,50 | HumanHLA-A*02:01Cancer, Epithelium, Melanoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07859_1 |
HER-2/neu 689-697 (HLA-A*02:01)
Her-2/neu peptide RLLQETELV (HLA-A*0201) for stimulation of T-cells. Single peptide (RLLQETELV) for... |
RLLQETELV | 57,50 | HumanHLA-A*02:01Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07858_1 |
HER-2/neu 369-377 (HLA-A*02:01)
KIFGSLAFL is a linear peptidic epitope studied as part of Receptor tyrosine-protein kinase erbB-2 from... |
KIFGSLAFL | 57,50 | HumanHLA-A*02:01Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07857_1 |
HBV core 18-27 (HLA-A*02:01)
FLPSDFFPSV is a linear peptidic epitope studied as part of Capsid protein from Hepatitis B virus and... |
FLPSDFFPSV | 57,50 | HBVHLA-A*02:01Hepatitis Flow Cytometry |
EP07855_1 |
HIV-1 p17 Gag 77-85 (HLA-A*02:01)
SLYNTVATL is a linear peptidic epitope (epitope ID59613) studied as part of Gag polyprotein from Human... |
SLYNTVATL | 57,50 | HIVHLA-A*02:01AIDS (HIV) Flow Cytometry Immunohistochemistry |
EP07854_1 |
Influenza MP 58-66 (HLA-A*02:01)
GILGFVFTL is a HLA-A2-restricted epitope from influenza matrix M1 protein. |
GILGFVFTL | 57,50 | Influenza VirusHLA-A*02:01Infection, Influenza, Swine Flu, Respiratory infection T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07741_1 |
HPV 16 E7 49-57 (H-2 Db)
RAHYNIVTF is a linear peptidic epitope studied as part of Protein E7 from Alphapapillomavirus 9 and Other... |
RAHYNIVTF | 57,50 | HPV 16H-2 DbCancer;Malignant genital cancers Flow Cytometry |
EP07605_1 |
RHAMM 165-173 (HLA-A*02:01)
RHAMM peptide ILSLELMKL (HLA-A*02:01) for stimulation of human RHAMM -specific CD8+ T-cells. The peptide is... |
ILSLELMKL | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry |
EP07604_1 |
EBV BMLF-1 280-288 (HLA-A*02:01)
EBV peptide GLCTLVAML (HLA-A*0201) for stimulation of T-cells. Single peptide (GLCTLVAML) for stimulation... |
GLCTLVAML | 57,50 | EBVHLA-A*02:01Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinomaAutoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinomaAutoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP07104_1 |
PADRE
PADRE-Peptide (AKFVAAWTLKAAA) is a linear peptidic epitope used for immune reactivity, T cell assays, B... |
AKFVAAWTLKAAA | 92,00 | |
EP06999_1 |
IE-1 316-324 (HLA-A*02:01)
Antigen Peptide IE 316–324 - HLA-A*02:01 (ILEETSVML) for stimulation of antigen-specific T cells in T cell... |
ILEETSVML | 57,50 | HLA-A*02:01other name: T1D Diabetes human prepro islet amyloid polypeptide ppIAPP 5-13 |
EP06998_1 |
IE-1 99-107 (HLA-A*03:01)
Antigen Peptide IE 99–107 - HLA-A*03:01 (RIKEHMLKK) for stimulation of antigen-specific T cells in T cell... |
RIKEHMLKK | 57,50 | HLA-A*03:01 |
EP06817_1 |
HPV 16 E7 11-19 (HLA-A*02:01)
YMLDLQPET is a linear peptidic epitope (epitope ID75074) studied as part of Protein E7 from... |
YMLDLQPET | 57,50 | HPV 16HLA-A*02:01Cancer;Malignant genital cancersother name: Heparanase 16ï¾–24 (HLA-A*02:01) Flow Cytometry |
EP06244_1 |
HCMV UL40 15-23 (HLA-E)
VMAPRTLIL is a linear peptidic epitope (epitope ID69921) studied as part of HLA class I histocompatibility... |
VMAPRTLIL | 57,50 | HCMVHLA-E* Flow Cytometry |
EP06165_1 |
HCMV pp65 16-24 (HLA-A*11:01)
CMV pp65(16-24) peptide GPISGHVLK (HLA-A*11:01) for stimulation of human CMV pp65 (16-24)-specific CD8+... |
GPISGHVLK | 57,50 | HCMVHLA-A*11:01Control;Infectious mononucleosis;Opportunistic infections T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP06163_1 |
EBV EBNA-3A 325-333 (HLA-B*08:01)
Antigen Peptide EBV EBNA3A HLA-B*08:01 (FLRGRAYGL) for stimulation of human EBV EBNA-3A(325-333) -specific... |
FLRGRAYGL | 57,50 | EBVHLA-B*08:01Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP05820_1 |
HCMV IE-1 316-324 (HLA-A*02:01)
Antigen Peptide CMV IE1 HLA-A*02:01 (VLEETSVML) stimulation of human CMV IE-1(316-324)-specific CD8+... |
VLEETSVML | 57,50 | HCMVHLA-A*02:01Infection, Control, Cancer, TORCH, Infectious mononucleosis, CMV hepatitis, Retinitis, Colitis, Pneumonitis, Esophagitis, AIDS, Cancer chemotherapy, Transplantation T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP05819_5 |
HCMV pp50 245-253 (HLA-A*01:01)
VTEHDTLLY is a linear peptidic epitope (epitope ID71290) studied as part of DNA polymerase processivity... |
VTEHDTLLY | 57,50 | HCMVHLA-A*01:01Infection, Control, Cancer, TORCH, Infectious mononucleosis, CMV hepatitis, Retinitis, Colitis, Pneumonitis, Esophagitis, AIDS, Cancer chemotherapy, Transplantation T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP05818_1 |
HCMV pp65 417 – 426 (HLA-B*07:02)
Antigen Peptide CMV pp65 - HLA-B*07:02 (TPRVTGGGAM) for stimulation of antigen-specific T cells in T cell... |
TPRVTGGGAM | 115,00 | HCMVHLA-B*07:02Infection, Control, Cancer, TORCH, Infectious mononucleosis, CMV hepatitis, Retinitis, Colitis, Pneumonitis, Esophagitis, AIDS, Cancer chemotherapy, Transplantation T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP05817_1 |
EBV EBNA-3A 379-387 (HLA-B*07:02)
Antigen Peptide EBV EBNA3A HLA-B*07:02 (RPPIFIRRL) for stimulation of human EBV EBNA-3A (379-387) specific... |
RPPIFIRRL | 57,50 | EBVHLA-B*07:02Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP05807_1 |
EBV LMP2 131-139 (HLA-A*24:02)
Single peptide (PYLFWLAAI) for stimulation of human EBV LMP2(131-139)-specific CD8+ T-cells. The peptide is... |
PYLFWLAAI | 57,50 | EBVHLA-A*24:02Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP05805_1 |
Tyrosinase 369-377 mutant (HLA-A*02:01) 371D
Antigen Peptide Tyrosinase 369-377 (371D) (HLA-A*02:01) YMDGTMSQV for stimulation of antigen-specific T... |
YMDGTMSQV | 57,50 | HumanHLA-A*02:01Hereditary disease, Albinism T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP05802_1 |
PRAME 100-108 (HLA-A*02:01)
Single peptide (VLDGLDVLL) for stimulation of human Prame (100-108)-specific CD8+T cells. The peptide is... |
VLDGLDVLL | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry |
EP05796_1 |
p53 264-272 (HLA-A*0201)
Single peptide LLGRNSFEV for stimulation of p53 (264-272)-specific CD8+ T-cells. The peptide is synthesised... |
LLGRNSFEV | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry |
EP05754_1 |
Melan - A, MART 1 26-35 mutant (HLA-A*02:01) 27L
Antigen Peptide [Leu27] - Melan - A MART-1 26-35 (HLA-A*02:01) ELAGIGILTV for stimulation of... |
ELAGIGILTV | 57,50 | HumanHLA-A*02:01other name: Human Mena protein (overexpressed in breast cancer) Flow Cytometry |
EP04776_1 |
HCMVos
VMAPQSLLL is a linear peptidic epitope studied as part of HLA class I histocompatibility antigen, alpha... |
VMAPQSLLL | 57,50 | HumanHepatitis Flow Cytometry |
EP04510_1 |
EBNA-1 Protein (562-570)
The Epstein-Barr virus (EBV), also called Human herpes virus 4 (HHV-4), is a virus of the herpes family... |
FMVFLQTHI | 57,50 | Humanother name: CEF24, Cytomegalovirus 378-389 |
EP01994_5 |
OVA (257-264) (H-2Kb)
This is a class I (Kb)-restricted peptide epitope of OVA, an octameric peptide from ovalbumin presented by... |
SIINFEKL | 57,50 | H-2 Kb AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Flow Cytometry |
EP01778_5 |
OVA (257-264) (H-2Kb)
This is a class I (Kb)-restricted peptide epitope of OVA, an octameric peptide from ovalbumin presented by... |
SIINFEKL | 57,50 | H-2 KbAIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Flow Cytometry |
EP01706_5 |
OVA - T4 , SIITFEKL, pT4, OVA (257 - 264) Variant (H-2Kb)
T4 peptide (SIITFEKL) is a variant of the agonist ovalbumin (OVA) peptide (257-264), SIINFEKL. OVA Peptide... |
SIITFEKL | 57,50 | H-2 KbControl Flow Cytometry |
EP01705_5 |
OVA - Y3, SIYNFEKL (H-2Kb)
OVA Peptide is a class I (Kb)-restricted peptide epitope of ovalbumin presented by the class I MHC (major... |
SIYNFEKL | 57,50 | H-2 KbControl Flow Cytometry |
EP11460_1 |
VP1 252-260 (HLA-B*07:02)
# |
GPLCKADSL | 57,50 | (HBoV1) (Human bocavirus type 1)HLA-B*07:02AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
EP14040_1 |
MAGE-A1-3/A5 Mouse Kb/Db
LGITYDGM is a linear peptidic epitope studied as part of MageA2 protein from Mus musculus (mouse), tested... |
LGITYDGM | 57,50 | mouseCancer;Melanoma Flow Cytometry |
EP11400_1 |
PSCA 105-113 (HLA-A*02:01)
# |
AILALLPAL | 57,50 | HumanHLA-A*02:01Cancer Flow Cytometry Immunohistochemistry |
EP11232_1 |
HER-2/neu 435-443 (HLA-A*02:01)
# |
ILHNGAYSL | 57,50 | HumanHLA-A*02:01Cancer T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
EP09901_1 |
MBP (84 - 97)
# |
VVHFFKNIVTPRTP | 115,00 | Multiple Sclerosis |
EP10014_1 |
[beta]-Amyloid (1-11)
Anionic interaction of A�(1-11) with Factor XII is suspected to cause the massive activation of the C4... |
DAEFRHDSGYE | 80,50 | HumanAlzheimer's Disease Neuroscience |
EP11277_1 |
HIV-1 Nef 137-145 (HLA-A*02:01)
LTFGWCFKL is a linear peptidic epitope (epitope ID39896) studied as part of Protein Nef from Human... |
LTFGWCFKL | 57,50 | HIV-1HLA-A*02:01AIDS (HIV) Flow Cytometry |
LB01288 |
Tetanus Toxin Peptide Pool
Pool of 326 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Tetanus... |
345,00 | P04958 Clostridium tetani (strain Massachusetts / E88) |
Viewed